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Abstract 
Non-freezing cold injury (NFCI) is caused by protracted skin cooling above the 
freezing point of tissue and up to ~15 °C which predominantly afflicts the extremity 
skin sites owing to their enhanced vasoconstrictor response to cooling. This cold 
injury may cause long term symptoms, possibly debilitating an individual for their 
lifetime. Whilst pain and excessive sweating of the injured skin site are common 
features, some individuals may appear asymptomatic until they are exposed to 
cold where they may experience an augmented vasoconstrictor response and 
rewarm slower than those without NFCI, thereby exposing those individuals to 
further cold injuries. 
 
Compared with Caucasians (CAU), individuals of African descent (AFD) are more 
susceptible to NFCI. The reason for the increased susceptibility in AFD is not 
known but may be due to a lower skin blood flow (SkBF) and therefore skin 
temperature (Tsk) during cooling and subsequent rewarming. There are no data 
investigating extremity (i.e. hand and foot) cooling and subsequent rewarming 
responses between ethnic groups. Additionally, it is not known how individuals of 
Asian descent (ASN) compare with these two ethnicities. Therefore, a series of 
studies are reported in this thesis that studied the ethnic difference in the response 
to cold and provided data on the mechanisms responsible for the differences 
observed between ethnic groups. 
 
The approach of the experiments described in this thesis followed in vivo testing of 
young healthy male participants from different ethnic groups. Study One 
demonstrated that local hand cooling (30 minutes at 8 °C) caused more intense 
and protracted finger vasoconstriction in AFD than CAU. Additionally, AFD 
experienced an onset of finger vasoconstriction sooner than CAU during 
progressive cooling. ASN responses were between that of AFD and CAU. The Tsk 
responses to local foot cooling (two minutes at 15 °C) were not different between 
ethnic groups. As ASN did not demonstrate measureable differences compared 
with the other ethnic groups they were not examined in the subsequent studies. In 
Study Two the responses to transdermally delivered vasoactive agents were 
studied in the extremities. The vasodilator response to the endothelium-dependent 
vasodilator, acetylcholine (ACh), was smaller in AFD than CAU in the non-
glabrous finger and toe skin sites. These skin sites did not demonstrate any 
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differences between ethnicities in response to an endothelium-independent 
vasodilator, sodium nitroprusside, or the vasoconstrictor noradrenaline. These 
studies provided evidence in support of an altered endothelium function in AFD 
which may contribute to the exaggerated vasoconstrictor response and slower 
rewarming in this group.  
 
In Study Three the responses to ACh were studied in the presence of 
cyclooxygenase (COX) inhibition, as this enzyme may be stimulating reactive 
oxygen species (as well as prostanoids) causing endothelium-dependent 
contracting factors. The results indicate that the vasodilator responses to local 
application of ACh in the non-glabrous foot and finger skin sites were lower in AFD 
than CAU irrespective of whether COX was inhibited or not. This study suggests 
that the COX pathway is not the primary source of dysfunction causing the lower 
vasodilator responses in AFD compared with CAU. However, the contribution of 
the COX pathway during local foot and hand cooling and rewarming in CAU and 
AFD is not known, therefore, Study Four investigated the vascular responses with 
and without COX inhibition. Following placebo, SkBF and Tsk did not differ 
between ethnic groups at the toe pad skin site during foot cooling (30 minutes at 8 
°C). Following aspirin consumption the toe pad skin site was cooler in CAU than 
AFD but SkBF did not differ between groups. During hand cooling (30 minutes at 8 
°C) AFD experienced significantly lower finger SkBF and Tsk compared with CAU 
irrespective of whether COX was inhibited or not. 
 
The studies in this thesis collectively demonstrate: 1) AFD respond to local hand 
cooling with an earlier onset of vasoconstriction, greater skin cooling and slower 
rewarming, and 2) the microcirculation of the non-glabrous skin sites of the foot 
and finger in AFD appears to exhibit a reduced response to ACh. The increased 
prevalence of NFCI in AFD may be attributable to the greater and sustained 
vasoconstrictor response to local cooling in the hands. The mechanisms 
controlling this response in AFD are not clear, but do not appear to be directly 
attributable to the COX pathway. The local foot cooling responses, which were 
largely comparable between AFD and CAU, highlights that there are other 
differences between ethnic groups which lead to the increased prevalence of NFCI 
in AFD.   
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1 Introduction 
1.1 Statement of the Problem 
A lightly clad resting individual exposed to cold environmental temperatures 
experiences vasoconstriction of the cutaneous microcirculation (Elstad et al. 
2014). This vasoconstrictor response serves as a defence mechanism preventing 
heat loss from the body in an attempt to delay the onset of hypothermia (Kenney 
and Armstrong 1996). Prolonged exposure to cold, which results in a skin 
temperature (Tsk) between 0 °C and 15 °C, may result in a cold injury known as 
non-freezing cold injury (NFCI), with the feet being more susceptible than the 
hands (Ungley and Blackwood 1942). Symptoms often include pain, whilst mild 
cooling of the affected extremity is associated with an exaggerated vasoconstrictor 
response and slow rewarming which may leave an individual prone to further cold 
injuries. These symptoms of NFCI may last for the remaining lifetime of an 
individual (Ungley et al. 1945). 
 
In the military population, particularly during war, cold injuries have resulted in 
hundreds of thousands of casualties (Paton 2001; Golden et al. 2013). However, 
NFCI is not solely a military problem as cases have also been reported in civilians 
(Ramstead et al. 1980; Wrenn 1991). Individuals who expose themselves to cold 
during leisure activities, such as mountaineering or cold expeditions, are prone to 
NFCI (O’Brien and Frykman 2003). The participation in leisure activities such as 
mountaineering is increasing; Sport England reported approximately 250,000 
individuals participate each month (Anonymous 2014), therefore the risk of NFCI is 
also increasing. 
 
A major predisposing risk factor on the incidence of NFCI is ethnicity. Individuals 
of African descent (AFD) are more susceptible to cold injuries compared with 
Caucasian individuals (CAU) under the same environmental conditions (DeGroot 
et al. 2003; Burgess and Macfarlane 2009). Despite increased awareness and 
education NFCI remains a problem, as highlighted in the United States Armed 
Forces between July 2009 and June 2014 there were 3,008 individuals who 
suffered a cold injury, with AFD injured at twice the rate of CAU (Connor 2014). 
 
The reason for the increased susceptibility to NFCI in AFD is not known, but skin 
blood flow (SkBF) and Tsk responses during and following local cooling may differ 
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between CAU and AFD. There is evidence that upon local cooling, AFD compared 
with CAU experience colder finger Tsk (Iampietro et al. 1959), but this study did not 
measure SkBF or the rewarming response. Compared with CAU, Asian individuals 
(ASN) may experience significantly warmer extremity Tsk during local cooling 
compared with CAU (Hirai et al. 1970; Little et al. 1971). 
  
The rewarming response is of particular interest as a local cold injury may result 
from an inadequate blood flow not matching the local metabolic tissue requirement 
during or following cold exposure. One study has recently measured SkBF during 
local hand cooling and subsequent rewarming in two groups of individuals, one 
group born and raised in tropical climates and the other in a temperate climate 
(Lee et al. 2013). The study reported that those who were born and raised in 
tropical climates responded to local finger cooling with a greater vasoconstrictor 
response leading to lower finger Tsk
 when compared to the temperate group. 
However, responses to foot cooling were not assessed and the tropical group 
contained different ethnicities. 
 
The reason for the greater vasoconstrictor response upon cold exposure and 
delayed rewarming in AFD is not known. Previous studies using vasoactive agents 
have shown the endothelium-dependent vasodilator response in AFD is 
attenuated compared with CAU (Stein et al. 1997). However, these studies 
measured SkBF at the forearm; a site that is not readily prone to NFCI. To date no 
research has investigated the vascular responses of the extremities to cooling and 
subsequent rewarming between ethnic groups or the local SkBF responses to 
vasoactive agents in skin sites prone to NFCI. Such tests should give an insight in 
to why AFD are more prone to NFCI. 
 
Understanding why particular ethnicities are susceptible to NFCI may help with the 
prevention and treatment of those who venture into cold environments. Therefore, 
as NFCI is a local injury the aims of the experiments reported in this thesis were: 
1) to study the responses between ethnic groups to local cooling and subsequent 
rewarming, and 2) to understand the mechanisms underpinning any differences 
observed. 
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1.2 Summary of Individual Chapters 
Following this introduction, Chapter Two reviews the relevant literature on 1) NFCI, 
2) control of SkBF and 3) ethnic differences in response to thermal and 
pharmacological stimuli; aiming to give an insight into the published research and 
providing a rationale and context for the studies conducted. With the scene set, 
Chapter Three details the equipment and procedures used in the studies, and 
discusses their advantages and limitations. 
 
Chapters Four to Seven detail the four investigations conducted between ethnic 
groups within this thesis. Specific methodology is also included in each chapter to 
supplement the General Methods (Chapter Three). As NFCI is a local injury the 
first study was conducted to see if there were SkBF differences between three 
ethnic groups (CAU, AFD and ASN) in response to local cooling of the foot and 
hand. It was observed that AFD responded to local hand cooling with a greater 
vasoconstrictor response and slower rewarming compared with CAU, whilst the 
responses of ASN were intermediate. Therefore, the mechanisms controlling SkBF 
in CAU and AFD were examined using locally applied vasoactive agents to the 
hands and feet in Study Two. It was found that the response to the endothelium-
dependent vasodilator, acetylcholine (ACh), was reduced in AFD compared with 
CAU.  
 
The next two studies attempted to answer the questions: in comparison to CAU 
why do AFD have 1) an exaggerated vasoconstrictor response to local cooling 
coupled with slower rewarming, and 2) a reduced response to ACh?  
 
Nitric oxide production is known to be attenuated in AFD which is attributed to a 
heightened oxidative stress, which is in part due to the enzyme cyclooxygenase 
(COX) (Kalinowski et al. 2004). COX inhibition is successful in improving the 
vasodilator response to ACh in hypertensive individuals (Taddei et al. 1998). It is 
not known if COX contributes to the blunted SkBF responses to ACh and the 
exaggerated cooling-induced vasoconstriction in AFD. Therefore, the contribution 
of the COX pathway was studied subsequently during application of ACh and, 
separately, during local cooling and rewarming. 
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The general discussion follows in Chapter Eight where the results from all four 
studies are considered collectively. The assumptions, delimitations and limitations 
are discussed in Chapter Nine which is followed by recommendations for future 
work in Chapter Ten. 
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2 Review of Literature 
A thorough search of the literature relevant to NFCI, control of SkBF and 
responses to thermal and pharmacological stimuli between ethnicities was 
undertaken. Keywords were entered online to a number of search engines 
including Google Scholar and PubMed. Particular authors were searched for and 
their list of publications reviewed for relevance. The reference list from articles that 
were relevant were analysed to further extend the literature review. Once the 
individual articles had been reviewed for content and originality they were grouped 
into sections.  
 
The Review of Literature contains three sections: 1) NFCI, 2) control of SkBF and 
3) ethnic differences in response to thermal and pharmacological stimuli. Within 
these sections, sub-headings have been utilised to further organise the literature. 
The aim of this review of the literature is to give an insight into what is already 
known about the topic and thus subsequently revealing what areas of research 
need to be further addressed. 
2.1 Non-Freezing Cold Injury 
An individual exposed to a cold environment is prone to local and systemic (i.e. 
hypothermia) cold injury. Local cold injuries may be classified as freezing-cold 
injury or NFCI. The former, as the name suggests, results when the tissue 
crystallises at a temperature below -0.55 °C – the freezing point of tissue 
(Keatinge and Cannon 1960; Mills 2001). NFCI occurs when tissue temperature 
remains low, typically between 0 °C and 15 °C, for a prolonged period of time. 
NFCI has been known throughout history as “trench foot” or “immersion foot”, their 
names describing the method of attainment of NFCI, however, the injury sustained 
is considered the same (Greene 1941). The most susceptible body areas to NFCI 
are the extremities (Ungley et al. 1945). The most recently published study on cold 
injuries reported that in 54 cold injuries observed, 72 % were in the feet, 25 % in 
the hands with the remaining injuries sustained in other skin sites (Daanen and 
van der Struijs 2005). 
 
The following sub-sections will 1) discuss the clinical features of NFCI and the 
long-term symptoms an individual may suffer from, 2) the pathogenesis of NFCI 
and 3) how ethnicity impacts on the susceptibility of NFCI. 
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2.1.1 Clinical Description and Features 
There are limited data from humans regarding the pathogenesis of NFCI, therefore 
NFCI is known as a clinical syndrome. This syndrome has progressive stages 
which present a multitude of signs and symptoms which overlap from one stage to 
the next, as a consequence, each case may differ. Despite this, attempts have 
been made to describe the different stages an individual may experience with 
NFCI.  
 
Much of the literature to date concerning NFCI is, unfortunately, reviews 
(Montgomery 1954; Lewis 1955; Meryman 1957; Francis and Golden 1985; 
Francis and Oakley 1996; Thomas and Oakley 2001; Imray and Oakley 2006; 
Imray et al. 2009; Imray et al. 2011). The literature which reports case studies of 
those suffering NFCI is discussed below to give an insight into the nature of NFCI. 
 
Captain Dobson (1917) provided notes on his experience of NFCI following a 
winter campaign of the First World War. It was reported that individuals initially 
experience a “very white” appearance of the affected skin site lasting hours to 
days. Following this, the extremities were reported to become very painful, red and 
swollen, this lasted longer than the previous stage. Later, the extremity was 
reported as “tender for some time afterwards”. Twenty five years later, Ungley and 
colleagues (1942; 1945) along with others (Webster et al. 1942; Berson and 
Angelucci 1944; Goldstone and Corbett 1944; Leigh 1946) were able to observe 
the signs and symptoms of individuals during differing stages of NFCI. The authors 
(Ungley and Blackwood 1942; Ungley et al. 1945) broadly classified four stages 
which an individual may experience starting with cold exposure. 
 
Cold exposure lasting hours or days causes the injured skin site to become numb, 
and may display an initial reddening but later demonstrates a pale white colour 
indicative of an intense vasoconstriction. The second stage, known as the pre-
hyperaemic stage, may last hours to days and is characterised by the injured area 
being cold to the touch, swollen and numb. The third stage, known as the 
hyperaemic stage, is more marked and prolonged, lasting between weeks and 
months. Within this stage, there are vascular disturbances which are characterised 
by the site remaining hot and red even in a cool environment. Swelling often 
increases alongside sensory disturbances characterised by a loss of sensation to 
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pin prick and thermal stimuli. Additionally, pain is common and is described as a 
“throb” or as “shooting pains”. As well as an absence of sweating there may also 
be gait disturbances when walking owing to nerve damage and pain. The final 
stage, known as the post-hyperaemic stage, may last for the remaining lifetime of 
an individual. This stage is characterised by reduced Tsk and reduced swelling of 
the injured skin site (although swelling may occur during cooling). Moreover, the 
skin site may demonstrate an exaggerated response to cooling (Golden et al. 
2013). Pain may still occur and excessive sweating appears a common feature at 
the injured skin site. 
2.1.2 Pathogenesis and Pathophysiology 
The initial causative factor (i.e. aetiology) for NFCI stems from a cold stimulus 
which consequently decreases SkBF (Thomas and Oakley 2001). The heightened 
sympathetic outflow to the microcirculation associated with cooling is further 
augmented by factors such as pain and stress whilst other factors such as 
dehydration and increased oedema further reduce local blood flow to viable tissue 
(Figure 2.1). Sustained low SkBF during cooling alongside subsequent reperfusion 
starts a cascade of physiological changes (i.e. pathogenesis) at the vascular and 
neural level. These physiological changes cause damage to tissue which result in 
the pathophysiology of NFCI (Ungley et al. 1945; Thomas et al. 1994). 
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Figure 2.1 Schematic diagram illustrating the putative aetiological factors and 
mechanisms of the pathogenesis of non-freezing cold injury 
Reproduced from Francis and Oakley (1996). 
 
Data concerning the pathogenesis of NFCI in human are completely lacking. Due 
to the lack of human data the understanding of the pathogenesis and long lasting 
damage due to NFCI has relied on human case studies and animal models. Of the 
studies included in this section on cold injury, five of them are human case studies 
whilst 16 are animal studies. No consistent experimental approach has been 
utilised; protocols have used in vitro and in vivo approaches and a variety of 
animals including dog, rabbit, rat and hamster applying cooling for varying periods 
of time from one to 96 hours. It is known that NFCI causes microcirculatory 
changes in the vessels supplying nerves, causing nerve degeneration along with 
debilitative changes in other vessels. The following section will firstly discuss the 
damage induced by NFCI to nerves and then the microcirculatory changes in other 
tissues. 
 
Direct cooling to nerves has been used to investigate the damage associated with 
NFCI. Nukada et al. (1981) directly cooled the sciatic nerve in rats to 3 °C for two 
hours and reported that this level of cooling caused profound oedema within the 
24 hours following cooling. The authors noted that over the following days the 
large myelinated nerves suffered degeneration whilst small myelinated and 
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unmyelinated nerves were spared, more so the latter than the former. The same 
laboratory subsequently published similar findings with different cooling periods. 
Cooling for three hours resulted in a subsequent no-reflow phenomenon (i.e. no 
return of nerve blood flow following one hour of rewarming) (Jia and Pollock 1997) 
but cooling for one hour, whilst resulting in ischemia, was well tolerated in that 
nerve blood flow ~50 minutes post-cooling returned to near pre-cooling baseline 
(Jia and Pollock 1998). Cooling for a greater period of time (90 minutes to 150 
minutes) caused nerve degeneration as a result of a sustained low nerve blood 
flow even following cooling.  
 
More recently Li et al. (2015) reported that the vasculature was compromised 
following rat sciatic nerve cooling through a loss in the blood-nerve barrier function 
(i.e. endothelium tight junctions were compromised) resulting in oedema. Whilst 
unmyelinated nerves appear to be well preserved during cooling, if it is intermittent 
rather than continuous all nerves appear to suffer degeneration (Jia and Pollock 
1999). This latter finding can be attributed to the increased reperfusion causing 
subsequent damage (see final paragraph in this section). 
   
Other experiments using animal models have utilised a different approach and 
have immersed part of the animal in cold water. Large and Heinbecker (1944) 
immersed dogs’ forelimbs in 6 °C water for 96 hours and found that all nerves 
were observed (five days post-cooling) to be adversely affected as a result of cold 
injury. In contrast, cooling a rabbit hind limb for 16 hours to 1 °C to 2 °C caused 
extensive damage (observed seven days post-cooling) to large myelinated fibres 
whilst small myelinated and unmyelinated fibres were spared (Irwin 1996). Large 
myelinated fibre damage and sparing of other fibres has been also been reported 
following cooling of the rat tail (Shurtleff et al. 1993). The longer cooling period (96 
hours) utilised in the Large and Heinbecker (1944) study may explain why all 
nerves were adversely affected. Support for this comes from Blackwood and 
Russell (1943) who demonstrated that the magnitude of injury was linked to the 
length of cooling, where they studied rats in cages that contained cold (3 °C to 4 
°C) water for periods between 24 hours to 96 hours. Analysis of human tissue from 
those who have suffered NFCI suggest that large myelinated fibres degenerate 
whilst the small and unmyelinated fibres are not greatly altered (Friedman 1945). 
These results suggest that myelinated fibres are most susceptible to injury 
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following a cold insult, but other fibres are also susceptible with longer or 
intermittent cooling.  
 
With damage to nerves there would presumably be an altered sensory function. 
Irwin et al. (1997) reported that a man who had suffered NFCI to his feet 
demonstrated impaired mechano-sensory function in addition to loss of sensation 
to both cold and warm stimuli, suggesting damage to large and small fibres. These 
findings are in agreement with other case reports from humans (Ungley and 
Blackwood 1942; Ungley et al. 1945). Sensory function also appears to be 
affected in rat tails that have been cooled. Ahlers et al. (1990) demonstrated that 
cold water immersion (1 °C to 4 °C) for greater than six hours initially (i.e. one day 
later) caused a decreased sensitivity to hot water (50 °C) in the rat tail, measured 
as the amount of time taken for the rat to remove the tail from the hot water. This 
decreased sensitivity was then replaced over days to weeks with a heightened 
sensitivity compared with baseline (i.e. prior to NFCI). These studies provide in 
vivo evidence that nerve function is adversely affected, in agreement with 
histological studies, which may lead to behavioural thermoregulatory changes. 
 
Along with nerve damage there also appears to be substantial changes in the 
microcirculation. Specifically, repeated skin cooling in a hamster model caused 
endothelium damage in capillaries and venous vessels, whilst arterioles remained 
unaffected (Endrich et al. 1982; Endrich et al. 1990). This endothelium damage 
was more prominent in the smaller vessels where the endothelium layer 
developed “gaps” which allowed leukocytes to adhere to the wall of the 
endothelium with red blood cells completely filling the lumen. Thomas et al. (1994) 
cooled rat tails to 1 °C for various durations (one to nine hours) and measured the 
laser Doppler SkBF in the tail during recovery. The authors reported that chronic 
cooling for less than three hours did not induce any subsequent changes in tail 
SkBF. However, two days after chronic cooling for greater than three hours, lower 
resting SkBF which did not vasoconstrict upon subsequent acute local cooling was 
observed. Eight days following local cold injury, elevated resting SkBF compared 
with pre-cold injury values which, again, did not vasoconstrict upon acute local 
cooling was observed. Sixteen days after cold injury there was a return of blood 
flow to pre-cold injury values but upon acute local cooling there was a greater 
vasoconstrictor response relative to pre-NFCI values. This lower blood flow in 
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response to a cold challenge following cold injury may leave an individual prone to 
further injury. 
 
The reasons for the altered vascular changes associated with cold injury may be 
multi-factorial. Recently, Stephens et al. (2009) presented in vitro data showing 
that caudal artery cooling for one hour was sufficient to attenuate the vasodilator 
response to ACh, an endothelium-dependent vasodilator, however the responses 
to sodium nitroprusside (SNP), an endothelium-independent vasodilator, were 
preserved. This study demonstrates that the endothelium may be particularly 
susceptible to NFCI causing a decreased synthesis in vasodilators in response to 
ACh. Support for this hypothesis has recently been demonstrated. Individuals who 
had been previously diagnosed with NFCI (and experience moderate to severe 
cold sensitivity), demonstrated lower SkBF and Tsk compared with controls with no 
history of cold injury following local cooling (Davey et al. 2013), but faster 
rewarming responses following local foot cooling are observed when cold-sensitive 
individuals are given a sub-lingual nitric oxide donor glycerol trinitrate (Hope et al. 
2014). Preliminary evidence has also suggested individuals with NFCI 
demonstrate an increased sensitivity to circulating adrenaline (Learmonth et al. 
1943; Ungley et al. 1945) which may also render an individual susceptible to 
further cold injury. 
 
There remains, however, controversy whether the injury takes place during cooling 
or during the reperfusion period. During cooling for two or more hours vascular 
stasis occurs resulting in hypoxia (Montgomery et al. 1954; Endrich et al. 1982). 
This hypoxia during cooling may not be the main cause for NFCI as cold reduces 
the metabolic demand of tissue, analogous to cold organ preservation, but if 
sustained the beneficial effect of cold may become the perpetrator causing the 
injury (Guibert et al. 2011). Inducing ischemia in animal models without cold or 
reperfusion results in little oedema and no fibre degeneration in the rat sciatic 
nerve (Nukada and McMorran 1994; Iida et al. 2003). If reperfusion followed 
ischemia in these studies then nerve degeneration was noted. Perry and Wadhwa 
(1988) showed that the ischemic-reperfusion injury could be attenuated if the 
amount of returning blood was gradually reintroduced or if the reperfused blood 
had a low partial pressure of oxygen. The reduction in injury with both 
methodological approaches following ischemia was attributed to the attenuated 
production of reactive oxygen species (ROS) during reperfusion. ROS, also known 
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as oxidants, are produced as a result of reduction-oxygen reactions and include 
superoxide (O2
-) produced from enzymes such as nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase (Paravicini and Touyz 2008). Further, 
COX, an enzyme which produces prostanoids from arachidonic acid (AA) (Vane 
1971; Vane et al. 1998), has also been shown to promote ROS (Kukreja et al. 
1986), such as O2
-, where an increased production of ROS is associated with 
endothelium-dependent contractions in response to ACh in a murine model (Yang 
et al. 2002; Tang et al. 2007). With subsequent rewarming following cold injury, AA 
that has accumulated is metabolised by COX to produce prostanoids, including 
thromboxane A2 (TXA2) which, along with O2
-, may promote vasoconstriction of the 
microcirculation (Bhaumik et al. 1995). In support of ROS eliciting injury as a result 
of a cold insult, Das et al. (1991) was able to attenuate cold-induced tissue injury 
with quinacrine, an agent used to prevent cell membrane breakdown through 
inhibition of phospholipase.  
2.1.3 Ethnicity and Cold Injuries 
Epidemiological studies have indicated ethnicity is a factor that impacts on the 
incidence of NFCI. Within the British Army, under similar conditions of training, 
clothing and nutrition, AFD were injured 30.3 times more often with cold injuries 
compared with their CAU counterparts (Burgess and Macfarlane 2009). During the 
Korean War, in 167 individual cases of cold injury in the United States military 
personnel, 138 (82.6 %) were in AFD whilst only representing ~33 % of the 
personnel (Orr and Fainer 1952). Similarly, a 19 year retrospective study by 
DeGroot et al. (2003) reported that AFD were injured 3.7 times as often as CAU in 
the United States army which supported earlier data from 1959 to 1961 (Miller and 
Bjornson 1962) and 1990 to 1995 (Candler and Ivey 1997). During United States 
army field training in Alaska AFD accounted for approximately 50 % of cold injuries 
experienced whilst only representing 10 % of the troops in training (Meehan 1955). 
Supporting this, during peacetime US military training, 220 cases of cold injuries 
were recorded within a 52 month period with AFD accounting for 140 cases (63.6 
%) although only representing 28.1 % of the total US military (Taylor 1992). More 
recently, a report published on October 2014 from the United States Armed Forces 
reported that AFD suffered cold injuries at twice the rate of CAU over a five year 
period (Connor 2014). 
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The increased susceptibility of cold injuries in AFD is also noted in civilian 
populations (Conway and Husberg 1999). The data regarding ASN are largely 
lacking. The reason for the disproportional incidence of cold injuries in AFD 
compared with CAU may be differences in SkBF and Tsk during cold exposure and 
subsequent rewarming. The responses to thermal and pharmacological stimuli 
between ethnic groups are discussed in section 2.3. Although NFCI includes, as 
discussed, neural and vascular changes, the present thesis is focussed on the 
vascular function in the cutaneous circulation in a non-injured population. 
Therefore, the next section reviews the control of the cutaneous circulation in 
healthy individuals. 
2.2 Control of Skin Blood Flow 
The skin is a large organ which covers a body surface area (BSA) of 
approximately 1.9 m2 where the dermis, beneath the superficial avascular 
epidermis (i.e. >1 mm below skin surface), contains a vascular bed which performs 
a primary role in the regulation of body temperature through control of the level of 
perfusion (Rowell 1977; Braverman 2000; Kanitakis 2002). Whole-body SkBF in 
man at rest in a thermoneutral environment is ~350 mL·min-1 but can exceed 8 
L·min-1 at rest in combination with whole-body heating (Rowell et al. 1969; Rowell 
et al. 1970; Detry et al. 1972; Rowell 1974). Afferent information regarding both 
skin and deep body temperature is relayed to the anterior hypothalamic-preoptic 
area which promotes efferent mechanisms promoting heat loss or heat 
conservation during heating or cooling, respectively (Boulant 2000; Johnson et al. 
2014). 
 
The deep horizontal dermal vascular layer contain micro-vessels with external 
diameters of ~50 µm (Braverman and Keh-Yen 1981). An ascending arteriole 
connects to a more superficial horizontal vascular layer characterised by a smaller 
vessel diameter between 18 µm to 23 µm (Yen and Braverman 1976). From the 
superficial horizontal layer, capillaries rise to form vertical loops with a diameter of 
~10 µm (Braverman and Yen 1977). Whilst vessels such as arterioles contain 
smooth muscle cells, the capillary loops do not but do contain pericytes which are 
cells with contractile proteins (Joyce et al. 1985). In the skin the cutaneous nerve 
fibres are predominantly sensory although autonomic nerve fibres are abundant 
(Roosterman et al. 2006). Sensory nerve fibres are found in both the dermis and 
the more superficial epidermis which respond to a number of stimuli including 
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cooling (<30 °C) affecting mainly the C and Aδ fibres, and heating (32 °C to 48 °C) 
affecting mainly the C fibres (Boulais and Misery 2008). These nerve fibres are 
believed to contain sensor proteins, including the transient receptor potential 
channels. The autonomic nerve fibres are made up from both adrenergic and 
cholinergic fibres and unlike sensory fibres are only found in the dermis regions 
(Roosterman et al. 2006). The autonomic nerve fibres innervate blood vessels, 
arteriovenous anastomoses (AVAs) as well as sweat glands and release various 
vasoactive substances including ACh and noradrenaline (NA), neuropeptide Y 
(NPY) and vasoactive intestinal polypeptide (VIP) (Roosterman et al. 2006). 
2.2.1 Mechanisms Controlling Skin Blood Flow 
Furchgott and Zawadzki (1980) were the first to demonstrate that the presence of 
the endothelial cells are required to elicit relaxation in response to ACh. The 
authors postulated that the endothelial cells were responsible for the release of a 
diffusible relaxing factor and termed it “endothelium-derived relaxing factor” 
(EDRF). Earlier studies reported that nitric oxide and nitric oxide donors (e.g. SNP) 
were capable of increasing cyclic guanosine monophosphate (cGMP) and were 
causal in the relaxation of smooth muscle cells (Arnold et al. 1977; Katsuki et al. 
1977). EDRF was implicated in eliciting relaxation using the same mechanisms as 
nitric oxide (Rapoport et al. 1983; Rapoport and Murad 1983). Shortly after these 
studies, EDRF was confirmed as nitric oxide (Palmer et al. 1987) with L-arginine 
the precursor (Palmer et al. 1988). 
 
More recent studies have demonstrated that within the human skin 
microcirculation, ACh-induced vasodilatation is mediated through both nitric oxide 
and prostaglandin dependent pathways (Kellogg et al. 2005; Holowatz et al. 2005). 
Both mediators rely on endothelium intracellular calcium concentration ([Ca2+]) 
(Singer and Peach 1982; Félétou 2011; Majed and Khalil 2012). Both nitric oxide 
and prostaglandins diffuse to the smooth muscle cell where they increase cGMP 
and cyclic adenosine monophosphate (cAMP), respectively, to elicit vasodilatation 
(Figure 2.2) (Arnold et al. 1977; Katsuki et al. 1977; Moncada et al. 1991; Majed 
and Khalil 2012).  
 
It is clear from this that the vasodilator response to ACh is dependent on 
endothelial cells producing nitric oxide and prostaglandins whilst nitric oxide 
donors, such as SNP, elicit their responses independently of the endothelium. 
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Thus, an insight into the function of an individual’s endothelium and their 
responses to nitric oxide per se can be obtained by using vasoactive agents such 
as ACh and SNP, respectively. 
 
Smooth muscle cell vasoconstriction may be mediated by endothelin-1 (ET-1) 
(Yanagisawa et al. 1988), angiotensin II (ANG II) (Pueyo and Michel 1997; Mehta 
and Griendling 2007), NA (Ahlquist 1948), TXA2 (Hamberg et al. 1975) and, at 
high concentrations prostacyclin (PGI2 - usually eliciting vasodilatation) can also 
elicit vasoconstriction (Williams et al. 1994; Tang and Vanhoutte 2008). The 
primary mechanism of these modulators is the up-regulation and sensitisation to 
[Ca2+] promoting myosin light chain kinase leading to phosphorylation of the 
myosin light chain eliciting the cross-bridge cycle of actin and myosin and causing 
a shortening of the smooth muscle cell (Figure 2.2) (Webb 2003; Yan et al. 2003; 
Mehta and Griendling 2007). 
 
Figure 2.2 Schematic of the mechanisms mediating smooth muscle cell relaxation 
and constriction 
ACh stimulates muscarinic receptors on the endothelial cell membrane which stimulates an increase in phospholipase C 
(PLC) and the production of inositol 1,4,5-trisphosphate (IP3) which releases Ca
2+
 from the endoplasmic reticulum (ER). 
Intracellular Ca
2+
 binds to calmodulin (CaM) and activates nitric oxide synthase (NOS) which converts L-arginine to nitric 
oxide (NO). Ca
2+
 also stimulates phospholipase A2
 
(PLA2) which promotes the release of arachidonic acid (AA) from the cell 
membrane. This AA is subsequently converted to various prostanoids, including prostacyclin (PGI2) and thromboxane A2 
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(TXA2), by cyclooxygenase (COX). Other mediators (?) may be co-transmitted with ACh which may include Substance P, 
calcitonin gene-related peptide and vasoactive intestinal polypeptide. NO from the endothelial cell or NO donors (e.g. SNP) 
diffuse to the smooth muscle cell and activate guanylate cyclase (GC) to form cyclic guanosine monophosphate (cGMP) 
which activates protein kinase G (PKG) and promotes Ca
2+
 storage in the sarcoplasmic reticulum (SR) as well as Ca
2+
 
efflux. PGI2 activates adenylate cyclase (AC) to form adenosine monophosphate (cAMP) which activates protein kinase A 
and has similar effects on Ca
2+
 as PKG. This decrease in Ca
2+
 as well as increase in PKG increases myosin light chain 
(MLC) phosphatase activity which dephosphorylates MLC eliciting relaxation of smooth muscle cells. Noradrenaline (NA), 
neuropeptide Y (NPY), angiotensin II (ANG II), endothlin-1 (ET-1) and TXA2 increase PLC which stimulates IP3 promoting 
Ca
2+
 release from the SR which binds to CaM increasing the activity of MLC kinase causing phosphorylation of MLC 
resulting in smooth muscle constriction. ANG II may also generate diacylglycerol (DAG) from PLC causing an increase in 
protein kinase C (PKC) causing increased force production for given [Ca
2+
]. Superoxide (O2
-
) promotes rho kinase (ROCK) 
which is capable of translocation of adrenergic receptors (α2C) to the cell surface and inhibiting MLC phosphatase . α, 
adrenergic receptor; AT1R, ANG II receptor type 1; ETA/B, ET-1 receptor; IP, PGI2 receptor; M3, muscarinic receptor 
(subtype 3); TP, TXA2 receptor; Y1, NPY receptor. 
2.2.2 Hands and Feet as Regulators 
The hands and feet have an enhanced capacity to support thermoregulation 
during both cooling and warming, acting as insulators in the former and radiators 
in the latter (Taylor et al. 2014)..At rest in a thermoneutral environment hand and 
foot blood flow is approximately 6.7 mL·100 mL·min-1 and 2.8 mL·100 mL·min-1, 
respectively (Caldwell et al. 2014). When these values are considered in respect 
to their segmental surface areas it is clear how the hands and feet can influence 
thermoregulation. Specifically, when compared to absolute whole-body SkBF 
during thermoneutral environments (350 mL·min-1) in an individual with a BSA of 
1.9 m2, relative blood flow of 184 mL·m2·min-1 is expected (Rowell 1977; Taylor et 
al. 2014). This is lower than that of the relative blood flow in thermoneutral 
environments expected in the hand (602 mL·m2·min-1) and foot (293 mL·m2·min-1) 
(calculations based on absolute blood flow: hand - 26.5 mL·min-1 and foot - 20.8 
mL·min-1 (Caldwell et al. 2014); surface area: hand - 0.044 m2 and foot - 0.071 m2 
(Taylor et al. 2014)).  
 
During local cooling, hand and foot blood flow decreases to ~2.2 mL·100 mL·min-1 
and ~0.7 mL·100 mL·min-1, respectively (Kunkel and Stead 1938; Spealman 1945; 
Allwood and Burry 1954; Caldwell et al. 2014) demonstrating effective insulation 
by directing blood to deeper vasculature. During local heating hand and foot blood 
flow rises up to values of 33 mL·100 mL·min-1 and 17 mL·100 mL·min-1, 
respectively (Kunkel and Stead 1938; Kunkel and Stead 1939; Allwood and Burry 
1954; Roddie and Shepherd 1956; Caldwell et al. 2014). More impressive than this 
is the relatively larger blood flow delivered to the fingers where ~80 mL·100 
mL·min-1 is observed during local hand immersion in 35 °C water (Nagasaka et al. 
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1987). Measurement of finger blood flow during whole-body and local finger 
heating is even greater, resulting in values upwards of 120 mL·100 mL·min-1 with 
the distal phalanges of the fingers exhibiting greater blood flow than the middle 
phalanges (Wilkins et al. 1938). This large blood flow observed in these peripheral 
skin sites is due to the relaxation of AVAs (see below). 
 
The control of SkBF is complex and not completely understood. It was first 
suggested, based on a comparison between individuals with Raynaud’s and 
controls, that there may be an interplay between two active sympathetic pathways 
influencing SkBF: a vasoconstrictor (adrenergic) and vasodilator (cholinergic) 
system (Lewis and Pickering 1931). In control individuals, anaesthesia of the ulnar 
nerve resulted in an increase in hand Tsk in thermoneutral environments, whereas 
in individuals with Raynaud’s, ulnar nerve anaesthesia did not produce an 
increase in hand Tsk in thermoneutral environments and the fifth finger remained 
cold during whole-body heating. As ulnar nerve block would effectively abolish 
both the vasoconstrictor and vasodilator impulses to the fifth finger, the absence of 
a rise in finger Tsk during whole-body heating is attributed to the loss of vasodilator 
impulses (Lewis and Pickering 1931). However, subsequent studies demonstrated 
that the rise in hand blood flow during whole-body heating is mainly mediated 
through an inhibition in the vasoconstrictor system in those with (Gaskell 1956) or 
without (Gaskell 1956; Roddie et al. 1957) Raynaud’s phenomenon. 
 
The forearm cutaneous circulation appears to be controlled by both a vasodilator 
and vasoconstrictor system, as nerve block, applied prior to or during whole-body 
heating, attenuated the vasodilator response (Grant and Holling 1938; Edholm et 
al. 1957). Additionally, atropine (a cholinergic receptor antagonist), applied prior to 
whole-body heating, reduced the vasodilator response (Roddie et al. 1957). 
Further, pre-synaptic adrenergic blockade prevented the vasoconstrictor response 
to whole-body cooling but not the centrally-induced vasodilator response to whole-
body heating (Kellogg et al. 1989). Collectively, these studies demonstrate dual 
innervation to the forearm cutaneous circulation. 
 
A more recent study demonstrated that the mechanisms controlling the increase in 
SkBF during whole-body heating differs between the dorsum aspect of the finger 
(non-glabrous) and the palm (glabrous) (Johnson et al. 1995). Specifically, the rise 
in SkBF during whole-body heating in the palm could be accounted for by the 
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withdrawal of the vasoconstrictor system as demonstrated with bretylium tosylate 
(a pre-synaptic nerve blockade) (Figure 2.3). When the dorsum of the finger was 
subjected to the same experimentation SkBF rose during whole-body heating even 
with the presence of bretylium. These observations on non-glabrous skin sites 
were similar to previous observations made on the forearm (Kellogg et al. 1989). 
From this, the authors (Johnson et al. 1995) concluded that non-glabrous (hairy), 
but not glabrous (non-hairy), skin sites were innervated by both an active 
vasoconstrictor and vasodilator system. 
 
Figure 2.3 Skin blood flow responses from the palm in response to whole-body 
heating with and without adrenergic neural blockade (bretylium tosylate) 
Data shown includes baseline at thermoneutral conditions (Tsk at ~32 °C), 0 to 6 minutes of heating 
(Tsk at ~39 °C) and final three minutes of heating. The rise in palm SkBF during whole-body heating 
can be explained by a withdrawal of the vasoconstrictor system. Reproduced from Johnson et al. 
(1995). 
  
An important feature of the control of SkBF through glabrous skin sites is the 
existence of AVAs. These vessels are low resistance conduits which allow high 
flow rates directly from arterioles to venules and are located deeper than capillary 
loops (Grant 1930; Grant and Bland 1931; Clark 1938; Mescon et al. 1956). 
Glabrous skin sites, such as the finger pads, have up to 236 AVAs per cm2, 
whereas no AVAs are found in non-glabrous skin sites of the hand or foot, or the 
volar surface of the forearm (Grant and Bland 1931). Allowing these AVAs to open 
or close can substantially influence the level of perfusion to the skin and therefore 
regulate the temperature of the extremities (Lewis 1930; Grant and Bland 1931; 
Nagasaka et al. 1987). During thermoneutral environments and at the start of 
gradual cooling, skin sites that contain AVAs (e.g. finger pad) demonstrate large 
oscillations in skin blood flow representing an opening and closing of these 
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structures (Elstad et al. 2014). When cooling is progressive and decreases finger 
Tsk to around 26 °C the AVAs shut, and the once oscillating blood flow is abolished 
(Elstad et al. 2014), revealing a low stable capillary perfusion (Flavahan 2015). 
  
The perfusion of AVAs is substantially influenced by adrenergic stimulation during 
heating and cooling (Hales et al. 1982). It seems, however, that the majority of 
research studying the control of SkBF over the past 20 years has readily accepted 
that glabrous skin is solely innervated by a vasoconstrictor system, and has 
concentrated on non-glabrous skin sites, predominantly the forearm. There is 
evidence that an active vasodilator system exists in glabrous skin (Lundberg et al. 
1989), with AVAs dilating in response to locally applied ACh (Grant 1930) with 
subsequent research showing cholinesterase (an enzyme that catalyses ACh) in 
close proximity to human AVAs (Beckett et al. 1956; Hurley and Mescon 1956; 
Mescon et al. 1956). More recent investigations have begun to study glabrous skin 
sites such as the finger pads or palm and have applied local heating (Boignard et 
al. 2005; Salvat-Melis et al. 2006; Roustit et al. 2008; Roustit et al. 2010; Metzler-
Wilson et al. 2012) or cooling (Roustit et al. 2011; Yamazaki 2012) using small 
Peltier elements whilst others have attempted to study the control of SkBF using 
local delivery of vasoactive agents with varying degrees of success (Roustit et al. 
2009; Kingma et al. 2010). Given the paucity of research on glabrous skin sites the 
following sections review the control of SkBF in healthy young non-glabrous skin 
sites. 
2.2.3 Mechanisms of Cutaneous Vasoconstriction with Cooling 
SkBF may be modified by both central and local control mechanisms. Centrally-
evoked responses can be induced using water-perfused suits to apply a thermal 
stimulus to a large proportion of the body whilst the local Tsk is maintained at a 
thermoneutral temperature. Central responses may also be induced by applying a 
thermal stimulus to one side of the body and measuring the responses on the 
contralateral side (Marshall et al. 1990). A local thermal stimulus is usually studied 
by immersing a hand or a foot in water or by using small (~7 cm2) Peltier heaters / 
coolers and measuring the responses locally. 
 
In thermoneutral environments the resting vessel tone is tonically vasoconstricted 
(Roddie et al. 1957), with increased sympathetic outflow leading to augmented 
levels of vasoconstriction (Green and Kepchar 1959; Fox and Edholm 1963). 
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Pronounced vasoconstriction is the thermoregulatory response to cold stimuli 
which reduces heat transfer from the skin to the environment through control of 
central and local pathways, these can work co-operatively as well as 
independently to maximize vasoconstriction. 
Centrally-Induced Vasoconstriction 
Central vasoconstriction occurs during cold exposure which decreases Tsk below a 
thermoneutral point (~33 °C) (Figure 2.4). This cutaneous vasoconstrictor 
response reflects the intensity of the cold exposure in that a greater stimulus leads 
to greater vasoconstriction until a basement plateau in SkBF is reached (Holowatz 
et al. 2011). Nerve signals travelling to cutaneous sympathetic axon terminals 
stimulate the release of NA which act on α adrenergic receptors to elicit 
vasoconstriction (Ahlquist 1948; Bylund et al. 1994). 
 
Early investigations observed that pre-synaptic adrenergic nerve blockade 
abolished the cutaneous vasoconstrictor response to whole-body cooling (Kellogg 
et al. 1989). Later, specific post-synaptic antagonism of α receptors were 
successful in attenuating the central vasoconstriction (Stephens et al. 2001). The 
remaining vasoconstrictor response was found to be mediated by a co-
transmission of NPY, where a combination of post-synaptic antagonism to both 
adrenergic and non-adrenergic receptors (Y1 antagonism to prevent effects of 
NPY) was successful in abolishing the central response to whole-body cooling 
(Stephens et al. 2004). These data demonstrate that with sufficient cooling there is 
a release of NA with a co-transmission of NPY causing the net effect of 
vasoconstriction. 
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Figure 2.4 Representative trace of centrally-induced cutaneous vasoconstriction 
during whole-body cooling 
Local Vasoconstriction 
A local decrease in Tsk causes a temperature dependent, local vasoconstriction 
(Barcroft and Edholm 1943). Early studies observed that the application of local 
anaesthetic to the dorsum of the finger was successful in abolishing the 
vasoconstrictor response to 30 seconds of local cooling (Lindblad et al. 1990). 
Extending the cooling duration has enabled further mechanisms to be revealed. 
SkBF responses to sustained local cooling are transient in that with rapid cooling 
SkBF is 1) initially constricted, 2) replaced with transient vasodilatation 3) and then 
followed by a prolonged vasoconstriction (Figure 2.5). Mechanisms controlling this 
response include sensory and adrenergic nerve activation as well as inhibition of 
nitric oxide synthase (NOS). 
 
With rapid local cooling (4 °C·min-1) (but not slow local cooling [0.33 °C·min-1]), the 
initial cooling can elicit vasodilatation (Yamazaki et al. 2006). Pre-synaptic 
adrenergic nerve blockade, post-synaptic adrenergic receptor antagonism or 
sensory nerve block (EMLA [Eutectic Mixture of Local Anaesthetics] cream) all 
reverse the initial vasoconstriction to vasodilatation (Johnson et al. 2005; 
Yamazaki et al. 2006; Hodges et al. 2007). This reversal is observed during the 
initial minutes of local cooling but not during later (prolonged) stages, which 
eventually leads to vasoconstriction. The origin of this vasodilatation is unknown, 
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but as discussed above, the blockade of sensory and adrenergic nerves as well as 
post-synaptic adrenergic receptors are not the sources, as their inhibition 
exacerbates the response. With prolonged cooling (>10 minutes) intact adrenergic 
function, but not sensory nerve function, is required to fully express cooling-
induced vasoconstriction (Hodges et al. 2007). Furthermore, an inhibition of nitric 
oxide production contributes to the decrease in SkBF with local cooling (Hodges et 
al. 2006). This collection of studies provides evidence that there is interplay 
between sensory and autonomic nerve fibres and nitric oxide inhibition that 
contributes to the vasoconstrictor response to local cooling. 
 
As well as a release of NA during cooling there appears to be a concurrent 
increase in the number of available adrenergic receptors. It was first observed that 
cooling-induced cutaneous constriction was predominantly mediated by the α2 
receptor (Flavahan et al. 1985; Ekenvall et al. 1988). More recent investigations 
have provided insight into this mechanism and reported that an α adrenergic 
receptor subtype, α2C, becomes “active” during cooling (Chotani et al. 2000) which 
is redistributed from the Golgi apparatus to the cell surface (Jeyaraj et al. 2001). 
Further studies revealed that this process is facilitated by Rho kinase (ROCK) 
(Bailey et al. 2004) which is initiated by the generation of ROS from smooth 
muscle mitrochondria (Bailey et al. 2005). Human α2C receptors on the smooth 
muscle cells of dermal arterioles have been confirmed (Chotani et al. 2004). 
ROCK has also been shown to facilitate vasoconstriction during local cooling in 
the skin of the human forearm (Thompson-Torgerson et al. 2007). 
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Figure 2.5 Representative trace of cutaneous vasoconstriction during local cooling 
2.2.4 Mechanisms of Cutaneous Vasodilatation with Heating 
The human cardiovascular system responds to heating with an effective 
redistribution of blood flow from splanchnic and renal vascular beds to the 
vasculature located in the skin (Rowell et al. 1970; Rowell 1974). The increased 
SkBF response during heating is dependent on the absolute temperature 
experienced centrally and locally. The greater perfusion of skin during heating 
promotes heat dissipation through heat transfer from the skin to the environment. 
Similar to the control of vasoconstriction during cold exposure, vasodilatation 
during heat exposure can be controlled through central and local pathways. 
Centrally-Induced Vasodilatation 
In contrast to the vasoconstrictor system, the sympathetic vasodilator system in 
humans is not tonically active in normothermic environments and is only activated 
following withdrawal of tonic vasoconstriction (known as passive dilatation) during 
increases in body temperature (Figure 2.6) (Roddie et al. 1957; Hodges and 
Johnson 2009). Early studies observed that the large increases in forearm SkBF 
with whole-body heating were attenuated or even abolished with nerve blockade 
(Grant and Holling 1938; Edholm et al. 1957; Roddie et al. 1957). The exact 
mechanisms controlling the active vasodilator system remain to be elucidated; 
however some progress has been made. It is clear that functional nitric oxide is 
required for the full expression of central vasodilatation, where NOS inhibition 
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reduces the vasodilator responses to whole-body heating (Kellogg et al. 1998; 
Shastry et al. 1998; Shastry et al. 2000; Holowatz et al. 2003). Additionally, 
inhibition of prostanoids (with COX inhibition) further reduces the vasodilator 
response to whole-body heating (McCord et al. 2006). The production of nitric 
oxide and prostanoids can be stimulated by numerous neurotransmitters, including 
ACh (Kellogg et al. 2005; Holowatz et al. 2005). 
 
ACh exerts its vasodilatory effects by stimulating the muscarinic receptor (M3) on 
endothelial cells (Furchgott and Zawadzki 1980; Caulfield and Birdsall 1998). 
Kellogg et al. (1995) reported that pre-treatment with a muscarinic receptor 
antagonist reduced the vasodilator response to whole-body heating but pre-
treatment with a pre-synaptic cholinergic nerve blockade (botulinum toxin) 
effectively abolished the vasodilator response. However, when muscarinic 
receptor antagonism was administered at the peak of the vasodilator response to 
whole-body heating no change in SkBF was observed (Shastry et al. 2000). These 
studies demonstrate that ACh appears to play a greater role in the initial phase of 
vasodilatation. In support of this, acetylcholinesterase inhibition (with neostigmine), 
which inhibits the hydrolysis of ACh, augmented the initial rise in SkBF during 
whole-body heating but did not differ from control sites at the end of whole-body 
heating (Shibasaki et al. 2002). Furthermore, when acetylcholinesterase was 
inhibited in combination with NOS inhibition, the early elevation in SkBF was 
abolished providing evidence that ACh was working through nitric oxide. 
Collectively, these studies demonstrate that ACh release from cholinergic nerves 
modulate the initial but not the prolonged phase of vasodilatation in response to 
whole-body heating. From these studies it was suggested that there may be a co-
transmitter(s) released with ACh. 
 
It is known that local infusion of VIP in normothermic conditions induces a local 
vasodilatation that is dependent on both histamine and nitric oxide release (Wilkins 
et al. 2004). With whole-body heating, vasodilatation can be attenuated with 
histamine-1 receptor antagonism providing evidence that histamine is involved in 
the central vasodilator response (Wong et al. 2004). From this, it was suggested 
that VIP is co-released with ACh, where VIP may stimulate the release of 
histamine from mast cells in the skin which bind to receptors on the endothelial cell 
(Wong et al. 2004; Holowatz et al. 2011). However, a VIP receptor antagonist, 
VIP10-28, administered locally during whole-body heating has resulted in equivocal 
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results with investigations reporting a decrease (Bennett et al. 2003) and an 
increase (Wilkins et al. 2005) in active vasodilatation during whole-body heating. 
The reason for the contrast in these findings is difficult to determine. More 
recently, an antagonist to receptors of VIP and another closely related peptide 
(pituitary adenylate cyclase activating polypeptide [PACAP]) delivered prior to 
whole-body heating attenuated vasodilatation (Kellogg et al. 2010). This study 
demonstrates that VIP along with PACAP appear to be involved in the vasodilator 
response to whole-body heating, although it is clear more work is needed. 
 
An alternative co-transmitter that may modulate SkBF during whole-body heating 
is Substance P. Desensitisation of neurokinin-1 (NK1) receptors (with local delivery 
of Substance P) reduces the central vasodilatation during whole-body heating by 
~35 % (Wong and Minson 2006). While definitive conclusions cannot be drawn 
from this study it does provide support that Substance P may be involved in 
central vasodilatation. 
 
The data concerning sensory nerves remain inconclusive at present. When 
sensory nerves are blocked with EMLA cream prior to whole-body heating the 
onset of vasodilatation shifts rightwards (i.e. towards a warmer deep body 
temperature), suggesting sensory nerves are important in the initiation of centrally-
induced vasodilatation (Wong 2013). In contrast to this, when sensory nerves are 
desensitised with chronic application of topical capsaicin (which activate transient 
receptor potential vanilloid-1 [TRPV-1] channels) the vasodilator response to 
whole-body heating is not altered (Charkoudian et al. 2001). The reason for the 
contradiction between the two studies is not clear. It is possible that the work by 
Charkoudian et al. (2001) was not successful in desensitising all known TRPV-1 
channels, as more recent work has shown that microdialysis delivered TRPV-1 
channel inhibition led to a reduced vasodilator response during whole-body 
heating (Wong and Fieger 2012). Therefore the role of sensory nerves and TRPV-
1 channels may potentially be of importance in the centrally-induced vasodilator 
response, although clarification is needed. 
 
The data so far suggest that the active vasodilator response to whole-body heating 
is mediated primarily through the increase in both nitric oxide and prostaglandins. 
The neurotransmitters responsible for eliciting the increases in these mediators 
are not completely clear but may include ACh, various peptides and histamine. 
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Figure 2.6 Representative trace of centrally-induced cutaneous vasodilatation 
during whole-body heating 
Local Vasodilatation 
Local warming of skin leads to a local increase in SkBF which reaches maximal 
levels when local Tsk is held at ~42 °C for >25 minutes (Barcroft and Edholm 1943; 
Taylor et al. 1984). Local skin heating induces a biphasic increase in SkBF that is 
mediated by two mechanisms where there is 1) an initial rapid axon reflex phase 
followed by a brief nadir and 2) a secondary phase that develops more slowly 
rising to a plateau in SkBF (Figure 2.7). The research investigating the control of 
SkBF during local heating suggests that there is an involvement from sensory and 
autonomic nerves stimulating chemical mediators including both nitric oxide and 
endothelium-dependent hyperpolarisation factors (EDHFs). 
 
Cutaneous sensory nerve blockade with EMLA cream attenuates the initial phase, 
but not the prolonged phase of the vasodilator response to local heating (Minson 
et al. 2001). More recently, TRPV-1 receptors, located on sensory nerve endings, 
have been found to substantially contribute to the axon reflex to local heating but 
are only moderately involved in the secondary plateau phase (Wong and Fieger 
2010). Moreover, NOS and TRPV-1 receptor inhibition additively reduced the 
prolonged vasodilator response suggesting TRPV-1 receptor activation stimulates 
the release of nitric oxide but is not the sole source. The neurotransmitters 
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released from sensory nerves that play a role in the vasodilatation are not clear at 
present but Substance P and calcitonin gene-related peptide (CGRP) are possible 
candidates (Wong and Minson 2011; Xanthos and Sandkühler 2014). 
 
Autonomic adrenergic fibres have been implicated in vasodilatation in response to 
local heating. Houghton and colleagues (Houghton et al. 2006) reported that pre-
synaptic nerve blockade abolished the axon reflex and also attenuated the 
prolonged phase of the vasodilator response to local heating. These findings were 
extended when it was reported that antagonism of pre-synaptic adrenergic nerve 
blockade, post-synaptic adrenergic or Y1 (NPY) receptors reduced the size of the 
axon reflex and the overall vasodilatation (Hodges et al. 2008; Hodges et al. 
2009). These adrenergic neurotransmitters appear to act on the endothelial cells 
stimulating an increase in nitric oxide, as combination with NOS inhibition did not 
further decrease the vasodilator response (Hodges et al. 2008). 
 
The role of nitric oxide in the response to local heating is undisputed. Nitric oxide 
has been shown to be moderately involved in the initial axon reflex (Minson et al. 
2001; Hodges et al. 2008) but has a substantial role in the prolonged phase of 
local heating (Kellogg et al. 1999; Minson et al. 2001). The vasodilator responses 
to local heating are attenuated with endothelial NOS inhibition but not with 
neuronal NOS inhibition (Kellogg et al. 2008b; Kellogg et al. 2008a; Kellogg et al. 
2009).  
 
Even with nitric oxide inhibited a substantial vasodilator response to local heating 
remains. Fieger and Wong (2010) demonstrated that blockade of adenosine 
receptors and nitric oxide inhibition reduced the vasodilator response to local 
heating to a greater extent than NOS inhibition alone. This study showed that 
although adenosine receptor activation may elicit vasodilatation through nitric 
oxide dependent pathways, other pathways are also involved. An earlier study 
demonstrated that adenosine evokes an increase in the release of nitric oxide and 
PGI2 from the rat aorta, which was attenuated with COX inhibition (Ray et al. 
2002). In line with this, the increase in blood flow in response to intra-arterial 
infusion of adenosine in the human femoral artery is mediated by both nitric oxide 
and prostaglandins (Mortensen et al. 2009). It is therefore possible that part of the 
vasodilator response in the human microcirculation of the skin is mediated by 
adenosine receptor activation which mediates its response through increases in 
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both nitric oxide and prostaglandins. However, inhibition of COX prior to local 
heating showed that the vasodilator responses were not different from control sites 
(Golay et al. 2004; Gooding et al. 2006; McCord et al. 2006) suggesting that 
prostaglandins do not play a major role during local heating. 
 
The remaining vasodilator response during rapid heating (0.1 °C·s-1) appears to be 
mediated by EDHFs (Brunt and Minson 2012; Choi et al. 2014). These EDHFs are 
a class of factors that cause vasodilatation through hyperpolarisation of cells 
(lowering of the cell membrane potential) which decreases Ca2+ influx promoting 
relaxation of vascular smooth muscle (Félétou and Vanhoutte 2009). Brunt and 
Minson (2012) also reported that the EDHF mediating approximately half of the 
EDHF-dependent vasodilatation were epoxyeicosatrienoic acids producing 
vasodilatation predominantly through calcium-activated potassium channels. 
When EDHFs were inhibited in combination with nitric oxide inhibition the local 
vasodilator response was almost completely abolished. Taken together, the data 
available so far demonstrate the majority of the vasodilator response to local 
heating is mediated through an increase in nitric oxide and hyperpolarisation of 
endothelial and smooth muscle cells (Figure 2.7). 
 
Figure 2.7 Representative trace of cutaneous vasodilatation during local heating 
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2.3 Ethnic Differences in Response to Thermal and Pharmacological 
Stimuli 
The reason for the increased NFCI susceptibility in AFD compared with CAU is not 
currently known. It is speculated that there may be local vascular differences 
between ethnic groups in response to local cooling. In an attempt to understand 
why AFD have an increased susceptibility to NFCI the following sections will firstly 
discuss the ethnic differences in the vascular responses to thermal stimuli and 
secondly to pharmacological stimuli (vasoactive agents). 
2.3.1 Thermal Stimuli 
The SkBF response to cooling, whether central or local, demonstrates a powerful 
vasoconstrictor response in an attempt to defend deep body temperature. Ethnic 
differences in the vasoconstrictor and vasodilator response to cooling and 
subsequent rewarming may provide an explanation for the increased susceptibility 
of AFD to NFCI. There are a number of laboratory based experiments that have 
investigated ethnic differences in response to local cooling. These investigations 
generally include two distinct durations of cooling: 1) two to three minutes and 2) 
>30 minutes. Tests utilising a shorter duration are commonly known as cold 
pressor tests which involve immersion of foot / hand in ice water or an ice pack 
placed on the forehead. Investigations that have utilised this test to study ethnic 
differences have generally reported that in comparison with CAU, AFD have a 
relatively greater increase in blood pressure and forearm vascular resistance in 
response to two to three minutes of forehead cooling (Anderson et al. 1988; 
Treiber et al. 1990; Sherwood et al. 1995), foot cooling (Stein et al. 2000) or hand 
cooling (Calhoun et al. 1993). Whilst the cold pressor tests are able to 
demonstrate greater central sympathetic sensitivity in AFD no information on the 
local SkBF or Tsk responses between ethnic groups were obtained in these 
studies. 
 
When extremity cooling is extended and sufficiently cold (<15 °C) there is firstly an 
initial vasoconstriction, followed by a paradoxical vasodilatation which is replaced 
with a new phase of vasoconstriction. Lewis (1930) first described this cyclical Tsk 
pattern during cooling as a “hunting response” whilst recent investigations use the 
term “cold-induced vasodilatation” (CIVD) where Tsk responses during the 
vasodilatory period are analysed in various ways (see Figure 3.7 in General 
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Methods). Before discussing the ethnic differences in CIVD, this section will firstly 
discuss the possible mechanisms and the different factors affecting the CIVD 
reaction.  
 
The first study to observe the CIVD response in humans reported that the 
occurrence of CIVD originated from AVAs (Lewis 1930). Support for this was 
provided by Grant and Bland (1931) who reported that whilst capillary blood flow 
demonstrated dilatation during cooling, the response was not strong enough to 
elicit any Tsk changes. It has been further demonstrated that anatomical locations 
that are abundant in AVAs elicit the CIVD response more readily (Fox and Wyatt 
1962) and CIVD is more pronounced in locations where increased numbers of 
AVAs are found (e.g. finger tips vs. first volar phalanx) (Grant and Bland 1931). 
Whilst no AVAs were found in the non-glabrous skin sites of the finger, the CIVD 
response is sometimes able to present itself in these skin sites; the rise in fingertip 
temperature was thought to have subsequently spread proximally (Grant and 
Bland 1931). The understanding of the control of SkBF in glabrous skin lags far 
behind that of non-glabrous skin. Therefore, the mechanisms controlling the CIVD 
responses that have been put forward require further testing. 
 
From the work of Lewis (1930) it was first suggested that the CIVD reaction arises 
from an axon reflex from sensory stimulation as those with nerve degeneration did 
not demonstrate any CIVD during cooling. However, more recent observations 
have provided evidence against this hypothesis, as electrical stimulation used to 
evoke an axon reflex in the finger during hand cooling did not increase SkBF 
(Daanen and Ducharme 2000).  
 
The more likely hypothesis for CIVD is that adrenergic stimulation and hence 
vasoconstriction is possibly decreased / interrupted during cooling leading to CIVD 
(Johnson et al. 1986; Daanen 2003). Rusch and colleagues (1981) demonstrated 
in a canine model that the vascular contractions to high concentrations of 
exogenous NA were attenuated during cooling. The study further demonstrated 
that the contractions to electrical stimulation were attenuated or even abolished 
with cooling to 10 °C and 5 °C, respectively. Collectively, these results provide 
evidence that cooling to ~10 °C interrupts adrenergic neurotransmission. This is 
supported by the findings that infusion of NA into a rat tail did not demonstrate 
CIVD during cooling (Gardner and Webb 1986) and the CIVD response being 
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greatly reduced in the human finger when pre-treated with local delivery of NA 
using iontophoresis (Keatinge 1961). Furthermore, the role of adrenergic inhibition 
in CIVD appears analogous to the transient vasodilatation observed with local 
cooling of the forearm (see Figure 2.5), however the forearm does not repeatedly 
demonstrate CIVD. Taken together, the likely mechanism controlling the CIVD 
response may not be an axon reflex in origin but instead may be due to an 
inhibition of adrenergic function (reducing NA release) causing a withdrawal of 
constriction thus increasing Tsk. 
  
Despite the underlying CIVD mechanism remaining unclear, it appears that the 
increased prevalence of such a response has important occupational and clinical 
relevance. As Tsk is raised during the CIVD response it has been presumed to 
provide protection of the extremities to cold injuries (Lewis 1941; Yoshimura and 
Iida 1950). Evidence for this was shown when local cold injuries were avoided 
during cold ambient environments when CIVD was present (Wilson and Goldman 
1970). More recently, Dutch soldiers who demonstrated a depressed CIVD 
response prior to winter training in Norway had an increased prevalence of cold 
injuries during the training compared with those who demonstrated a greater CIVD 
response (Daanen and van der Struijs 2005). A similar observation was made in 
the Swedish army, where a slower rewarming response following local hand 
cooling was associated with an increased prevalence of cold injuries during 
subsequent training (Brändström et al. 2008). Therefore, it appears that the CIVD 
response during cooling provides protection to local cold injuries. 
 
There are many factors that may impact on the occurrence of CIVD. As shown in 
Table 2.1 these factors may broadly be considered experimental manipulations or 
individual factors. The conclusion from this table is that careful control of these 
factors should be considered during experimentation.  
 
When considering groups who are chronically exposed to cold environments, such 
as Inuits or Arctic Indians (Native Americans), the Tsk experienced during cold 
exposure is greater than non-acclimatised CAU (Brown and Page 1952; Brown et 
al. 1953; Brown et al. 1954b; Brown et al. 1954a; Meehan 1955a; Elsner et al. 
1960). In contrast to the data that show Tsk cannot be positively affected by local 
cold acclimation (see Table 2.1), other studies have observed those who have an 
occupation where they are consistently exposed to cold environments (both locally 
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and whole-body) (e.g. fishing) demonstrate an enhanced CIVD reactivity 
compared with controls from the same population (Krog et al. 1960; LeBlanc et al. 
1960; Nelms and Soper 1962). Additional observations have reported that CAU 
who are acclimatised to cold environments experience similar Tsk to those of Inuits 
during cold exposure (Miller and Irving 1962). Support for an acclimatisation 
response has been shown recently when a group of Swedish army recruits 
reacted with a faster rate of finger Tsk rewarming following local cooling after 15 
months training in a cold environment when compared with pre-training 
(Brändström et al. 2008). Furthermore, individuals residing in colder locations 
experience greater CIVD reactivity than those from warmer locations within the 
same country (Yoshimura and Iida 1951; Mathew et al. 1979). Collectively, these 
observations demonstrate those who are chronically exposed to cold 
environments (acclimatisation) experience warmer Tsk during cold exposures.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
 
Table 2.1 Summary of factors that may impact on the cold-induced vasodilatation 
reactivity 
Variable CIVD Reactivity Reference 
Experimental Factors 
Deep Body Temperature  reactivity with warmer 
deep body temperature 
Daanen et al. 1997; 
Dobnikar et al. 2009 
Time of Day Morning < afternoon Yoshimura and Iida 1950 
Summer vs. Winter Winter < summer Yoshimura and Iida 1950 
Cooling Medium  reactivity with lower water 
temperature 
Lewis 1930; Hirai et al. 
1970; Mekjavic et al. 2013 
Surface Area Cooled  reactivity with smaller 
surface area cooled 
Sendowski et al. 1997; 
Sendowski et al. 2000 
Individual Factors 
Cold Acclimation 
(Repeated extremity 
immersions over days) 
No change (fingers and 
toes) 
O’Brien 2005; Geurts et al. 
2006; Reynolds et al. 2007 
 reactivity (fingers) Geurts et al. 2005; Mekjavic 
et al. 2008; Daanen et al. 
2012 
 reactivity (toes) Daanen et al. 2012 
Hypoxia 
No change in CIVD, but 
slower rewarming with acute 
hypoxia 
Keramidas et al. 2014c 
No change in CIVD, but 
slower rewarming with 10-
day exposure to hypoxia 
when tested at normoxia 
Keramidas et al. 2014b 
Age 
Young (25 years) > old (67 
years) 
Sawada 1996 
7-14 & 25-29 > 15-24 & 30-
79 (years) 
Yoshimura and Iida 1951 
Gender No difference Yoshimura and Iida 1951; 
Tyler et al. 2015 
Physical Fitness 
Training  reactivity Keramidas et al. 2010 
35-day bed rest  reactivity Keramidas et al. 2014a 
 
In line with the increased susceptibility of AFD to NFCI there also appears to be 
differences between ethnic groups who are equally acclimatised when exposed to 
cold stimuli. Generally, AFD have a depressed CIVD response compared with 
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CAU(Table 2.2). When ASN participants are compared with CAU it appears that 
ASN may experience warmer extremity Tsk during local cooling compared with 
CAU (Hirai et al. 1970; Little et al. 1971). 
 
There does, however, appear to be several caveats for the ASN data. In the study 
by Little et al. (1971), the ASN group who were not accustomed to cold 
experienced warmer finger Tsk during hand cooling compared with CAU, whereas 
another ASN group who were accustomed to cold did not differ from CAU. 
However, the amplitude of the CIVD waves tended to be greater in CAU compared 
with both ASN groups. In the other study, Hirai et al. (1970) tested ASN who had 
resided in America for a minimum of two to 18 months which poses questions 
regarding climate variation between ethnicities. The authors also tested two other 
ASN groups who resided in Japan and reported that these two groups had lower 
CIVD reactivity than the ASN group living in America. The authors speculated that 
diet and climate differences were responsible for the CIVD reactivity differences 
between ASN living in Japan versus America; the authors did not suggest the 
same argument for the differences between CAU and ASN. Taken together, the 
data comparing CAU and ASN appear to be limited by the experimental design, in 
that seasonal variation may have biased the CIVD responses. 
 
The experimental set-ups investigating the CIVD responses between ethnic 
groups are inconsistent (Table 2.2). Additionally, the experiments have not 
measured local SkBF. Whilst Tsk is often cited as a good indicator of the 
underlying SkBF the relationship is non-linear. Barcroft and Edholm (1943) 
demonstrated the non-linearity by recording forearm SkBF using venous-occlusion 
plethysmography over a range of temperatures and reported that SkBF is 
relatively unchanged when Tsk is between 20 °C and 30 °C. This non-linear 
relationship has been recently demonstrated in the finger pad during cooling using 
laser Doppler (Elstad et al. 2014). The authors demonstrated that finger pad SkBF 
was well maintained during cooling when Tsk fell from 35 °C to 30 °C, but fell 
dramatically at approximately 26 °C. In addition to the previous studies not 
measuring SkBF, most did not report any rewarming responses following local 
cooling. The rewarming period is of particular interest as a local cold injury may 
result from an inadequate blood flow not matching the local metabolic tissue 
requirement during / following cold exposure (Ungley and Blackwood 1942; 
Webster et al. 1942; Blackwood 1946; Jia and Pollock 1997; Guibert et al. 2011). 
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One study has recently measured local SkBF during 4 °C immersion of the middle 
finger in differing populations (Lee et al. 2013). The study reported that those who 
were from warmer climates, such as Nigeria and Vietnam, demonstrated a 
depressed CIVD reactivity compared with those who were born and raised in more 
temperate climates in China or Japan. However, similarly to the Hirai study (Hirai 
et al. 1970), some participants (absolute number not reported) from warmer 
climates had only been living in Japan for five months prior to testing which, again, 
provides uncertainty regarding seasonal differences. The authors recognised this 
limitation and reported no relationship between the period of residency in Japan 
and CIVD reactivity. Whilst this study provides an insight into the differences 
between individuals from differing climates, the participants were not split by 
ethnicity. Splitting participants by ethnic group would provide more insight into the 
possible reasons why AFD are more susceptible to NFCI compared with CAU. 
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Table 2.2 Summary of investigations using the cold-induced vasodilatation test between ethnicities 
   CIVD Variables 
Reference Group Experimental Set-up Average Skin 
Temperature (°C) 
Minimum Skin 
Temperature (°C) 
Onset Time of 
CIVD (minute) 
Number of CIVD 
Waves 
Hirai et al. 1970 
CAU Left index and middle fingers of 
left hand and (whole) right hand in 
5 °C water for 30 min (Tsk from 
right middle) 
8.3 * - 9.1 * - 
ASN 10.5 - 6.5 - 
Iampietro et al. 1959 
CAU All fingers in 0 °C water for 45 
min 
7.2 * 1.8 * 9.2 * - 
AFD 2.7 0.3 15.9 - 
Jackson et al. 1989 
CAU Whole hand in 5 °C water for 20 
min 
7.6 * 6.5 * 8.2 * - 
AFD 6.8 5.7 11.2 - 
Little et al. 1971 
CAU Whole hand exposed to 0 °C air 
for 60 min 
19.4 * - 8.3 2.8 
ASN^ 24.6 - 4.0 4.1 
Meehan 1955b $ 
CAU All fingers in 0 °C water for 30 
min 
~5.0 - - - 
AFD ~2.2 - - - 
Newman 1969 
CAU Whole hand in 5 °C water for 30 
min 
9.3 * 7.7 * 8.4 * - 
AFD 7.6 6.7 12.9 - 
* Significant difference between-groups (P < 0.05), $ no statistical results were reported, ^ ASN group not chronically exposed to cold.
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2.3.2 Pharmacological Stimuli 
Previous investigations have reported that the responses to endothelium-
dependent vasodilators (e.g. ACh) are attenuated in healthy normotensive AFD 
compared with CAU (Table 2.3). Further, vasodilatation in response to 
isoproterenol (β receptor agonist) in AFD appears to be attenuated compared with 
CAU. Isoproterenol may also elicit a release of nitric oxide from endothelial cells, 
meaning isoproterenol is able to induce vasodilatation through an increase in both 
cGMP and cAMP. Cardillo and colleagues (1999) infused a NOS inhibitor prior to 
infusion of isoproterenol, with the results demonstrating an attenuated vasodilator 
response in AFD compared with CAU even in the presence of a NOS inhibitor. 
This study demonstrates that both the cGMP and cAMP pathway are operating 
inefficiently in AFD compared with CAU. The responses to glyceryl trinitrate and 
SNP, both endothelium-independent vasodilators, are mixed but out of the six 
studies, four demonstrated an attenuated response in AFD compared with CAU 
(Table 2.3). It is not clear why the results are mixed but the studies that observed 
a lower vasodilator response had larger sample sizes. The response to 
vasoconstrictors has not been as extensively studied, but the responses appear 
mixed (Table 2.3).  
 
The reason for the attenuated vasodilatation in AFD is not clear. Nitric oxide is 
able to react rapidly with O2
- to produce the oxidant peroxynitrite (ONOO-), thus 
reducing nitric oxide bioavailability (Brown and Feairheller 2013). O2
- is produced 
from various sources including COX, which, along with reducing nitric oxide 
bioavailability (Gryglewski et al. 1986), produces endothelium-dependent 
vasoconstrictor factors (Yang et al. 2002; Tang et al. 2007; Tang and Vanhoutte 
2009; Vanhoutte 2011). Previous research has shown AFD compared with CAU 
exhibit a heightened oxidative stress and a reduced bioavailability of nitric oxide 
(Kalinowski et al. 2004; Feairheller et al. 2011). This oxidative stress in AFD is 
reduced with inhibition of NADPH oxidase or COX, which leads to an increased 
bioavailability of nitric oxide (Kalinowski et al. 2004). In line with this, nebivolol, a 
β2 antagonist with antioxidant properties, decreased isolated endothelial cell 
concentrations of O2
- and ONOO- and restored nitric oxide bioavailability in AFD to 
similar levels as CAU (Mason et al. 2005). Collectively, these results demonstrate 
that the increased oxidative stress experienced by AFD leads to reduced nitric 
oxide availability. 
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The data comparing ASN and CAU responses to pharmacological stimuli are 
relatively less developed. Murphy et al. (2007) demonstrated that ASN had a lower 
forearm SkBF increase in response to both intra-arterial infusion of ACh and SNP. 
In contrast, Chambers et al. (1999) reported no differences in brachial artery 
diameter between CAU and ASN in response to sublingual delivery of glyceryl 
trinitrate. The differences between these studies in response to the endothelium-
independent vasodilatation may be explained by the different vascular beds under 
investigation (i.e. resistant vs. conduit, respectively) as well as differing vasoactive 
agents and route of administration. Shantsila et al. (2011) utilised iontophoresis to 
deliver ACh and SNP transdermally to the forearm in CAU and ASN with systolic 
heart failure. The authors reported that despite both groups exhibiting heart failure, 
ASN had a diminished response compared with CAU to ACh but not SNP. These 
data indicate that ASN have an attenuated endothelium-dependent vasodilator 
response compared with CAU. 
 
The investigations that tested healthy individuals all utilised either invasive or 
systemic techniques (i.e. sublingual spray) to deliver vasoactive agents and 
measured blood flow at the forearm or brachial artery. The data linking local hand 
or foot responses to thermal stimuli and pharmacological stimuli are therefore 
limited. To date only one study has locally delivered ACh and SNP to CAU and 
AFD using iontophoresis (Pienaar et al. 2014). The results from that study showed 
AFD had a lower vasodilator response in the forearm to both ACh and SNP 
compared with CAU. However, it remains unknown whether there are any ethnic 
differences in response to vasoactive agents in skin sites prone to NFCI. 
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Table 2.3 Vascular responses to various vasoactive agents between Caucasian and African descent individuals  
Vasoactive Agent Mechanism of Action Reference Delivery Route Method of SkBF 
Measurement 
Results 
Vasodilators      
Endothelium-dependent      
Acetylcholine / Methacholine 
M3 receptor agonist, PGI2 and NO which 
diffuses to SMC 
Stein et al. 1997; Jones 
et al. 1999; Cardillo et 
al. 1999 
Brachial artery 
infusion 
Forearm VOP  vasodilatation in 
AFD 
Endothelium-independent      
Glyceryl trinitrate 
Metabolised by ALDH2 to NO 
Campia et al. 2002 Sublingual spray  Brachial artery 
ultrasound 
 vasodilatation in 
AFD 
Perregaux et al. 2000 Sublingual spray Brachial artery 
ultrasound 
No difference 
Isoproterenol 
Non-selective SMC β receptor agonist,  
cAMP,  PKA,  [Ca2+], inhibition of MLCK 
Lang et al. 1995; Stein 
et al. 1997; Cardillo et 
al. 1999; Stein et al. 
2000 
Brachial artery 
infusion 
Forearm VOP  vasodilatation in 
AFD 
Sodium nitroprusside 
Interacts with oxyhaemoglobin to release NO 
Stein et al. 1997; 
Cardillo et al. 1998; 
Cardillo et al. 1999 
Brachial artery 
infusion 
Forearm VOP  vasodilatation in 
AFD 
Jones et al. 1999 Brachial artery 
infusion 
Forearm VOP No difference 
Vasoconstrictors      
Angiotensin II SMC AT1R agonist,  [Ca
+
], activation of 
MLCK, phosphorylation of MLC 
Jones et al. 1999 Brachial artery 
infusion 
Forearm VOP No difference 
Phenylephrine  SMC α1 agonist,  [Ca
+
], activation of MLCK, 
phosphorylation of MLC 
Stein et al. 2000 Brachial artery 
infusion 
Forearm VOP  vasoconstriction 
in AFD 
ALDH2, aldehyde dehydrogenase; AT1R, angiotensin II type 1 receptor; Ca
2+
, calcium; cAMP, cyclic adenosine monophosphate; M3, muscarinic receptor subtype 3; MLC, 
myosin light chain; MLCK, myosin light chain kinase; NO, nitric oxide; PGI2, prostacyclin; PKA, protein kinase A; SMC, smooth muscle cell; VOP, venous-occlusion 
plethysmography. Shaded boxes highlight studies where no differences between CAU and AFD were observed.
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In summary, those who experience low Tsk for a protracted period of time are 
susceptible to NFCI. AFD experience lower Tsk during local cooling compared with 
CAU; this may increase the susceptibility to NFCI in AFD. ASN may or may not 
experience different cooling profiles compared with CAU. There are currently no 
data reporting local SkBF responses between ethnic groups. The pharmacological 
investigations point to a possible dysfunctional endothelium in the forearm 
microcirculation in AFD, perhaps as a result of an increased oxidative stress. 
However, there are no data investigating the differences between ethnic groups in 
response to local delivery of vasoactive agents in the extremities. 
 
The aim of the experiments presented in this thesis was to investigate why AFD 
are more susceptible to NFCI by 1) studying the responses between ethnic groups 
in response to local hand and foot cooling and 2) to elucidate the mechanisms 
controlling any differences. The studies firstly investigated the differences between 
ethnic groups in response to local cooling of the extremities (Study One). Next, the 
responses to locally delivered vasoactive agents to skin sites susceptible to NFCI 
were conducted to investigate the possible mechanisms underpinning the 
differences in SkBF responses to cold (Study Two). The final two studies in this 
thesis examined the responses to vasoactive agents (Study Three) and local 
cooling (Study Four) whilst a pathway that may affect SkBF is blocked, thus 
assessing its contribution. 
2.4 Thesis Hypotheses 
It was hypothesised that: 
 
H01: During local extremity cooling and rewarming AFD will not differ in their 
SkBF and Tsk responses compared with CAU or ASN.  
HA1: During local extremity cooling and rewarming AFD will have a significantly 
lower SkBF and Tsk compared with CAU, with ASN individuals responding 
similarly to CAU. 
 
H02: Those who experience a greater vasoconstrictor response to local cooling 
and slower rewarming will not differ in their responses to endothelium-
dependent or -independent vasodilator agents, nor will they differ in their 
responses to a vasoconstrictor agent. 
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HA2: Those who experience a greater vasoconstrictor response to cooling and 
slower rewarming will exhibit lower endothelium-dependent and -
independent vasodilatation, as well as an exaggerated response to a 
vasoconstrictor. 
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3 General Methods 
This section describes the general methods used throughout the experimental 
studies reported in this thesis. Specific details for each study are included in the 
appropriate chapters. 
3.1 Ethical Considerations 
All experiments within this thesis complied, at all times, with The Declaration of 
Helsinki, as adopted at the 18th World Medical Association General Assembly, 
Helsinki, Finland, 1964 and last amended at the 59th World Medical Association 
General Assembly, Brazil 2013. Each study received a favourable ethical opinion 
from the BioSciences Research Ethics Committee (BSREC) and its successor, the 
Science Faculty Research Ethics Committee (SFEC) in accordance with University 
of Portsmouth regulations. 
3.2 Participants 
After being informed of the purpose, procedures and known risks associated with 
participation in the study written, informed consent was obtained from each 
participant who volunteered. Participation in an experiment was conditional upon 
completion of the Departmental Sport and Exercise Science exercise and health 
history questionnaire. This questionnaire was reviewed for anything which might 
have influenced the results or increased the risk for participants. Independent 
medical officer advice was sought if needed. 
 
Participants were asked to self-identify their ethnic group. To minimise 
heterogeneity participants were only recruited if both parents and all four 
grandparents had known to originate from the same ethnic group. Healthy male 
CAU, ASN and AFD participants between 18 and 30 years of age participated in 
the experimental studies. Country of birth and time residing in the UK is described 
within each study. The upper age limit was adhered to as older individuals have 
shown to have altered vasodilator (Holowatz et al. 2003; Holowatz et al. 2005) and 
vasoconstrictor capacity (Kenney and Armstrong 1996; Degroot and Kenney 
2007). Additionally, as the female menstrual cycle is known to effect SkBF 
(Hashimoto et al. 1995; Charkoudian et al. 1999; Clifton et al. 2005) females were 
not recruited for the experimental studies.  
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Similar exclusion criteria were used throughout the series of experimental studies. 
To minimise the impact of various factors on SkBF, participants were not permitted 
to volunteer for experimentation if they were regularly exposed to cold 
environments or had any cold injuries (Golden et al. 2003; Davey et al. 2013), 
diabetes mellitus (Khan et al. 2000), peripheral vascular diseases (e.g. Raynaud's) 
(Cooke and Marshall 2005) or hypertension (Farkas et al. 2004). Additionally, 
participants were excluded if they were taking any medications or if they had any 
history of asthma. Individuals were only permitted to volunteer if they were non-
smokers as nicotine is known to alter SkBF (Waeber et al. 1984).  
 
Participants were asked to abstain from consuming alcohol for 24 hours and 
participating in exercise or consuming caffeine for 12 hours; this is due to alcohol 
consumption (Gillespie 1967; Rosito et al. 1999; Rang et al. 2012), caffeine 
(Daniels et al. 1998; Kim et al. 2013) and exercise (Kim et al. 2013) altering SkBF 
responses.  
3.3 Anthropometry 
Height was measured using a stadiometer (Leicester, Bodycare, UK) and 
participants' mass using digital weighing scales (Ohaus I-10, Ohaus Corporation, 
USA). BSA was estimated using the equation by Du Bois and Du Bois (1916). 
Length of participants' hand, foot and forearm were measured using a 
segmometer (Segmometer 4, Rosscraft, Canada) and forearm girth measured at 
the widest point using a steel flexible tape (Anthropometric Tape, Rosscraft, 
Canada). Hand and forearm volume was calculated using a water displacement 
method where participants immersed their hand and forearm into a cylinder until 
the medial epicondyle was in line with a marked point inside the cylinder; water 
was then filled to the marked point. Participants then removed their hand and 
forearm and the cylinder was weighed. This mass was subtracted from the known 
weight of the cylinder when filled to the marked point which gave the participants' 
hand and forearm volume. This same principle was employed for hand and foot 
volumes. 
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3.4 Experimental Conditions and Measures 
3.4.1 Environmental Conditions 
The environmental temperature chosen for each study was monitored utilising a 
wet (Twb), (dry) bulb (Tdb), globe thermometer ([WBGT], Grant Instruments, UK) 
and recorded on an Eltek 1000 series data logger (Grant Instruments, UK) every 
minute. Refrigerated immersive coolers (C1G, Grant Instruments, UK) were used 
in combination with a water bath incorporating a mechanical circulator with heating 
capacity (GR150, Grant Instruments, UK) to control water temperature. An 
unstirred water bath with heating capacity (SUB 14, Grant Instruments, UK) was 
also used in Study One and Study Four. The temperature of each water bath was 
measured using at least one thermistor and recorded using a Squirrel 1200 series 
data logger (Grant Instruments, UK). 
3.4.2 Laser Doppler Flowmetry 
Principle 
Laser Doppler flowmetry (LDF) estimates blood flow from skin sites including 
arterioles, capillaries and post-capillary venules of the upper dermal plexus 
(Krogstad et al. 1995; Bergersen et al. 1999; Braverman 2000; Choi and Bennett 
2003). It is thought that the circulation through AVAs is also measured as these 
structures are approximately 1 mm below the skin surface (Mescon et al. 1956). 
This technique is similar to photoplethysmography, however this method was not 
considered for use as 1) there is no known calibration, meaning comparison 
between individuals is difficult, 2) it does not measure speed of blood cells and 3) 
it is dependent on blood absorbing light, thus the technique is influenced by 
variations in tissue oxygenation (Swain and Grant 1989; Wright et al. 2006).  
 
The LDF technique takes advantage of the physical principle governing waves 
called the Doppler effect named after the Austrian physicist, Christian Doppler 
[1803 - 1853], who first suggested light waves behaved in a similar fashion to 
sound waves (Leahy et al. 1999; Choi and Bennett 2003). The Doppler effect is 
defined when a wave source (e.g. sound or light) and observer (e.g. photo-
detector) are in relative motion to each other, the frequency of the wave changes 
in relation to the speed of the relative motion. Choi and Bennett (2003) gave the 
analogy of a train and an observer, where as the “train moves toward an observer, 
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its whistle pitch (frequency) increases”. This shift in frequency can be used to 
calculate speed (e.g. of blood cells) from a reference frequency (e.g. laser) (Choi 
and Bennett 2003). 
 
Laser light is monochromatic (of one wavelength) and coherent (in sync) meaning 
that it is emitted in an unscattered beam at a single frequency. When this laser 
strikes an object, such as a blood cell, the light is scattered and some of it 
reflected back to the source (i.e. laser Doppler probe). There are two components 
reflected back to the source; one consists of light of the same frequency as the 
originally transmitted light, the second component is the scattered light that is 
reflected off a moving object that is of a different frequency. The amount of shift in 
frequency is dependent upon the speed of the moving object. The mixing of these 
two dissimilar frequencies of reflected light produces a phenomenon called optical 
beating. These beat frequencies are then interpreted by the laser Doppler machine 
and analysed to yield “flux” (a product of average speed and concentration of 
blood cells) given as an arbitrary value between zero and 1000, relating to 
minimum and maximum scale, respectively (Choi and Bennett 2003).  
 
The LDF utilises a probe that shines a laser light (semi-conductor laser diode) at a 
wavelength of 785 nm (moorVMS-LDF2, Moor Instruments, UK). These probes 
are available as twin or multi-fibre designs. Twin fibre probes include a single 
emitting fibre and single receiving fibre. Multi-fibre probes contain a ring of eight 
collecting fibres around a central delivery fibre providing an averaged signal for a 
larger tissue volume in comparison to the twin fibre probe (~3.14 mm3 vs. ~0.20 
mm3, respectively). The depth of tissue measured is reportedly between 1 mm to 
1.5 mm (Johnson et al. 1984; Braverman 2000; Choi and Bennett 2003; Brothers 
et al. 2010; Roustit and Cracowski 2012) whilst others have reported less than 1 
mm using a computational model (Fredriksson et al. 2009). Depth of sampled skin 
is not dependent on blood oxygen saturation or skin pigmentation (e.g. black or 
white skin) (Hardy et al. 1956; Fredriksson et al. 2009; Roustit and Cracowski 
2012), whilst blood concentration and wavelength of laser light is known to effect 
depth of sampled tissue (Krogstad et al. 1995; Fredriksson et al. 2009). 
Equipment 
LDF (moorVMS-LDF2) was used in the experiments in this thesis to measure 
SkBF. Multi-channel fibre-optic probes (VP1T / 7, Moor Instruments, UK) were 
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utilised in all studies and sampled at 40 Hz. This probe can also measure Tsk, 
though it is only suitable for stable conditions as there is a large lag in temperature 
change compared with thermistors. The data from the laser Doppler were 
recorded using a data acquisition system and software (Powerlab and LabChart 7, 
AD Instruments, New Zealand). 
Calibration 
LDF is not calibrated against an actual measurement of skin perfusion, therefore 
calibration was carried out against a solution of polystyrene microspheres. The 
LDF system is set to automatically read the Brownian motion of these 
microspheres as approximately 20 % to 22 % of the maximum scale (i.e. 200 – 
220 laser Doppler units [LDU]). This calibration procedure allows comparisons 
between studies utilising arbitrary LDU. The method of LDF has shown good 
correlation with other methods such as venous-occlusion plethysmography 
(Johnson et al. 1984) and xenon clearance (Holloway and Watkins 1977). 
Normalisation 
The assumption that a different LDU is indicative of different SkBF can be 
misleading. The complex underlying microvascular anatomy can greatly influence 
LDU recordings; previous investigations have reported large SkBF differences 
across the forearm skin site (Johnson et al. 1984), with large differences noted 
within 1 mm to 6 mm (Tenland et al. 1983; Braverman et al. 1990; Braverman and 
Schechner 1991) demonstrating extensive spatial variability. This spatial variability 
may due to the ascending arterioles spaced 1.5 mm to 1.7 mm apart, thus the 
laser Doppler probe may potentially “miss” high flow regions causing variability 
between skin sites (Braverman et al. 1990). Furthermore, in a resting individual, 
SkBF measured using LDF at the same skin site varies greatly over minutes to 
days (Tenland et al. 1983; Braverman and Schechner 1991).  
 
These limitations can be overcome using a number of approaches. LDU can be 
normalised to baseline (or maximum - with local heating to ~43 °C for ~25 min) 
with subsequent data expressed as a percentage change, in an attempt to reduce 
the confounding effects of differences in probe placement. Both the spatial and 
temporal variability can be reduced by sampling from a larger volume of tissue 
(Cracowski et al. 2006). Multi-channel fibre-optic probes as well as normalisation 
were used in the experimental studies to reduce the spatial and temporal 
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variability. Baseline (starting) SkBF was also averaged over a period of time (e.g. 
20 seconds) to further attenuate the temporal variability. The point at which the 
SkBF data were normalised and time period averaged differed between each 
study but principally was at a point where SkBF appeared stable. Specific details 
of normalisation are detailed in each study. 
3.4.3 Skin Temperature 
A range of techniques are available to measure Tsk. The present thesis used two 
techniques within the experimental studies, thermistors and infrared thermography 
(IRT). 
Thermistor 
Contact skin thermistors are easy to mount using breathable adhesive tape 
(Transpore Tape, 3MTM, USA) and are useful in combination with methods such as 
LDF. Most thermistor based systems have a negative temperature coefficient; that 
is, their resistivity decreases with increasing temperature (Wright et al. 2006). A 
signal of 35 mV per °C is typical, which is nearly 1000 times greater than a 
thermocouple-based system making thermistors more sensitive in comparison. 
Thermistors are known for long-term stability (Togawa 1985), producing an error of 
only 0.05 °C (Bull 2008) and are more suited to temperatures experienced by 
humans in comparison to thermocouple-based systems. The experiments in this 
thesis, where applicable, utilised a type U thermistor. 
Thermistor Calibration 
All thermistors used in experimental studies were checked for accuracy prior to 
experimental use at eight reference temperatures (5 °C, 10 °C, 15 °C, 20 °C, 25 
°C, 30 °C, 35 °C and 40 °C). The thermistors were held at these temperatures in a 
precision water bath (Grant Instruments, UK) and compared to a UKAS calibrated 
precision digital thermometer (T600, Digitron Ltd, UK). Only skin thermistors that 
deviated less than, or equal to, 0.2 °C from the precision thermometer at each of 
the reference temperatures were used for the experimental studies. Where 
appropriate (i.e. repeat tests) the same thermistors were used for the same skin 
site between visits. 
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Infrared Thermography 
The term thermography is commonly used for the method of forming a two-
dimensional image of an object’s surface temperature (Togawa 1985; Ring and 
Ammer 2012). IRT is a non-contact technique which transforms the energy 
radiated from objects in the infrared band into an electronic video signal which can 
be displayed in colour on a computer and stored (Meola and Carlomagno 2004; 
Hildebrandt et al. 2010). The amount of thermal radiation emitted by an object is 
dependent on the emissivity of the object, defined as the ratio of the actual amount 
of infrared energy emitted compared to the theoretically perfect amount that could 
be emitted from a perfect radiator (known as a black body) (Swain and Grant 
1989; Jones 1998; Bernard et al. 2013). Human skin has an emissivity of 0.98, 
independent of skin colour (Steketee 1973; Togawa 1989; Jones 1998; Juzeniene 
et al. 2009; Ring and Ammer 2012). Therefore the temperature displayed by an 
infrared camera pointed at skin should be directly related to the temperature.  
  
IRT has previously been utilised in various disciplines such as local cold exposure 
(Brändström et al. 2008; Costello et al. 2012; Hope et al. 2014), identification of 
sporting injuries (Hildebrandt et al. 2010), testing individuals with NFCI (Ahle et al. 
1990; Eglin et al. 2013), profiling reactive hyperaemia (Stikbakke and Mercer 
2008), extremity nerve damage (Ruijs et al. 2008), individuals with Raynaud's 
phenomenon (Ring and Ammer 2012) as well as during medical operations 
(Mercer et al. 2010). Despite the wide range of investigations utilising IRT it 
appears that the validity (vs. thermistors) and reliability are compromised when 
used during dynamic conditions such as exercise (due to sweat accumulation on 
the skin) (James et al. 2014; Bach et al. 2015). Therefore, it is recommended that 
IRT is only used when static, not wet and at a consistent distance from the 
camera. Both intra- and inter-observer measurements of Tsk utilising IRT within a 
short time frame (i.e. seconds to minutes) are reliable (Packham et al. 2012). Day-
to-day recordings, however, demonstrate reduced reliability which is more 
prominent in extremity skin sites (Zaproudina et al. 2008; Hildebrandt et al. 2010). 
 
An infrared camera (A320G, FLIR systems, UK) was utilised in Study One. Points 
of interest (i.e. Great toe pad) were located and measured during subsequent 
offline analysis in the software (ThermaCAM™ Researcher).  
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3.4.4 Iontophoresis 
Transdermal iontophoresis is a technique for controlled delivery of vasoactive 
agents locally into the skin which enables the study of microcirculation function. 
Iontophoresis has been utilised to study the control of the microcirculation of 
young healthy (Noon et al. 1998; Srinivasa and Marshall 2011) and older healthy 
individuals (Tao et al. 2004), as well as the microcirculation of those with clinical 
conditions such as Raynaud’s phenomenon (Easter and Marshall 2005), 
hypertension (Farkas et al. 2004) and diabetes (Arora et al. 1998). 
Mechanism 
Iontophoresis allows transdermal drug delivery based on the transfer of charged 
molecules using a low intensity electric current (Figure 3.1) (Roustit et al. 2014). 
The vasoactive agent is placed in a circular ring in contact with the skin and 
connected to either an anode or cathode with the remaining electrode placed on 
the skin which closes the electric circuit. A laser Doppler probe is placed in the 
centre of the circular ring to allow measurement of the microcirculation (Figure 
3.2).  
 
Figure 3.1 Schematic of the iontophoresis process eliciting vasodilatation 
Adapted from Mahe et al. (2012).  
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Figure 3.2 Picture of the iontophoresis set-up on the forearm skin site 
 
During application of iontophoresis an electric field is applied across the skin with 
charged molecules entering the skin and away from the electrodes as a result of 
electrorepulsive forces (Pikal 2001; Tesselaar and Sjöberg 2011; Roustit et al. 
2014). That is, a vasoactive agent that is positively charged (e.g. ACh, bradykinin) 
is placed under the positive electrode (anode) and one that is negatively charged 
(e.g. SNP) is placed under the negative electrode (cathode). In addition to the 
electrorepulsive mechanism, when an electric current is applied to the skin there is 
flow of fluid from anode to cathode as the skin is negatively charged (i.e. counter-
ions try to neutralise skin charge) (Kalia et al. 2004). This second mechanism is 
known as electroosmosis and is the means by which neutral molecules may be 
used with iontophoresis (Green 1996). How the active agent passes into the skin 
and to the receptor level is not completely understood to date; it appears that the 
predominant route seems to be through hair follicles and sweat ducts, whilst the 
intercellular spaces of the stratum corneum may also provide another route 
(Tesselaar and Sjöberg 2011). 
 
An important limitation of iontophoresis is the unknown dose delivered which can 
only be estimated. By applying an electric current (mA) over a period of time 
(seconds) a known charge is delivered and is expressed as millicoulombs (mC) 
[time × current]) (Tesselaar and Sjöberg 2011). This known charge can be utilised 
to calculate the mass of vasoactive agent delivered with the use of the Faraday 
constant (F [96485] = elementary charge × Avogadro constant). The following 
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calculation assumes that all of the applied current is due to the passage of drug 
ions. 
 
                             
                              
     
 
 
That is, if iontophoresis of ACh is applied for 20 seconds at 25 μA then the 
equation would follow: 
 
          
                        
     
 
 
Approximately 2000 μg of ACh is placed within an iontophoresis Perspex ring (1 g 
ACh in 100 mL [10,000 μg per mL], 0.2 mL placed in ring); therefore ~0.05 % of 
the Perspex ring content is delivered locally using the above calculation. In 
practice, however, not all of the applied current will carry drug ions and will include 
other ions from the drug solution or counter-ions (e.g. Na+, K+, CI-) that travel from 
the skin to the electrode (Tesselaar and Sjöberg 2011), thus limiting the above 
calculation. Furthermore, various other factors may influence the microcirculatory 
response to iontophoresis of vasoactive agents; these are described below. 
Factors Influencing Iontophoresis 
Vasoactive Agent Concentration and Current Strength 
Greater vasoactive agent concentrations are associated with increased blood flow 
(Droog et al. 2004; Kotzki et al. 2013) although a plateau appears to exist (Droog 
et al. 2004). Additionally, the current strength applied with iontophoresis has a 
linear relationship with blood flow, in that greater applied current leads to greater 
blood flow responses (Hui et al. 2001; Droog et al. 2004; Christen et al. 2004). 
However, a large increase in current strength may cause irritation and damage to 
skin (Dixit et al. 2007).  
Current Application: Intermittent versus Continuous  
The applied current profile can be either continuous or intermittent; a continuously 
applied current is utilised to elicit a maximum response whereas an intermittent 
protocol is supposed to elicit a representation of a dose-response curve. A 
continuously applied current may cause polarisation of the skin which may reduce 
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the efficiency of drug delivery (Dixit et al. 2007). This may be overcome by using 
an intermittent current whereby during the "off" period (interval) the skin becomes 
depolarised and returns to its initial non-polarised state. However, maximum SkBF 
responses to ACh administration with intermittently applied current does not differ 
from continuously applied current (Christen et al. 2004).  
Diluents and Non-Specific Vasodilatation 
The solution used to dilute the vasoactive agent, such as water or sodium chloride 
(saline), known as the “vehicle”, has been shown to elicit a non-specific 
vasodilatation when used alone, described as an axon reflex (Grossmann et al. 
1995; Durand et al. 2002a; Durand et al. 2002c; Durand et al. 2003; Tartas et al. 
2005; Sauvet et al. 2011). Whilst the exact mechanisms controlling this non-
specific vasodilatation remain unclear, progress has been made. Inhibition of COX 
(with aspirin) (Durand et al. 2002b; Durand et al. 2002c), local anaesthesia (Morris 
and Shore 1996; Durand et al. 2002b) or desensitization sensory nerves (with 
chronic capsaicin application) (Durand et al. 2002b) each reduce the non-specific 
vasodilatation. Furthermore, the use of clopidogrel (a platelet adenosine 
diphosphate [ADP] receptor inhibitor) does not alter the non-specific vasodilator 
response which suggests that if platelets are involved in the response, then it is 
through the COX pathway and not the ADP pathway (Rousseau et al. 2008). From 
this, it appears that there is a release of prostaglandins from nerve endings 
following excitation leading to vasodilatation. This non-specific vasodilatation may 
be attenuated by manipulation of the vehicle and current / charge used during 
iontophoresis. 
 
Ferrell et al. (2002) demonstrated that iontophoresis of distilled water alone 
induced a greater non-specific vasodilatation than 0.5 % saline solutions (sodium 
chloride) but no SkBF differences between ACh and SNP were observed when 
diluted in either water or sodium chloride. Khan et al. (2004) observed a greater 
electrical skin resistance during iontophoresis of deionised water compared with 
sodium chloride (at both anode and cathode). However, when ACh and SNP were 
diluted in deionised water or sodium chloride resistance did not differ, whilst SkBF 
was lower when diluted with sodium chloride than deionised water. The lower 
SkBF associated with sodium chloride may be due to the ionic competition 
between sodium chloride and the vasoactive agent; there would be limited 
competition between the vasoactive agent and deionised water. It appears that 
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iontophoresis of water alone requires a greater voltage to drive a given current due 
to the lower number of ions, and in turn greater resistance, when compared with 
sodium chloride (Asberg et al. 1999). Therefore iontophoresis of water alone used 
to demonstrate vehicle effects may in fact not represent a vehicle response.  
 
Current density (mA·cm2) and charge density (mC·cm2) appear to be important 
considerations (Singh et al. 1999; Droog et al. 2004; Kalia et al. 2004; Christen et 
al. 2004) as it has been shown that an iontophoresis protocol using a low current 
density is able to attenuate the non-specific vasodilatation at both the anode and 
cathode (Droog et al. 2004). Specifically, limiting cumulative charge density to <7.8 
mC·cm2 largely attenuates the non-specific vasodilatation at both the anode and 
cathode. 
Skin Site Variability and Skin Resistance 
Local SkBF may influence the vasoactive agent absorption to underlying tissue as 
drug clearance will presumably be increased with high SkBF (Roustit et al. 2014). 
Glabrous skin contains large numbers of AVAs which have the ability to 
substantially increase SkBF; thus the rate of drug clearance would presumably be 
greater in glabrous skin sites compared with non-glabrous skin sites (Roustit et al. 
2009). Glabrous skin sites such as the palms have thick stratum corneum and lack 
hair follicles which may be presumed to inhibit drug penetration. Iontophoresis has 
been successfully used in palm skin sites (Kingma et al. 2010) but not at the finger 
pad (Roustit et al. 2009); the reason for the discrepancy may be due to the greater 
SkBF “clearing” of the drug at the finger pad.  
 
Epidermal thickness (Freeman et al. 1962), stratum corneum thickness (Thomson 
1955) and water content of the skin (Berardesca and Maibach 1996) does not 
differ between white (CAU) and black (AFD) skin (Thomson 1955; Freeman et al. 
1962; Weigand et al. 1974; Wesley and Maibach 2003), whereas CAU skin 
contains fewer cell layers of the stratum corneum than that of AFD skin, described 
as “more compact” in the latter group (Weigand et al. 1974). This may contribute 
to the known greater skin resistance in the young and adult population of AFD 
compared with CAU (Johnson and Corah 1963). The data concerning ASN skin 
properties is largely conflicting and thus inconclusive (Wesley and Maibach 2003). 
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Equipment and Vasoactive Agents 
In the present thesis a battery powered iontophoresis controller was utilised 
(MIC2, Moor Instruments, UK). The iontophoresis controller was connected to the 
data acquisition system for online recording of current delivered and resistance 
measured during application. The skin sites under investigation were gently 
cleaned with water for injection. The iontophoresis chamber, a small Perspex ring 
(MIC-ION1R-P1, Moor Instruments, UK) with an inner diameter of 0.95 cm (0.71 
cm2) incorporating a platinum electrode, was placed on the skin and filled with 
approximately 0.2 mL of vasoactive agent (diluted in water for injection). The 
reference electrode was attached to the participant within 5 cm to 10 cm of the 
active electrode using an adhesive gel pad (Figure 3.2). The protocol utilised 
varied slightly with each drug but all were intermittent with a maximum applied 
current of 100 μA. See Study Two and Study Three. 
 
Acetylcholine chloride ([ACh] 1 w/v %, 55.05 mM) was obtained either as Miochol-
E (Bausch and Lomb, UK) or in powder form (Sigma-Aldrich, UK) and diluted into 
water for injection. SNP (Rottapharm Madaus, Barcelona, Spain) was dissolved 
into water for injection to a concentration of 0.01 w/v % (0.34 mM). NA (Hospira, 
Leamington Spa, UK) was diluted into water for injection to a concentration of 0.5 
mM (0.008 w/v %). As SNP and NA are photosensitive, solutions were wrapped in 
foil and stored in the dark prior to use. Solutions were made and used within eight 
hours. 
3.4.5 Perceptual Measurements 
Thermal Sensation and Thermal Comfort 
Visual analogue scales were used to ascertain perceptual thermal sensation and 
thermal comfort ratings, both overall and locally, utilising a 20 cm scale with verbal 
descriptors (Figure 3.3). Using a non-permanent marker, participants placed a 
straight vertical line, on the scale that best reflected how they “felt” in relation to 
their thermal sensation and thermal comfort at the time of asking. Markings were 
removed after being recorded, before the participant was asked again. 
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Figure 3.3 Thermal sensation and thermal comfort scale 
Not to scale.  
3.4.6 Tests Using Local Cooling 
The protocols that utilised local cooling are detailed below. 
Sensory Threshold Test  
Participants were tested for their sensitivity in detecting a cold temperature 
stimulus using a thermal sensitivity tester (Figure 3.4, Physitemp Instruments Ltd., 
USA) in a climate controlled room set to 26 °C. The system includes a water pump 
and tank unit (9.4 L capacity, PTU-110A), connected to a controller (NTE-2 A) by a 
water tubing system. The controller is connected to a thermal plate (5 cm × 4 cm × 
3 cm thick) by two additional water tubes and mounted on a stage. The thermal 
plate has an accuracy of 0.1 °C, a rate of temperature change of 0.33 °C·s-1 and a 
temperature range of 0 °C to 50 °C.  
 
The thermal plate was inverted, mounted on a guiding system to facilitate 
stabilisation during testing and placed on the volar side of the right forearm 
approximately 5 cm from the elbow joint and then separately on the middle finger 
pad for the assessment of thermal sensitivity. The arm was rested on a padded 
table throughout and participants were asked not to move their forearm or fingers 
for the duration of the test (approximately ten minutes for each skin site). 
Participants were instructed that a cold stimulus would be presented to the skin 
through the thermal plate. Immediately after the presentation of the cold stimulus 
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participants were instructed to report whether they perceived a change in the 
starting temperature of the plate (30 °C). After each temperature change the plate 
was returned to the starting temperature. If the participant perceived a cold 
stimulus the subsequent stimulus was of a smaller magnitude. In the event that the 
cold stimulus was not perceived the subsequent stimulus was of a greater 
magnitude. Sham stimuli were intermittently provided whereby no stimulus was 
presented. Final cold sensory threshold was determined as the temperature 
preceding the point at which the cold stimulus was not perceived on three 
consecutive occasions. 
 
 
Figure 3.4 Picture of the thermal plate placed on the forearm 
Cold Sensitivity Test 
The protocol used in the experiments had been established previously in our 
laboratory which is used to identify cold sensitivity (Eglin et al. 2013; Davey et al. 
2013). Participants entered a climate controlled room set to 30 °C, removed their 
socks and shoes, and rested in a recumbent position for 15 minutes. Following 
this, participants cycled on an electronically braked ergometer (Tunturi T4 Alpha 
150, Tunturi Fitness B.V., Netherlands) for 12 minutes at an external workload of 
50W. Participants then rested in a recumbent position for an additional five 
minutes. During this rest period, a laser Doppler probe was applied to the Great 
toe pad on the right foot using double sided adhesive rings to measure SkBF using 
a LDF monitor (Figure 3.5).  
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Participants then placed their right foot into a plastic bag to keep the foot dry and 
then immersed it up to the point of the mid-malleoli into a stirred water bath 
maintained at 15 °C for two minutes. Following the two minute immersion period, 
participants removed their foot from the water bath and plastic bag and continued 
to rest in a recumbent position for a further ten minutes to allow spontaneous 
rewarming. An infrared camera was utilised to measure the right Great toe Tsk, 
which was measured distally to the laser Doppler probe. The camera was pointed 
at the volar aspect of the feet and placed one meter away from the participant. 
 
 
 
Figure 3.5 Picture of the cold sensitivity test set-up 
Cold-Induced Vasodilatation Test  
The protocol used in the experiments was adopted from previous investigations 
(Cheung and Mekjavic 2007; Reynolds et al. 2007). Participants rested in a 
recumbent position in a climate controlled room (30 °C) and laser Doppler probes 
and skin thermistors were applied to skin sites under investigation. In Study One, 
which included hand cooling only, the skin sites included were the middle and 
index finger pad on the right hand for the laser Doppler probe and skin thermistor 
respectively, attached using a single piece of adhesive tape. In Study Four both 
foot and hand were locally cooled. For the foot cooling, laser Doppler probes were 
attached to the Great toe pad on the right foot and to the medial aspect of the 
dorsum of the foot positioned proximally to the toes. Skin thermistors were applied 
to the medial aspect of the Great toe pad and medially to the laser Doppler probe 
on the dorsum foot. For the hand cooling, laser Doppler probes and skin 
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thermistors were attached to the finger pad and dorsum aspect of the middle 
phalanx of the third and second finger, respectively, of the right hand.  
 
Following the rest period, participants placed their right hand or foot into a plastic 
bag to keep it dry, and immersed either, their hand up to the styloid process or 
their foot to the mid-malleoli in a water bath maintained at 35 °C for five minutes 
whilst SkBF and Tsk data were recorded. Following this, participants removed their 
hand or foot, still within the plastic bag, and immediately placed it in a 
mechanically stirred water bath maintained at 8 °C for a further 30 minutes (Figure 
3.6). Participants then removed their hand or foot from the water bath and plastic 
bag to allow spontaneous rewarming in air for ten (Study One) or 15 (Study Four) 
minutes. The CIVD cycle during 8 °C water immersion was assessed from the Tsk 
measurements and included: average Tsk, minimum Tsk, number of CIVD waves, 
onset time of first CIVD wave, Tsk prior to onset of first CIVD wave and maximum 
Tsk during the first CIVD wave and amplitude of CIVD wave (Figure 3.7). 
 
 
Figure 3.6 Picture of the cold-induced vasodilatation test set-up for the hand 
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Figure 3.7 Typical trace of finger skin temperature during hand immersion in water 
at 8 °C and subsequent rewarming in air at 30 °C showing variables analysed 
during cold-induced vasodilatation 
Vasomotor Threshold Test 
Participants sat in a climate controlled room set to 30 °C for 20 minutes whilst 
being instrumented. A laser Doppler probe and thermistor were applied to the 
participants' middle and index finger pads, respectively, on the immersed hand 
and covered by one layer of transparent film dressing (TegadermTM, 3MTM, USA). 
Following the 20 minute period, participants immersed their right hand and forearm 
just above the medial epicondyle of the humerus in a water bath maintained at 35 
°C for ten minutes (Figure 3.8). After ten minutes the water temperature was 
gradually reduced to 10 °C over approximately 32 minutes. Following this, the 
water bath was reheated over approximately 25 minutes. Once the water reheated 
to 35 °C the experiment ended. Since this was a novel test, a study was 
undertaken to assess its repeatability; the results of that study are in Annex One. 
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Figure 3.8 Picture of the vasomotor threshold test set-up 
3.5 Withdrawal Criteria 
Participants were withdrawn completely from the study on request of the 
participant or by the decision of the principal investigator or supervisor. 
Additionally, attainment of any of following criteria led to cessation of the study: 
 During extremity immersion in 8 °C, if Tsk fell below 8 °C for more than 15 
minutes or 4 °C at any time. 
 Any adverse effect to iontophoresis of any vasoactive agent. 
No participant reached any of these criteria. 
3.6 Statistical Analyses 
Statistical analyses were conducted using IBM SPSS for Windows (IBM SPSS 
Statistics, USA). The normality of the data was assessed with a Shapiro-Wilk test 
and visual inspection of box plots. To control for Type I errors (“false positives”) an 
α threshold value of 0.05 was chosen. Statistical significance was determined if 
test statistics returned a value less than this threshold and denoted as P. When a 
study required a test of differences between groups, and the data were considered 
parametric, an analysis of variance (ANOVA) was performed to establish 
significant differences. Post-hoc analyses were conducted by independent and 
dependent samples t-test. Bonferroni adjustments were applied if multiple 
comparisons were made. When assumptions of parametric data were not met, 
non-parametric analyses were utilised with appropriate post-hoc testing (see 
individual studies for specific analyses). Mean and standard deviations (SD) were 
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reported for parametric data whilst median (Mdn) and interquartile ranges (IQR) 
were reported for non-parametric data in text. 
 
One problem with P values is using them as an “all-or-none” approach whereby 
values that are marginally under 0.05 are considered significant whilst values 
above 0.05 are considered non-significant. Furthermore, significant testing is 
biased by sample sizes. An approach that has been utilised to combat these 
disadvantages is the use of effect sizes. These effect sizes measure the size of an 
observed effect which is not influenced by sample sizes (Field 2013). Effect sizes, 
where appropriate, were calculated using Cohen’s d for parametric data denoted 
by d in text (0.2, 0.5 and 0.8 as small, medium and large effect sizes, respectively) 
and Rosenthal’s r for non-parametric data denoted by r in text (0.1, 0.3 and 0.5 as 
small, medium and large effect sizes, respectively) (Field 2013). 
 
Power calculations were performed using StatMate (GraphPad) to establish the 
appropriate sample size required for testing. Data from similar studies (O’Brien 
2005; Reynolds et al. 2007) showed that ten participants were needed for Study 
One. As Study Two was a different protocol, data from other studies (Stein et al. 
1997; Brocx and Drummond 2009) were utilised to provide sample size estimates 
with results showing that approximately 12 participants were needed. Study Three 
and Study Four utilised data from the first two studies and led to similar sample 
size estimates.  
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4 Study One - The Effect of Ethnicity on the Vascular Responses to Cold 
Exposure of the Extremities 
4.1 Introduction 
As discussed in the Review of Literature, NFCI occurs mainly in the feet or hands 
following prolonged exposure to tissue temperatures above freezing and up to 
about 15 °C (Ungley and Blackwood 1942), with AFD more likely to be injured than 
CAU (Miller and Bjornson 1962; Taylor 1992; Conway and Husberg 1999; 
DeGroot et al. 2003; Burgess and Macfarlane 2009; Connor 2014). The reason for 
the disproportionate incidence of cold injuries in AFD compared with CAU may be 
differences in SkBF, and therefore Tsk, during cold exposure and subsequent 
rewarming.  
 
Immersion of an extremity into cold water (<15 °C) results in vasoconstriction 
followed by cyclical vasodilatation (Lewis 1930). This CIVD, usually demonstrated 
in the finger, serendipitously maintains manual performance and may prevent cold 
injuries in individuals who are normothermic (Daanen 2003). Therefore the CIVD 
test is sometimes used to determine an individual’s susceptibility to cold injuries 
(Yoshimura and Iida 1950; Daanen and van der Struijs 2005). The CIVD response 
appears to be blunted in AFD compared with CAU (Meehan 1955b; Iampietro et 
al. 1959; Newman 1969; Jackson et al. 1989), whereas ASN may have a 
pronounced CIVD response compared with CAU (Hirai et al. 1970; Little et al. 
1971), although this has not been shown conclusively. If CIVD is protective, this 
could be part of the reason why AFD are more susceptible to cold injury.  
  
As well as the CIVD test, there are other cold challenges that can be applied to the 
extremities to study vascular responses. A cold sensitivity (CS) test has previously 
been utilised to help diagnose NFCI (Eglin et al. 2013). This test examines both 
the SkBF and Tsk response to a two minute immersion of the foot in 15 °C water 
and subsequent rewarming whilst in a warm (30 °C) room. The rationale being that 
a lower starting Tsk (i.e. prior to cooling) and a slower rate of rewarming are 
indicative of cold sensitivity. With cooling and rewarming, the point at which 
maximal (or near maximal) vasoconstriction and the release of this 
vasoconstriction occur can be identified (see Annex One). An earlier onset of 
maximal vasoconstriction during cooling and a later release of this 
vasoconstriction during rewarming results in greater tissue cooling ("dose" of cold 
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skin) and, presumably, a greater risk of NFCI. In Annex One the identification of 
the onset of maximal vasoconstriction was found to be more repeatable than the 
release of vasoconstriction. Altered thermal sensation to cold stimuli may also 
increase the risk of NFCI by influencing behavioural thermoregulation. One 
previous investigation reported that white British males had a similar cold sensory 
threshold on their volar forearm as south Asian males (Watson et al. 2005). 
However, no previous research has investigated forearm or finger cold sensory 
thresholds between CAU, ASN and AFD groups. 
 
No previous research has investigated the vascular responses of the hands, as 
well as the feet, to cold exposures between ethnic groups utilising techniques such 
as LDF. Differences in the vascular responses to cold exposure between ethnic 
groups could underpin the increased susceptibility to NFCI in AFD. The aim of 
Study One was to investigate SkBF and Tsk responses in different ethnic groups 
during hand and foot cooling and subsequent rewarming.  
4.2 Hypotheses 
H01. During local cooling and subsequent rewarming local SkBF and Tsk 
between ethnicities will not differ. 
HA1. During local cooling and subsequent rewarming AFD will experience 
lower local SkBF and Tsk compared with CAU and ASN. 
 
H02. The thermal perception of the finger and forearm to cold will not differ 
between ethnicities. 
HA2. The thermal perception of the finger and forearm to cold will be 
different between ethnic groups. 
4.3 Methods 
4.3.1 Participants 
A favourable ethical opinion was received from the BioSciences Research Ethics 
Committee in accordance with University regulations (BSREC 12 / 070a). Thirty 
male volunteer participants were recruited: ten CAU, ten ASN and ten AFD, their 
physical characteristics are presented below (see results). One CAU was born in 
South Africa and had resided in the UK for over 12 years; all other CAU were born 
in UK. Three AFD were born in the UK whilst six were born in Africa (Zimbabwe, 
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Nigeria and Ghana) and one in Italy and had resided in the UK for an average of 
eleven years with a minimum of seven years. Seven ASN were born in the UK 
whilst two were born in Asia (Vietnam and Nepal) and one in Africa (Tanzania) and 
had resided in the UK for an average of three years with a minimum of two years. 
4.3.2 Experimental Procedures and Measurements 
Participants were required to attend the laboratory on two occasions to undertake 
three extremity cold water immersions and a sensory threshold test. On one visit 
participants completed a CS test of the right foot followed by a CIVD test of the 
right hand. On the other visit, participants first completed a sensory threshold test 
followed by a vasomotor threshold (VT) test of the right hand and forearm. The two 
laboratory visits were randomised and separated by at least 24 hours (Figure 4.1 
and Figure 4.2). Anthropometric measurements were collected on a separate visit.  
 
Cold Sensitivity Test (30 °C) Cold-Induced Vasodilatation Test (30 °C) 
15 min 12 min 5 min 2 min 10 min 10 min 5 min 30 min 10 min 
Rest Exercise Rest 15 °C 
Immersion 
Rewarm Rest 35 °C 
Immersion 
8 °C 
Immersion 
Rewarm 
Figure 4.1 Schematic of the experimental procedure for the cold sensitivity and 
cold-induced vasodilatation test for Study One 
  
Sensory Threshold Test Vasomotor Threshold Test 
Room 1 (26 °C) Room 2 (30 °C) 
~10 min ~10 min 20 min 10 min ~32 min ~25 min 
Forearm Finger Instrumentation 35 °C 
Immersion 
Cooling to 10 °C Rewarming to 
35 °C 
Figure 4.2 Schematic of the experimental procedure for the sensory threshold and 
vasomotor threshold test for Study One 
Sensory Threshold Test 
Cold sensory thresholds were determined using an adjustable temperature 
controlled Peltier plate placed on the forearm and finger pad skin sites conducted 
in climate controlled room (mean [SD] Tdb: 26.0 [0.5] °C, Twb: 19.6 [4.9] °C, WBGT: 
21.5 [3.4] °C) (see page 72 and Figure 4.2).  
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Cold Sensitivity Test 
Participants entered a climate controlled room (mean [SD] Tdb: 30.1 [0.7] °C, Twb: 
19.9 [1.8] °C, WBGT: 22.9 [1.3] °C), rested, exercised, and then placed their right 
foot into a plastic bag and into a water bath maintained at 15.0 (0.2) °C for two 
minutes. Following this, participants removed their foot from the water and plastic 
bag to allow spontaneous rewarming (see page 73 and Figure 4.1). 
Cold-Induced Vasodilatation 
Following the CS test, participants rested for a further ten minutes in the same 
climate controlled room (mean [SD] Tdb: 30.1 [0.7] °C, Twb: 20.3 [1.8] °C, WBGT: 
23.2 [1.3] °C). Participants placed their right hand in a plastic bag, then into a 
water bath maintained at 35.1 (0.3) °C for five minutes. Following this, participants 
removed their hand, still within the plastic bag, and immediately placed it into a 
water bath maintained at 7.9 (0.1) °C for a further 30 minutes. Participants then 
removed their hand from the water bath and plastic bag to allow spontaneous 
rewarming (see page 74 and Figure 4.1).  
Vasomotor Threshold Test 
Participants sat in a climate controlled room for 20 minutes whilst instrumented 
(mean [SD] Tdb: 30.1 [0.6] °C, Twb: 18.8 [1.8] °C and WBGT: 22.2 [1.3] °C). 
Following this, participants immersed their right hand and forearm directly (no 
plastic bag) into a water bath maintained at 35.2 (0.2) °C for ten minutes. After ten 
minutes the water temperature was gradually reduced to 10.0 (0.1) °C over 32 (1) 
minutes. Following this, the water bath was reheated to 35 °C over 25 (1) minutes 
(see page 76 and Figure 4.2). 
Data Analyses  
SkBF was calculated as minute averages, normalised and expressed as 
percentage change from that recorded prior to exposure of the extremity to cold 
water (set at 100 %). SkBF during the two minute foot immersion in the CS test 
was averaged between 30 to 90 seconds to avoid any movement artefact from 
placing the foot into the water. From the infrared camera, Great toe Tsk was 
recorded immediately pre and post local cooling and every minute during 
rewarming. For the CIVD test, finger Tsk obtained from the thermistor was plotted 
every minute, and from the sampled data which was recorded every five seconds, 
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the CIVD variables were determined as explained previously (see General 
Methods, Figure 3.7). Baseline finger Tsk was recorded five seconds prior to 
cooling. For SkBF during the CIVD test, average, minimum and area under the 
curve (AUC) from normalised values were calculated. SkBF was further analysed 
by splitting the data into quartiles (<25 %, 25 % to 49 %, 50 % to 74 % and >75 % 
of the SkBF observed during immersion in 35 °C water) and calculating the time 
spent within each quartile. For the VT test data, Tsk was recorded every five 
seconds during the immersion period and calculated as minute averages. Tsk was 
plotted on the x-axis against SkBF minute averages of the corresponding time and 
all data was assessed by three individuals to determine the onset and release of 
vasoconstriction. See Annex One for more details. 
Statistical Analyses  
If the data were parametric then an ANOVA was performed to establish significant 
differences with post hoc analysis conducted, where appropriate, by independent 
samples t-test with Bonferroni adjustments applied. When the assumptions of 
parametric tests were not met, a Kruskal-Wallis test was utilised with post-hoc 
analysis conducted, where appropriate, using a Mann-Whitney U test. 
4.4 Results 
There were no significant differences in the participant characteristics between 
ethnic groups, except for height with pairwise comparisons indicating CAU were 
significantly taller than AFD (Table 4.1, P = 0.024). Absolute SkBF expressed as 
LDU prior to extremity immersion in cold water was not significantly different 
between ethnic groups for the CS test, CIVD test, or VT test (Table 4.2, P > 0.05). 
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Table 4.1 Mean (SD) physical characteristics for each ethnic group 
Variable CAU ASN AFD 
Age (years) 20 (1) 20 (1) 20 (1) 
Height (m) 1.8 (0.1)* 1.8 (0.1) 1.7 (0.1) 
Body mass (kg) 78.5 (13.4) 73.5 (10.8) 78.3 (17.3) 
Body surface area (m2) 2.0 (0.1) 1.9 (0.1) 1.9 (0.2) 
Body mass/body surface area (kg⋅m2) 39.1 (4.2) 38.5 (3.1) 40.3 (4.5) 
Hand length (cm) 19.9 (0.7) 20.2 (0.8) 20.0 (1.3) 
Forearm length (cm) 28.4 (2.1) 27.4 (1.6) 28.3 (1.7) 
Forearm girth (cm) 27.4 (2.3) 27.1 (1.5) 28.2 (2.1) 
Hand and forearm volume (L) 1.7 (0.3) 1.5 (0.2) 1.6 (0.2) 
* Significant difference between CAU and AFD, P < 0.05. n = 10 for each group. 
 
Table 4.2 Mean (SD) skin blood flow expressed as absolute laser Doppler units 
(LDU) at rest in air at 30 °C prior to the cold sensitivity (CS) test and in 35 °C water 
prior to the cold-induced vasodilatation (CIVD) and vasomotor threshold (VT) tests 
  Baseline Skin Blood Flow (LDU)  
Test Site CAU ASN AFD 
CS test  Great toe pad 177 (55) 239 (89) 251 (92) 
CIVD test  Finger pad 261 (87) 292 (108) 321 (104) 
VT test  Finger pad 260 (63) 272 (33) 318 (78) 
n = 10 for each group. 
4.4.1 Sensory Threshold Test 
Cold sensory thresholds were not significantly different between ethnic groups for 
the forearm (CAU n = 10: 0.3 [0.2] °C, ASN n = 10: 0.3 [0.2] °C, AFD n = 10: 0.5 
[0.3] °C, P > 0.05) or finger pad (Mdn [IQR] CAU n = 10: 0.6 [0.9] °C, ASN n = 10: 
1.0 [2.6] °C, AFD n = 9: 1.5 [1.7] °C, P > 0.05). Due to equipment failure only nine 
AFD were tested for the finger pad. 
4.4.2 Cold Sensitivity Test 
Figure 4.3 shows the Great toe Tsk and SkBF responses to the CS test during the 
immersion and rewarm period. Great toe Tsk was similar between ethnic groups 
prior to immersion (Mdn [IQR] CAU: 34.6 [1.2] °C, ASN: 35.3 [1.4] °C, AFD: 35.5 
[1.4] °C, P > 0.05). No significant differences were observed between ethnic 
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groups for Great toe Tsk immediately post-immersion or during subsequent 
rewarming (P > 0.05). SkBF during the foot immersion period was not significantly 
different between ethnic groups (P > 0.05). However, during rewarming, Great toe 
SkBF was significantly lower in AFD compared with CAU at minute five (Mdn [IQR] 
90 [15] % vs. 130 [59] %, P = 0.008, r = 0.68) and six (Mdn [IQR] 92 [17] % vs. 
130 [42] %, P = 0.031, r = 0.57). 
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Figure 4.3 Mean (SD) Great toe skin temperature (a) and normalised skin blood 
flow (b) during foot immersion in 15 °C water and subsequent rewarming in 30 °C 
air during the cold sensitivity test for CAU, ASN and AFD groups 
* Significant difference between CAU and AFD, P < 0.05. Vertical dashed line represents start of 
rewarm. n = 10 for each group. 
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4.4.3 Cold-Induced Vasodilatation Test 
Figure 4.4 shows the index finger Tsk and middle finger SkBF responses to both 
the immersion and rewarm period. Finger Tsk was similar between ethnic groups 
prior to immersion (Mdn [IQR] CAU: 35.6 [0.4] °C, ASN: 35.8 [0.5] °C, AFD: 35.9 
[0.2] °C, P > 0.05) and during hand immersion in 8 °C water except for the final 
minute of immersion (Mdn [IQR] CAU: 10.4 [2.3] °C vs. AFD: 9.3 [1.7] °C, P = 
0.047, r = 0.54). During rewarming AFD experienced a lower finger Tsk compared 
with CAU up to the sixth minute of rewarming (P = 0.006 to 0.038, r = 0.56 to 0.69) 
which represented a slower rate of finger rewarm (2.5 [0.7] °C·min-1 vs. 3.2 [0.4] 
°C·min-1, P = 0.037, d = 1.22) whilst neither group differed from ASN (3.0 [0.6] 
°C·min-1, P > 0.05). Additionally, AFD experienced a lower finger Tsk compared 
with ASN at the tenth minute of rewarming (Mdn [IQR] 29.3 [10.9] °C vs. 33.6 [1.6] 
°C, P = 0.029, r = 0.58).  
 
Finger SkBF was lower in AFD compared with CAU at various time points 
throughout hand immersion in 8 °C water and subsequent rewarming (P = 0.003 to 
0.047, r = 0.54 to 0.74). ASN also experienced a lower finger SkBF compared with 
CAU at the 29th minute of hand immersion in cold water (P = 0.021, r = 0.60).  
 
Average finger SkBF during hand immersion was significantly greater in CAU 
compared with ASN (Table 4.3, P = 0.036, r = 0.56) and AFD (P = 0.023, r = 0.60). 
Additionally, AFD had a significantly lower minimum SkBF compared with CAU (P 
= 0.033, r = 0.57) but neither group differed from ASN (P > 0.05). The AUC for 
finger SkBF during hand immersion was significantly lower in ASN (P = 0.036, r = 
0.56) and AFD (P = 0.023, r = 0.60) compared with CAU. During rewarming, the 
AUC for finger SkBF was significantly lower in AFD compared with CAU (P = 
0.002, r = 0.76) whilst ASN did not differ from either group (P > 0.05).  
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Table 4.3 Median (IQR) skin blood flow variables during immersion in 8 °C water 
and subsequent rewarming in 30 °C air in the cold-induced vasodilatation test 
Variable CAU ASN AFD 
Average SkBF during 
immersion (%) 
42 (24)*† 25 (8) 24 (13) 
Minimum SkBF during 
immersion (%) 
8 (5)* 6 (3) 5 (4) 
AUC during immersion 75779 (43111)*† 45535 (14122) 43288 (23694) 
AUC during rewarming 46039 (20861)* 37566 (12326) 25380 (22332) 
AUC = Area under the curve. * Significant difference between CAU and AFD, P < 0.05; † significant 
difference between CAU and ASN, P < 0.05. n = 10 for each group. 
 
During hand immersion, CAU spent a longer period of time in the 25 % to 49 % 
quartile of finger SkBF compared with AFD (Figure 4.5, P = 0.036, r = 0.56) and a 
shorter period of time in the <25 % quartile compared with both AFD (P = 0.004, r 
= 0.71) and ASN (P = 0.033, r = 0.57). ASN also spent a shorter period of time in 
the 50 % to 74 % quartile compared with CAU (P = 0.017, r = 0.62). During 
rewarming, following hand immersion, CAU experienced a longer period of time in 
the >75 % quartile compared with AFD (P = 0.004, r = 0.72) and, similarly to the 
hand immersion period, a shorter period of time in the <25 % quartile compared 
with AFD (P = 0.001, r = 0.79). ASN also spent a shorter period of time in the <25 
% quartile compared with AFD (P = 0.038, r = 0.56). 
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Figure 4.4 Mean (SD) finger skin temperature (a) and normalised skin blood flow 
(b) during hand immersion in 8 °C water and subsequent rewarming in 30 °C air 
during the cold-induced vasodilatation test for CAU, ASN and AFD groups 
* Significant difference between CAU and AFD, P < 0.05; † significant difference between CAU and 
ASN, P < 0.05; # significant difference between ASN and AFD, P < 0.05. Vertical dashed line 
represents start of rewarming. n = 10 for each group. 
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Figure 4.5 Mean time spent in each quartile of skin blood flow during 30 minute of 
immersion in 8 °C water (a) and 10 minute of rewarming in 30 °C air (b) during the 
cold-induced vasodilatation test for CAU, ASN and AFD groups 
* Significant difference between CAU and AFD, P < 0.05; † significant difference between CAU and 
ASN, P < 0.05; # significant difference between ASN and AFD, P < 0.05. n = 10 for each group. 
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Table 4.4 presents the CIVD variables between ethnic groups. Minimum finger Tsk 
was significantly different between ethnic groups with AFD experiencing a 
significantly lower minimum finger Tsk compared with ASN (P = 0.029, d = 1.09) 
and, although lower, was not statistically significant compared to CAU (P = 0.061, 
d = 1.44). Although the number of CIVD waves did not differ between ethnic 
groups, nine CAU experienced at least one CIVD whilst only six AFD and six ASN 
experienced the same number of waves. Furthermore, three CAU experienced two 
CIVD waves whilst this occurred in only one AFD and two ASN. 
 
Table 4.4 Mean (SD) or median (IQR) cold-induced vasodilatation variables during 
immersion in 8 °C water during the cold-induced vasodilatation test 
Variable CAU ASN AFD 
Average Tsk (°C)
+ 13.02 (2.90) 11.97 (2.01) 11.50 (2.29) 
Minimum Tsk (°C) 9.69 (0.55) 9.81 (1.09)
# 8.84 (0.63) 
 CAU (n = 9) ASN (n = 6) AFD (n = 6) 
Number of waves+ 1.00 (1.00) 1.00 (1.25) 1.00 (1.00) 
Onset time of CIVD (minute) 11.35 (7.67) 9.56 (4.84) 16.89 (7.01) 
Tsk prior to onset of CIVD (°C)
+ 10.95 (6.10) 10.28 (4.24) 9.10 (2.72) 
Max Tsk during CIVD (°C) 15.57 (4.28) 15.65 (3.74) 13.44 (4.04) 
Amplitude (°C) 3.36 (1.62) 3.83 (1.45) 3.08 (1.68) 
+ 
Mdn (IQR), 
# 
Significant difference between ASN and AFD, P < 0.05. n = 10 for average and 
minimum Tsk. 
4.4.4 Vasomotor Threshold Test 
Finger Tsk was similar between groups prior to cooling (CAU: 35.6 [0.2] °C, ASN: 
35.5 [0.2] °C, AFD: 35.4 [0.2] °C, P > 0.05). The onset of maximal vasoconstriction 
was significantly different between ethnic groups with AFD experiencing 
vasoconstriction at a warmer finger Tsk compared with CAU during water cooling 
(Figure 4.6, 21.2 [4.4] °C vs. 17.0 [3.1] °C, P = 0.034, d = 1.11). However, the 
onset of maximal vasoconstriction for ASN was intermediate (17.7 [2.4] °C, P > 
0.05) and did not differ from either CAU or AFD. Two ASN were not included in the 
analysis for the onset of maximal vasoconstriction as their onset points could not 
be established. The release of vasoconstriction was also significantly different 
between ethnic groups with it occurring in AFD at a significantly warmer finger Tsk 
compared with CAU during water warming (Mdn [IQR] 22.0 [7.9] °C vs. 12.1 [4.1] 
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°C, P = 0.002, r = 0.76). The onset of the release of vasoconstriction for ASN (18.4 
[9.0] °C, P > 0.05) did not differ from either CAU or AFD. 
 
 
Figure 4.6 Mean (SD) finger skin temperature (°C) at which the onset of 
vasoconstriction and the release of vasoconstriction occurred during hand and arm 
cooling and rewarming for CAU, ASN and AFD groups 
* Significant difference between CAU and AFD, P < 0.05. n = 10 for each group except for ASN 
onset of vasoconstriction only (n = 8). 
4.5 Discussion 
The primary findings from this study were 1) during hand immersion in cold water, 
AFD experienced a more intense and protracted finger vasoconstriction than CAU 
(Figure 4.4 and Figure 4.5) and 2) vasoconstriction occurred at a warmer finger Tsk 
in AFD compared with CAU (Figure 4.6). The differences in the vascular 
responses during the CIVD test led to AFD experiencing a slower rewarm of finger 
Tsk. The responses from ASN were largely intermediate. However, no significant 
physiological differences were demonstrated during the milder CS test on the foot, 
nor were there any differences in sensory thresholds between ethnic groups. 
These findings lead to the rejection of H01 and partial acceptance of HA1. This latter 
hypothesis is only partly accepted as, for example, there were no Tsk differences 
between ethnic groups during the foot immersion protocol. However, the findings 
in the present study accept H02 and reject HA2. 
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Previous investigations have demonstrated that AFD experience different CIVD 
patterns compared with CAU (Meehan 1955b; Iampietro et al. 1959; Newman 
1969; Jackson et al. 1989), however the results demonstrate there were no CIVD 
differences between AFD and CAU. Minimum finger Tsk did not go as low in ASN 
compared with AFD, but neither group differed from CAU. These data do not 
support previous work (Hirai et al. 1970) which suggested ASN have a greater 
protection against cold exposure compared with CAU. Hirai et al. (1970) immersed 
just one digit at various temperatures (0°C, 5°C and 10°C, separately) for 30 
minutes. It was reported that increasing the depth of immersion depressed the 
CIVD reaction to a greater extent in ASN compared with CAU. The greater surface 
cooled in this study may provide a possible explanation why the present study did 
not observe any differences between these two ethnic groups. Furthermore, ASN 
in that study (Hirai et al. 1970) may have been influenced by factors such as the 
time spent residing in the country and seasonal variation rather than ethnic 
differences (Yoshimura and Iida 1950). 
 
At various times throughout hand immersion and subsequent rewarming, SkBF 
was significantly lower in AFD compared with CAU. Further analyses revealed that 
during hand immersion AFD and ASN spent a greater period of time in the lowest 
SkBF quartile (i.e. <25 %) compared with CAU and during subsequent rewarming 
AFD spent less time in the highest SkBF quartile (i.e. >75 %) compared with CAU. 
These data indicate that whilst CIVD may provide protection against cold injuries 
(Yoshimura and Iida 1950; Daanen and van der Struijs 2005) the relative SkBF 
experienced during hand immersion and subsequent rewarming may, in part, also 
determine an individual's susceptibility to NFCI. The present study and the higher 
number of AFD compared with CAU who suffer NFCI provide support for this idea. 
 
The lower SkBF observed in AFD during hand immersion and subsequent 
rewarming could be a result of augmented vasoconstriction, attenuated 
vasodilatation or a combination of the two. Plasma ET-1, a potent vasoconstrictor 
released from endothelial cells (Yanagisawa et al. 1988), has been shown to 
potentiate the sympathetic vasoconstrictor response to cooling (Yang et al. 1990; 
García-Villalón et al. 1997). ET-1 levels in AFD may (Evans et al. 1996; Treiber et 
al. 2000) or may not (Hong et al. 2006; Cooper et al. 2009) be greater at rest 
compared with CAU; however, in response to forehead cooling AFD exhibit higher 
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levels of ET-1 compared with CAU (Treiber et al. 2000), although AFD started the 
test with greater levels of ET-1. Whilst plasma NA at rest does not differ between 
AFD and CAU (Hohn et al. 1983), AFD demonstrate a greater forearm 
vasoconstrictor response to phenylephrine, an α1 agonist, when compared with 
CAU (Stein et al. 2000), although no forearm blood flow differences are noted with 
ANG II (Jones et al. 1999). Vasoactive agents that induce endothelium-dependent 
vasodilatation have previously been shown to be attenuated in AFD compared 
with CAU (Stein et al. 1997; Cardillo et al. 1999; Stein et al. 2000). However, the 
literature regarding endothelium-independent vasodilatation is mixed (see Review 
of Literature, page 54). Taken together, it could be possible that the endothelium is 
compromised in the extremities of AFD which may result is an exaggerated 
cooling response. 
 
The VT test provided an insight into the onset of maximal, or near maximal, 
vasoconstriction and the release of this vasoconstriction during progressive 
cooling and rewarming in water. The results show that AFD experienced a longer 
period of time under a vasoconstrictor tone. None of the test conditions were 
severe enough to elicit NFCI, but if repeated cold exposures and / or longer 
duration cold stimuli were applied, then AFD may be at greater risk of NFCI due to 
a longer period of vasoconstriction (Ungley et al. 1945; Jia and Pollock 1997). The 
results from Annex One demonstrated that only the onset of maximal 
vasoconstriction could be repeatedly identified, therefore caution should be used 
when interpreting the release of vasoconstriction. 
 
Another possible cause for the increased risk of cold injuries in AFD may be 
diminished thermal sensation of cold and consequent behavioural response. 
However, in support of a previous study comparing white British and south Asian 
individuals (Watson et al. 2005), the present study found no significant differences 
between groups in cold sensory thresholds in the forearm; this is extended by 
reporting no ethnic differences in the finger pad. 
 
The CS test is used to identify cold sensitivity and aid in the diagnosis of NFCI, 
with a low pre-immersion toe or finger Tsk and slower rate of rewarming indicating 
cold sensitivity (Eglin et al. 2013). CAU experienced a higher Great toe SkBF at 
minute five and six during rewarming compared with AFD, but these statistical 
differences are not considered physiologically significant because 1) the 
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differences in Great toe SkBF between AFD and CAU did not result in significant 
differences in Great toe Tsk, and 2) by minute five Great toe SkBF for AFD had 
almost returned to baseline values (i.e. 100 %). The insignificant physiological 
differences between ethnic groups in the CS test may be due to a number of 
factors: the gentle exercise prior to foot immersion in the CS test is undertaken to 
promote a vasodilated state and minimise any central vasoconstrictor response on 
the local response to the foot immersion. Whilst this has been shown to increase 
the reproducibility of the test (Eglin et al. 2005) it may have masked any underlying 
ethnic differences. Perhaps more importantly, a two minute immersion period and 
15 °C water used in the CS test may not have been a strong enough cold stimulus 
to elicit differences between ethnic groups as were observed in the CIVD and VT 
test which involved a greater cold stimulus (longer immersion time and lower water 
temperature). These latter tests are probably more representative of the conditions 
which cause NFCI. 
 
Possible methodological differences between CIVD studies may help explain why 
the present study did not observe any differences in the CIVD variables assessed 
from Tsk. Water temperatures between 0 °C and 5 °C have been used previously, 
with the addition of one investigation immersing participants' extremities for 45 
minutes (Iampietro et al. 1959) compared with 30 minutes in the present study. 
Thus, the cold water immersion in the previous investigations would have provided 
a greater sympathetic stimulus perhaps enabling differentiation of the CIVD 
responses between ethnic groups. 
 
It is concluded that on hand cooling, AFD experience a greater vasoconstrictor 
response and also rewarm later and slower than CAU. As a consequence, the 
extremities, in particular the fingers, of AFD experience a greater “dose” of cold 
skin which may make them more likely to acquire a NFCI during exposure to cold. 
Differences in the sensitivity to vasoactive agents between AFD and CAU affecting 
both vasodilator and vasoconstrictor capacity may play a role in the protracted 
vasoconstrictor response observed during local cooling and subsequent 
rewarming. No previous investigations have studied the control of SkBF between 
CAU and AFD in skin sites that may be affected by NFCI (e.g. fingers and toes). 
This is addressed in the next study. 
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5 Study Two - Vascular Responses of the Extremities to Transdermal 
Application of Vasoactive Agents in Caucasian and African Descent 
Individuals 
5.1 Introduction 
Study One demonstrated that during local hand cooling and subsequent 
rewarming AFD experience lower SkBF and slower rewarming compared with 
CAU. The responses from ASN were intermediate; therefore this group is not 
studied subsequently. It appears that the greater susceptibility of AFD to NFCI 
may be due to differences in the control of SkBF compared with CAU. The control 
of SkBF has previously been examined using vasoactive agents that influence 
endothelium-dependent or -independent vasodilatation, as well as 
vasoconstriction. Previous investigations have reported that AFD experience an 
attenuated response to endothelium-dependent vasodilators (e.g. methacholine or 
ACh) compared with CAU in the forearm circulation (Stein et al. 1997; Jones et al. 
1999; Cardillo et al. 1999; Pienaar et al. 2014). Blood flow responses to an 
endothelium-independent vasodilator (e.g. SNP or glyceryl trinitrate) appears to be 
mixed, with some observations showing similar responses between AFD and CAU 
(Jones et al. 1999), whilst others have shown a lower blood flow response in AFD 
compared with CAU (Stein et al. 1997; Cardillo et al. 1999; Pienaar et al. 2014). 
The vascular responses to vasoconstrictor agents (e.g. ANG II or phenylephrine) 
has not been as extensively studied, but responses may (Stein et al. 2000), or 
may not (Jones et al. 1999), differ between ethnic groups. 
 
Likewise to studies that have utilised iontophoresis of vasoactive agents in the feet 
of patients with diabetes (a condition known to effect the feet) (Arora et al. 1998; 
Hamdy et al. 2001), it is appropriate in the present study to assess the skin sites 
susceptible to NFCI (e.g. hands, feet). Daanen and van der Struijs (2005) showed 
that in 54 individuals who suffered a NFCI during winter military operations, 72 % 
occurred in the feet, 25 % in the hands with the remaining injuries occurring on the 
head. Furthermore, it is of interest to investigate both glabrous and non-glabrous 
extremity skin sites as NFCI occurs at both sites, but the control of SkBF appears 
to differ between these sites (see Review of Literature, page 33). 
 
The SkBF responses to local application of vasoactive agents in CAU and AFD in 
skin sites susceptible to NFCI are not known. Therefore, the aim of Study Two was 
97 
 
to examine endothelium-dependent and -independent vasodilator responses by 
using ACh and SNP, respectively. Any potential vasoconstrictor differences 
between ethnic groups to NA were also assessed. Both non-glabrous and 
glabrous skin sites on the fingers and toes as well as the forearm were tested.  
5.2 Hypotheses 
H01. Responses to ACh, SNP and NA will not differ between ethnic 
groups. 
HA1. AFD will have an attenuated response to ACh and SNP and an 
exaggerated response to NA compared with CAU. 
5.3 Methods 
5.3.1 Participants 
A favourable ethical opinion was received from the Science Faculty Ethics 
Committee in accordance with University regulations (SFEC 2013-042). 12 CAU 
and 12 AFD male volunteers participated in the study, which included two CAU 
and six AFD from Study One. In the present study all CAU were born in the UK. 
Four AFD participants were born in the UK whilst eight had resided in the UK for 
an average of six years with a minimum of three years; four were born in 
Zimbabwe, two in Nigeria, one in Ghana and one in Italy.  
5.3.2 Experimental Procedures and Measurements 
Each participant attended the laboratory on three occasions separated by at least 
24 hours. Participants received local transdermal application of ACh, SNP or NA 
using iontophoresis in a balanced order at the same time of day. All experiments 
were carried out in a quiet temperature controlled room. Tdb was maintained 
between 23 °C and 24 °C. Pilot testing demonstrated that participants at rest in 
these environmental temperatures were within the “vasomotor zone” (i.e. neither 
fully vasoconstricted nor vasodilated) and provided an ideal baseline to observe 
vasodilatation and vasoconstriction respectively. Each participant was supine 
throughout the experiment. Blood pressure, from the contralateral arm used for 
iontophoresis, was recorded pre and post each application of iontophoresis and 
measured using an automated monitor (Minimon 7137 Plus, Kontron Instruments, 
UK). All participants rested for 20 minutes to allow Tsk and SkBF to stabilise before 
application of iontophoresis.  
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Iontophoresis was applied to the left side of the body to the volar aspect of the 
forearm, non-glabrous site of the middle finger (middle phalanx), non-glabrous site 
of the Great toe (proximal phalanx), middle finger pad and Great toe pad. The 
order of sites tested was randomised. Each skin site was cleaned with water for 
injection prior to iontophoresis. 
 
In pilot studies iontophoresis was difficult to conduct on AFD as it appeared that 
they had greater skin resistance which limited the current that could be applied. 
Approximately 25 μA could be consistently delivered to both AFD and CAU 
participants, whilst applying 50 μA and 100 μA was less successful. Therefore the 
protocol was adapted based on previous investigations using an intermittent 
protocol of similar duration (Morris and Shore 1996; Hendry and Marshall 2004; 
Srinivasa and Marshall 2011). This greater electrical skin resistance in AFD has 
previously been observed (Johnson and Corah 1963; Pienaar et al. 2014). The 
laser Doppler and iontophoresis equipment utilised in this study are described in 
the General Methods (see page 62 and 71). The laser Doppler probe was utilised 
to measure SkBF as well as Tsk. To test the effects of the vehicle at the cathode, 
the iontophoresis protocol was repeated on a separate day on randomly selected 
participants. 
Protocols 
Acetylcholine 
ACh (1 w/v % [55.05 mM], Miochol-E, Bausch and Lomb, UK) was used at the 
anode with the cathode placed proximally to the site of interest. The protocol 
(Table 5.1) consisted of six pulses of 25 μA followed by one pulse of 50 μA and 
one of 100 μA for 20 seconds all separated by 60 second intervals in which no 
current was applied. After an interval of five minutes the protocol was repeated on 
the next skin site. 
Sodium Nitroprusside 
SNP (0.01 w/v % [0.34 mM], Rottapharm Madaus, Barcelona, Spain) was used at 
the cathode with the anode placed proximally to the site of interest. The protocol 
consisted of six pulses of 25 μA followed by one pulse of 50 μA and one of 100 μA 
for 20 seconds all separated by 120 second intervals in which no current was 
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applied as the dilator response to SNP takes longer to develop than ACh (Ramsay 
et al. 2002; Hendry and Marshall 2004). After an interval of five minutes the 
protocol was repeated on the next skin site. 
Noradrenaline 
NA (0.5 mM [0.008 w/v %], Hospira, Leamington Spa, UK) was used at the anode 
with the cathode placed proximally to the site of interest. The protocol consisted of 
six pulses of 25 μA followed by one pulse of 50 μA and one of 100 μA for 30 
seconds all separated by 60 second intervals in which no current was applied. 
After an interval of five minutes the protocol was repeated on the next skin site. 
5.3.3 Data Analyses 
Due to high skin resistance it was not possible to deliver all of the current pulses in 
each skin site for all participants; this occurred more in the AFD participants. As a 
consequence, the number of participants contributing to the data decreased as the 
current increased. Participants who were able to receive the iontophoresis charge 
were included in the data analysis. Analysis of the SkBF data showed the results 
were similar if only those who completed the protocol were included compared to 
inclusion of all participants until they were not able to receive the desired current. 
Therefore, as it was desirable to include as many participants as possible in the 
analyses, all participants until they were not able to receive the desired current 
were included. As blood pressure remained constant throughout the study (see 
results), SkBF was expressed in LDU rather than cutaneous vascular conductance 
(i.e. flux / mean arterial pressure [MAP]). Responses evoked in the cutaneous 
circulation by iontophoresis were expressed as percentage change from that prior 
to iontophoresis in the resting condition (averaged over 20 seconds for ACh and 
30 seconds for SNP and set at 0 %). For responses to ACh, average SkBF was 
calculated over the final 20 seconds of the interval between successive pulses and 
between 40 to 60 seconds after the final pulse (Figure 5.1). For SNP, average 
SkBF was calculated over the final 30 seconds of the interval between successive 
pulses and at 90 to 120 seconds after the final pulse (Figure 5.2). As responses to 
NA are shorter-lasting (Hendry and Marshall 2004) baseline for NA was identified 
as the minimum SkBF during the 60 seconds prior to iontophoresis and the 
minimum SkBF was identified between each pulse and between 0 to 60 seconds 
after the final pulse (Figure 5.3).  
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Table 5.1 Protocol overview for Study Two  
 Protocol 
 
Acetylcholine 
Sodium 
nitroprusside 
Noradrenaline 
Polarity Positive Negative Positive 
Duration of 
current (seconds) 
20 20 30 
Interval 
(seconds) 
60 120 60 
Current 6 × 25 μA 
1 × 50 μA 
1 ×100 μA 
6 × 25 μA 
1 × 50 μA 
1 ×100 μA 
6 × 25 μA 
1 × 50 μA 
1 ×100 μA 
Charge 6 × 0.5 mC 
1 × 1 mC 
1 × 2 mC 
6 × 0.5 mC 
1 × 1 mC 
1 × 2 mC 
6 × 0.75 mC 
1 × 1.5 mC 
1 × 3 mC 
Current density 6 × 0.035 mA·cm2 
1 × 0.070 mA·cm2 
1 × 0.141 mA·cm2 
6 × 0.035 mA·cm2 
1 × 0.070 mA·cm2 
1 × 0.141 mA·cm2 
6 × 0.035 mA·cm2 
1 × 0.070 mA·cm2 
1 × 0.141 mA·cm2 
Charge density 6 × 0.704 mC·cm2 
1 × 1.409 mC·cm2 
1 × 2.817 mC·cm2 
6 × 0.704 mC·cm2 
1 × 1.409 mC·cm2 
1 × 2.817 mC·cm2 
6 × 1.056 mC·cm2 
1 × 2.113 mC·cm2 
1 × 4.225 mC·cm2 
Charge = time (seconds) × current (mA). Current density = current (mA) ÷ area of iontophoresis 
chamber (0.71 cm
2
). Charge density = charge (mC) ÷ area of iontophoresis chamber (0.71 cm2). 
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Figure 5.1 Representative trace of forearm skin blood flow in response to 
acetylcholine 
Filled grey bars indicate the time period which was averaged. 
 
 
Figure 5.2 Representative trace of forearm skin blood flow in response to sodium 
nitroprusside 
Filled grey bars indicate the time period which was averaged. 
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Figure 5.3 Representative trace of toe pad skin blood flow in response to 
noradrenaline 
Arrows indicate the minimum data point 
5.3.4 Statistical Analyses 
An independent samples t-test was utilised to compare participant characteristics 
and blood pressures between ethnic groups. A paired samples t-test was utilised 
to assess within-group change in blood pressure from pre to post iontophoresis. 
The SkBF data were not normally distributed therefore group comparisons were 
conducted utilising a Mann-Whitney U test. Half-maximal effective dose (ED50) 
expressed as 95 % confidence intervals was calculated using GraphPad (Version 
5, USA). Maximal SkBF (for ACh and SNP) and minimum SkBF (for NA) was 
calculated for each participant and compared between ethnic groups. The point at 
which the SkBF was at a maximum or minimum was not always identified following 
the final pulse, therefore maximum SkBF was taken from wherever it was highest 
and minimum SkBF was taken from whenever it was lowest.  
5.4 Results 
Both ethnic groups were of similar age (CAU: 21 [3] years, AFD: 21 [2] years), 
height (CAU: 1.8 [0.1] m, AFD: 1.8 [0.1] m) and mass (CAU: 73.4 [10.7] kg, AFD: 
73.6 [12.2] kg). 
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5.4.1 Baseline Skin Blood Flow and Skin Temperature 
Prior to iontophoresis local SkBF (Table 5.2) and Tsk (Table 5.3) did not differ 
between ethnic groups at any skin site except AFD had a lower resting SkBF at 
the glabrous toe compared with CAU prior to SNP application (P = 0.014) however 
this did not translate to a difference in Tsk. As expected, resting SkBF was higher 
in the glabrous skin sites compared to the non-glabrous skin sites and this was 
demonstrated more so in the fingers. Not all participants could receive the first 
pulse of iontophoresis due to high skin resistance; therefore only those who 
successfully received the first pulse were included in the analyses. 
 
Table 5.2 Median (IQR) local skin blood flow (LDU) prior to iontophoresis at each 
skin site 
 Baseline Skin Blood Flow (LDU) 
 Acetylcholine Sodium 
nitroprusside 
Noradrenaline 
Site CAU AFD CAU AFD CAU AFD 
Forearm 15 (10) 
n = 12 
18 (16) 
n = 11 
16 (8) 
n = 12 
15 (6) 
n = 11 
17 (17) 
n = 11 
11 (14) 
n = 11 
NGF 58 (24) 
n = 12 
53 (21) 
n = 11 
61 (31) 
n=12 
36 (117) 
n = 8 
55 (35) 
n = 12 
59 (102) 
n = 11 
GF 399 (182) 
n = 11 
326 (370) 
n = 9 
341 (249) 
n = 12 
255 (293) 
n = 12 
247 (283) 
n = 11 
122 (462) 
n = 11 
NGT 18 (37) 
n = 12 
11 (34) 
n = 9 
20 (22) 
n = 12 
11 (8) 
n = 12 
11 (27) 
n = 12 
16 (18) 
n = 11 
GT 38 (124) 
n = 12 
13 (53) 
n = 8 
44 (61)* 
n = 12 
15 (24) 
n = 10 
71 (163) 
n = 11 
41 (94) 
n = 9 
* Significant difference between CAU and AFD, P < 0.05. NGF = Non-glabrous finger, GF = 
Glabrous finger, NGT = Non-glabrous toe, GT = Glabrous toe. 
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Table 5.3 Median (IQR) local skin temperature (°C) prior to iontophoresis at each 
skin site 
 Baseline Skin Temperature (°C) 
 Acetylcholine Sodium 
nitroprusside 
Noradrenaline 
Site CAU AFD CAU AFD CAU AFD 
Forearm 28.9 (1.2) 
n = 12 
28.4 (1.1) 
n = 11 
28.8 (0.6) 
n = 12 
27.7 (1.6) 
n = 11 
29.4 (1.9) 
n = 11 
29.2 (1.4) 
n = 11 
NGF 29.1 (1.9) 
n = 12 
28.7 (1.2) 
n = 11 
29.6 (2.7) 
n = 12 
27.3 (2.0) 
n = 8 
30.2 (0.8) 
n = 12 
29.5 (2.4) 
n = 11 
GF 29.7 (2.0) 
n = 11 
30.5 (4.8) 
n = 9 
30.2 (3.6) 
n = 12 
28.8 (4.8) 
n = 12 
30.4 (1.9) 
n = 11 
30.2 (3.3) 
n = 11 
NGT 26.6 (3.3) 
n = 12 
27.1 (3.2) 
n = 9 
26.6 (2.4) 
n = 12 
27.0 (3.5) 
n = 12 
27.6 (3.4) 
n = 12 
27.6 (3.4) 
n = 11 
GT 26.3 (3.9) 
n = 12 
25.5 (2.7) 
n = 8 
25.4 (4.4) 
n = 12 
24.3 (2.9) 
n = 10 
28.2 (2.4) 
n = 11 
26.9 (3.4) 
n = 9 
NGF = Non-glabrous finger, GF = Glabrous finger, NGT = Non-glabrous toe, GT = Glabrous toe. 
5.4.2 Blood Pressure 
Blood pressure did not differ between ethnic groups prior to iontophoresis of ACh, 
SNP or NA (Table 5.4). Blood pressure did not differ between ethnic groups post 
iontophoresis, or within-participants pre to post iontophoresis. 
 
Table 5.4 Mean (SD) blood pressure (mmHg) prior to iontophoresis 
 Blood Pressure (mmHg) 
 Acetylcholine Sodium 
nitroprusside 
Noradrenaline 
Variable CAU AFD CAU AFD CAU AFD 
Systolic 120 (11) 121 (9) 119 (9) 124 (9) 120 (7) 123 (9) 
Diastolic 60 (6) 64 (8) 62 (5) 65 (8) 62 (7) 63 (5) 
MAP 80 (6) 83 (8) 81 (5) 85 (8) 81 (6) 83 (6) 
MAP = Mean arterial pressure. CAU n = 12, AFD n = 12. 
5.4.3 Responses to Acetylcholine 
In the non-glabrous finger, AFD demonstrated less vasodilatation for a given 
current (Figure 5.4) (P = 0.043 to 0.014, r = 0.48 to 0.52), a lower maximum 
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vasodilatation (Mdn [IQR], AFD n = 11, 41 [234] %, CAU n = 12, 351 [451] %, P = 
0.011, r = 0.53) and a greater ED50 (95% confidence intervals, AFD = 136 μA to 
223 μA, CAU = 40 μA to 117 μA, P < 0.001) compared with CAU. In the non-
glabrous toe, again AFD demonstrated less vasodilatation for a given current (P = 
0.024 to 0.023, r = 0.50 to 0.68) and a lower maximum vasodilatation (Mdn [IQR], 
AFD n = 9, 116 [318] %, CAU n = 12, 484 [720] %, P = 0.018, r = 0.51) compared 
with CAU, however ED50 was similar. There were no SkBF differences between 
groups for the forearm, glabrous toe or finger skin sites. 
 
Figure 5.4 Mean (SD) skin blood flow responses to iontophoresis of acetylcholine 
in CAU and AFD 
* Significant difference between CAU and AFD, P < 0.05. n = 12, unless stated. Note scale change 
for Forearm skin site. 
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5.4.4 Responses to Sodium Nitroprusside 
In the forearm skin site AFD demonstrated less vasodilatation for a given current 
(Figure 5.5) (P = 0.027 to 0.004, r = 0.46 to 0.58) and a greater ED50 (95% 
confidence intervals, AFD = 130 μA to 167 μA, CAU = 80 μA to 107 μA, P < 0.001) 
compared with CAU, however maximum vasodilatation was similar. Following the 
final pulse on the glabrous toe skin site AFD had a smaller SkBF response 
compared with CAU (P = 0.018, r = 0.61). There were no other differences for any 
skin site except CAU had a greater SkBF response in the glabrous toe compared 
with AFD following the final pulse (P = 0.018, r = 0.61). 
 
Figure 5.5 Mean (SD) skin blood flow responses to iontophoresis of sodium 
nitroprusside in CAU and AFD 
* Significant difference between CAU and AFD, P < 0.05. n = 12, unless stated. Note scale change 
for Forearm skin site. 
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5.4.5 Responses to Noradrenaline 
In response to NA there were no SkBF differences over time at any skin site 
between ethnic groups. Additionally, there were no ethnic differences for maximum 
decrease in SkBF for any skin site (Table 5.5). The responses to transdermal 
delivery of ACh, SNP and NA to the various skin sites in the two ethnic groups are 
summarised in Table 5.6. 
 
Table 5.5 Median (IQR) and mean (SD) maximum percentage decrease in skin 
blood flow in response to iontophoresis of noradrenaline 
 Ethnicity 
Site CAU AFD 
Forearm ^ -39 (15) % 
n = 11 
-29 (55) % 
n = 11 
Non-glabrous finger -65 (23) % 
n = 12 
-54 (25) % 
n = 11 
Glabrous finger -64 (21) % 
n = 11 
-65 (25) % 
n = 11 
Non-glabrous toe -44 (32) % 
n = 12 
-46 (27) % 
n = 11 
Glabrous toe -58 (27) % 
n = 11 
-46 (33) % 
n = 9 
^ Mdn (IQR). 
 
Table 5.6 Summary of skin blood flow results for Study Two 
 Responses 
Group Acetylcholine 
Sodium 
nitroprusside 
Noradrenaline 
CAU  forearm, NGF, 
NGT 
 forearm, NGF, 
NGT 
 forearm, NGF, GT 
AFD  forearm, NGF, 
NGT 
 
 forearm  forearm, NGF, GF, 
NGT, GT 
CAU vs. 
AFD 
NGF and NGT 
CAU > AFD 
Forearm  
CAU > AFD 
No differences 
NGF = Non-glabrous finger, GF = Glabrous finger, NGT = Non-glabrous toe, GT = Glabrous toe. 
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5.4.6 Responses to Vehicle 
There was a significant vasodilator response to the SNP vehicle in the forearm 
skin site (P = 0.003). Due to low participant numbers statistical analyses could not 
be performed on the other skin sites, but did not appear to show the same trace as 
the forearm skin site (Figure 5.6). 
 
Figure 5.6 Mean (SD) skin blood flow responses of iontophoresis of vehicle at 
cathode presented as percentage change 
n = 5 forearm, n = 2 for all other skin sites. NGF = Non-glabrous finger, GF = Glabrous finger, NGT 
= Non-glabrous toe, GT = Glabrous toe. 
5.5 Discussion 
In the present study, comparing young healthy male CAU and AFD participants, 
there was an attenuated increase in SkBF for a given current in response to ACh 
in the non-glabrous finger and non-glabrous toe in AFD (Figure 5.4); however 
these differences were not repeated with SNP (Figure 5.5) or NA (Table 5.5). This 
is in contrast to other studies which report lower blood flow responses in AFD 
compared with CAU to both ACh and SNP (Stein et al. 1997; Cardillo et al. 1999; 
Pienaar et al. 2014). The results of the present study reject H01, but do not provide 
full support for HA2. 
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Results from the forearm skin site in response to ACh displaying similar blood flow 
responses between ethnic groups appear to contrast previous findings (Stein et al. 
1997; Jones et al. 1999; Cardillo et al. 1999). The difference in results may be 
attributable to a different method of measuring SkBF (i.e. venous-occlusion 
plethysmography) and / or delivery of vasoactive agent (i.e. brachial infusion). 
Intra-arterial infusion would allow a greater concentration of the vasoactive agent 
to be delivered compared with iontophoresis. For example, Cardillo et al. (1999) 
infused ACh at >7.5 μg per minute for five minutes which would equate to >37.5 
μg delivered. In contrast, based on the calculation presented earlier in the General 
Methods (see section 3.4.4), using iontophoresis for five minutes at 25 μA would 
deliver 14.1 μg. The greater concentration delivered using infusions may highlight 
differences between ethnic groups that may not be readily observed with 
iontophoresis; however, local delivery of the vasoactive agent to the skin site 
under investigation is an advantage of iontophoresis. In combination with the 
previous results, the forearm microcirculation may or may not differ between ethnic 
groups. However, this is the first study to demonstrate that the microcirculation 
reactivity of the non-glabrous finger and toe skin sites differ between CAU and 
AFD (Maley et al. 2015); this may play a role in the increased susceptibility of AFD 
to NFCI. 
 
A previous observation reported that electrical skin resistance correlates with a 
lower SkBF in response to iontophoresis of ACh in the forearm skin site (Pienaar 
et al. 2014). Pienaar et al. (2014) correlated SkBF responses with electrical skin 
resistance but did not split the data into CAU and AFD. The conclusion that 
iontophoresis in AFD is limited by resistance may be flawed as this ethnic group is 
known for 1) higher skin resistance (Johnson and Corah 1963) and 2) decreased 
endothelium reactivity (Stein et al. 1997; Jones et al. 1999; Cardillo et al. 1999), 
which are two independent variables; therefore a conclusion cannot be drawn from 
one correlation including both CAU (known for low skin resistance, “normal” 
endothelium reactivity) and AFD data (known for high skin resistance, decreased 
endothelium reactivity) (i.e. high skin resistance does not cause decreased 
endothelium reactivity). When the SkBF results of the present study were 
correlated with electrical skin resistance the only moderate correlation was for 
AFD on the forearm skin site (R2 = 0.3); however, this was driven by one 
participant and when that particular participant was removed the R2 value dropped 
to 0.03. There was no other skin site for any other vasoactive drug in the present 
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study that showed support for a correlation between electrical skin resistance and 
SkBF responses. 
 
The present study supports the findings that a difference exists in response to 
SNP at the forearm (Stein et al. 1997; Cardillo et al. 1998; Cardillo et al. 1999; 
Pienaar et al. 2014). Reduced vasodilatation in AFD compared with CAU in 
response to SNP would suggest an altered function at the smooth muscle cell 
level. However, a non-specific vasodilator response is prominent at the cathode 
site where SNP is used (Morris and Shore 1996). Subsequent testing in the 
present study revealed a large increase in forearm SkBF in response to 
iontophoresis of the SNP vehicle at the cathode, whilst the other skin sites did not 
demonstrate the same response (Figure 5.6). The increase in SkBF observed 
upon electrical stimulation has been shown to stimulate sensory nerves (Schmelz 
et al. 2000) which release vasodilators CGRP and Substance P (Sauerstein et al. 
2000; Xanthos and Sandkühler 2014). This, therefore, is a limitation of the 
iontophoresis technique in that the responses to iontophoresis of SNP in the 
forearm circulation may, in part, be influenced by a sensory component (Morris 
and Shore 1996).  
 
It was expected that NA would cause a greater SkBF decrease in AFD compared 
with CAU; this was not the case in the present study. Previous research has 
showed that CAU and AFD do not differ in response to intra-arterial infusion of 
ANG II (Jones et al. 1999); others have shown that intra-arterial infusion of 
phenylephrine causes a greater vasoconstrictor response in AFD than CAU (Stein 
et al. 2000). Both vasoactive agents appear to exert their vasoconstrictor effects 
by modulating intracellular [Ca2+] but the reason for the discrepancy between 
studies may be due to different mechanism of action; ANG II acts on the 
endothelium as well as the smooth muscle cell, whereas phenylephrine, an α1 
receptor agonist, primarily acts upon the smooth muscle cell (Pueyo and Michel 
1997; Rang et al. 2012). NA is able to activate α (vasoconstrictor) as well as β 
(vasodilatory) adrenergic receptors (Ahlquist 1948; Bylund et al. 1994) which may 
have masked any increased sensitivity in α receptors in AFD.  
 
Combining the present study results with Study One (Maley et al. 2014) it is 
possible that the altered endothelium function of AFD may contribute to the 
exaggerated vasoconstriction and delayed rewarming in response to local cooling; 
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this may help explain why this group is more susceptible to NFCI. The role of the 
endothelium during cooling has previously been demonstrated, where inhibition of 
NOS prior to local forearm cooling lead to a 35 % decrease in SkBF, with 
subsequent cooling leading to a further 23 % decrease (Hodges et al. 2006). This 
demonstrates that the endothelium plays an important role in the response to local 
cooling, and any defect in its function may exaggerate the cooling response; Study 
One and the present study thesis provide support for this hypothesis.  
 
ACh binds to muscarinic receptors on the endothelial cell surface and produces 
mediators to effect vasodilatation (Furchgott and Zawadzki 1980; Furchgott 1983). 
These mediators include prostanoids, metabolised by COX (Vane 1971; Vane et 
al. 1998), including PGI2 which is a known vasodilator (Moncada et al. 1976; Duffy 
et al. 1998; Vane and Corin 2003). Similarly to AFD in the present study, 
hypertensive individuals exhibit a reduced response to ACh (Taddei et al. 1993) 
but when COX was inhibited, the vasodilator responses to ACh were increased 
(Taddei et al. 1997a; Taddei et al. 1997b). That is, COX appears to be limiting the 
response to ACh; whether the diminished response to ACh in AFD is due, in part, 
to a dysfunctional COX pathway is not known. This question is addressed next. 
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6 Study Three - Skin Blood Flow Responses to Locally Applied 
Acetylcholine in Caucasian and African Descent Individuals With and 
Without Cyclooxygenase Inhibition 
6.1  Introduction 
Study Two demonstrated that endothelium-dependent, but not -independent 
vasodilatation or vasoconstriction, was significantly attenuated in AFD compared 
with CAU in non-glabrous finger and toe skin sites. The vasodilator response to 
ACh is reliant on both prostaglandins and nitric oxide (Kellogg et al. 2005; 
Holowatz et al. 2005). Prostanoids are produced from AA, released from the cell 
membrane, metabolised by the enzyme COX (Vane et al. 1998) to produce 
prostaglandin H2 which is further metabolised by various synthase enzymes to 
produce prostanoids, PGI2, PGF2, PGD2, PGE2 and TXA2 (Hamberg et al. 1975; 
Moncada et al. 1976; Moncada and Vane 1979; Félétou 2011). The vascular wall 
synthesises each of these prostanoids, with the most abundant being PGI2, whilst 
platelets are the main source of TXA2 (Moncada and Vane 1978; Dubois et al. 
1998; Tang and Vanhoutte 2008; Félétou 2011; Majed and Khalil 2012). Whilst in 
young healthy individuals the physiological responses to the two most important 
prostaglandins in vascular function (TXA2 [vasoconstriction] and PGI2 
[vasodilatation]) are stable, it appears that PGE2 is able to exert both 
vasoconstriction and vasodilatation by acting on different receptor subtypes 
(Félétou 2011; Majed and Khalil 2012). 
 
Under various physiological conditions the role of these prostanoids may differ. In 
murine models it has been shown that PGI2 has a biphasic effect on smooth 
muscle cell relaxation; low PGI2 concentrations elicit relaxation but higher 
concentrations elicit constriction by acting on the thromboxane-prostanoid receptor 
as opposed to the IP receptor (i.e. IP receptor activation stimulates vasodilatation) 
(Williams et al. 1994). Subsequent studies provided support for this finding and 
further demonstrated that COX increases ROS (Yang et al. 2002; Tang et al. 
2007) and that PGI2 synthase expression is augmented in spontaneously 
hypertensive rats compared with normotensive rats (Tang and Vanhoutte 2008). 
This latter finding is in line with a human study where they found that 
polymorphism of the PGI2 synthase gene was associated with hypertension (Iwai 
et al. 1999). 
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More specifically to humans, over the past ten years Professor Stefano Taddei 
and his colleagues have provided great insight into the control of blood flow and 
the link with oxidative stress, through comparisons between hypertensive 
individuals and controls. Specifically, they have demonstrated that COX inhibition 
accentuates the response to ACh in individuals with hypertension (Taddei et al. 
1993), which was due to restoration of nitric oxide dependent vasodilatation 
(Taddei et al. 1997a). They later demonstrated that normotensive aged (>60 
years) and hypertensive individuals (>46 years) exhibit similar endothelium 
dysfunction which was restored with COX inhibition (Taddei et al. 1997b). The 
antioxidant, vitamin C, also had a similar effect as COX inhibition in both groups 
(Taddei et al. 1998; Taddei et al. 2001). More recently the group performed an in 
vitro study on human small arteries where they noted the antioxidant, ascorbic 
acid, and a non-selective COX inhibitor accentuated the vasodilator response to 
ACh with ascorbic acid reducing O2
- production to levels observed in normotensive 
samples (Virdis et al. 2013). Collectively, this group have provided sound evidence 
that COX is a source of oxidative stress in humans which subsequently diminishes 
nitric oxide bioavailability, demonstrated by a reduced response to ACh. Whether 
the endothelium dysfunction in AFD observed in Study Two is as a result, in part, 
of a differing contribution of the COX pathway between ethnic groups is not 
known. 
 
Aspirin (also known as acetylsalicylic acid) irreversibly inhibits COX by acetylation 
(acetyl group transferred from one molecule to another) of the active site of COX 
(Vane 1971; Vane and Botting 2003). A single dose of aspirin (500 mg) takes 30 
minutes to reach maximum drug concentration in plasma and has shown to 
effectively inhibit platelet aggregation and greatly reduce prostanoid production 
(>80 %, measured from serum) (Nagelschmitz et al. 2014). Whilst aspirin inhibits 
COX in endothelium and smooth muscle cells (Smith and Willis 1971; Jaffe and 
Weksler 1979; Hla and Bailey 1989), platelets are exposed to peak concentrations 
of aspirin in the portal circulation before metabolism of aspirin by the liver 
(Pedersen and FitzGerald 1984), suggesting that platelet COX may be inhibited 
first compared with peripheral (systemic) endothelial and smooth muscle cells. 
Single doses of both small (<100 mg) and large (>325 mg) doses of aspirin inhibit 
both platelet COX and vascular wall COX in a dose dependent manner (Warner et 
al. 2011). 
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COX inhibition in combination with ACh application in the forearm microcirculation 
has shown to attenuate vasodilator responses in healthy individuals (Kellogg et al. 
2005; Holowatz et al. 2005). However, COX inhibition has been shown to 
accentuate the vasodilator response to local application of ACh in the non-
glabrous site of the finger in young healthy individuals (Hendry and Marshall 
2004). This suggests that the role of COX in the non-glabrous finger promotes 
vasoconstriction (i.e. further vasodilatation is observed with COX inhibition). 
Whether the COX contribution differs between CAU and AFD in response to local 
application of ACh in non-glabrous extremity skin sites is not known. Therefore, 
the aim of Study Three was to establish the COX contribution to ACh-induced 
vasodilatation using iontophoresis in both CAU and AFD. 
6.2  Hypotheses 
H01. SkBF responses to ACh following placebo or aspirin consumption in the 
foot and finger skin sites will not differ between CAU and AFD. 
HA1. SkBF responses to ACh following placebo or aspirin consumption in the 
foot and finger skin sites will be greater in CAU than AFD.  
 
H02. SkBF responses to ACh in the foot and finger skin sites within-participants 
will not differ between placebo and aspirin trials. 
HA2. SkBF responses to ACh in the foot and finger skin sites within-participants 
will differ between placebo and aspirin trials. 
6.3 Methods 
6.3.1 Participants 
A favourable ethical opinion was received from the Science Faculty Ethics 
Committee in accordance with University regulations (SFEC 2014-050a). 
Participants were made aware of the purpose, procedure and risk of the study 
prior to giving their informed written consent. 12 CAU and 12 AFD male volunteers 
participated in the study, which included six CAU and five AFD participants from 
Study Two. All CAU were born in the UK. Eight AFD were born in the UK whilst 
four were born in Africa (Zimbabwe, Ghana, Kenya and Uganda) and had resided 
in the UK for an average of 11 years with a minimum of seven years.  
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6.3.2 Experimental Procedures and Measurements 
Participants attended the laboratory on one occasion where they received 
iontophoresis of ACh. On the day of testing participants were asked to consume 
150 mL of diluted orange squash immediately prior to entering a temperature 
controlled room set at Tdb of 23.2 (0.8) °C. All participants rested for 30 minutes in 
a supine position to allow Tsk and SkBF to stabilise before application of 
iontophoresis. Participants were supine throughout the experiment. Iontophoresis 
of ACh (1 w/v % [55.05 mM], Sigma-Aldrich, UK), diluted in water for injection, was 
applied to either the right medial or right lateral dorsum aspect of the foot first. 
Secondly, iontophoresis was applied to the third or fourth non-glabrous finger skin 
site (medial phalanx) on the right hand (Figure 6.1). Following this, participants 
were then asked to consume 150 mL of diluted orange squash which contained 
600 mg of dissolved aspirin (Boots Company, UK), blinded to the participant. This 
dose of aspirin has been shown to inhibit, 86 % of bradykinin-induced production 
of PGI2 and 99 % inhibition of TXA2 production by platelets at 30 minutes (Heavey 
et al. 1985).  
 
Thirty minutes after aspirin consumption, iontophoresis began on the foot at a skin 
site that had not been used (medial or lateral). Following this, iontophoresis was 
applied to the second finger skin site (third or fourth). The reason for not using the 
same skin site was that during pilot experiments the vasodilator responses to 
iontophoresis of ACh were much longer lasting that 30 minutes, thus using the 
same skin site would influence subsequent SkBF results; this has been noted in 
the literature previously (Brocx and Drummond 2009). The order of participants’ 
skin sites tested (lateral vs. medial dorsum, third vs. fourth finger) was balanced 
between-participants. 
 
Placebo Foot Site 1 Finger Site 1  Aspirin 
600 mg 
Foot Site 2 Finger Site 2 
Figure 6.1 Schematic of the experimental procedure for Study Three 
  
The iontophoresis protocol employed in the present study was the same as Study 
Two which consisted of six pulses of 25 μA (0.5 mC) followed by one pulse of 50 
μA (1mC) and one of 100 μA (2 mC) applied for 20 seconds separated by 60 
second intervals in which no current was applied. On completion of the protocol, 
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and after an interval of five minutes, the protocol was repeated on the next skin 
site. Blood pressure from the contralateral arm was recorded pre and post 
iontophoresis application and measured using an automated monitor (Minimon 
7137 Plus, Kontron Instruments, UK).  
 
The repeatability of iontophoresis was also assessed on a separate day in six 
participants. Briefly, volunteers participated in the same protocol without aspirin 
consumption; that is, their second drink did not contain aspirin. This would enable 
assessment of the site-to-site variation (i.e. medial vs. lateral foot, middle vs. 
fourth finger). Comparisons were also made with the main protocol results from 
these six individuals on their first foot and finger skin site (i.e. placebo). The order 
of skin sites tested on the separate day was reversed compared with the main 
protocol. That is, if an individual in the main protocol was started on the medial 
aspect of the foot, then the repeatability session started on the lateral aspect of the 
foot. The reason for this was to rule out the possibility that starting the 
iontophoresis protocol after a longer period of time resting (i.e. 30 minutes vs. ~80 
minutes) does not result in a different SkBF response. 
6.3.3 Data Analyses 
Due to high skin resistance it was not possible to deliver all of the current pulses in 
each skin site for all participants; this occurred more in the AFD participants. As 
skin resistance during iontophoresis has been suggested to influence the 
vasodilator responses to ACh (Puissant et al. 2014), following placebo the SkBF 
responses (average over the six pulses of 25 μA) were correlated with skin 
resistance (average over the six pulses of 25 μA) and were plotted for CAU and 
AFD separately and R2 calculated. As blood pressure remained constant 
throughout the iontophoresis protocol (see results), SkBF at baseline is expressed 
as LDU rather than CVC. Only those who were able to receive the first pulse of 
iontophoresis were included in analyses. Responses evoked in the cutaneous 
circulation by iontophoresis were expressed as percentage change from that prior 
to iontophoresis in the resting condition (averaged over 20 seconds and set at 0 
%). For responses to ACh, average SkBF was calculated over the final 20 
seconds of the interval between successive pulses and between 40 to 60 seconds 
after the final pulse. ED50, expressed as 95 % confidence intervals, maximal 
percentage change and AUC were also calculated as described in the Study Two. 
117 
 
6.3.4 Statistical Analyses 
Baseline LDU, Tsk and mean arterial blood pressure between- and within-
participants were compared using an independent and paired samples t-test, 
respectively. When analysing ED50, maximal percentage change, AUC and SkBF 
over time between- and within-participants a mix of both parametric and non-
parametric analyses were used and presented as mean (SD) or Mdn (IQR), 
respectively. Repeatability of ACh over time and between skin sites was assessed 
with CV % and ICC. Responses were repeatable if they met the a priori criteria set 
at; CV of <35 % and ICC >0.4, which has been previously recommended as 
repeatable criteria for SkBF responses to iontophoresis using LDF (Sauvet et al. 
2011; Puissant et al. 2013). 
6.4 Results 
6.4.1 Participant Characteristics 
CAU and AFD were of similar age (Mean [SD], 22 [4] years and 20 [2] years), 
height (Mean [SD], 178.2 [6.9] cm and 176.0 [7.9] cm) and body mass (Mean [SD], 
73.1 [12.3] kg and 74.1 [12.8] kg) (all P > 0.05). 
6.4.2 Mean Arterial Pressure 
MAP at baseline for CAU and AFD following placebo (Mean [SD], 83 [8] mmHg 
and 87 [8] mmHg, respectively, P > 0.05) and aspirin (Mean [SD], 84 [5] mmHg 
and 88 [9] mmHg, respectively, P > 0.05) did not differ between- or within-
participants (P > 0.05). 
6.4.3 Baseline Laser Doppler Units 
There were no baseline LDU differences between- or within-participants for either 
the foot or finger skin sites (Table 6.1, P > 0.05). 
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Table 6.1 Mean (SD) baseline laser Doppler units for the foot and finger skin sites 
following placebo and aspirin consumption in CAU and AFD 
 Baseline Skin Blood Flow (LDU) 
 Foot Finger 
 Placebo Aspirin Placebo Aspirin 
CAU 12 (6) 
n = 12 
11 (4) 
n = 12 
54 (19) 
n = 11 
47 (23) 
n = 11 
AFD 10 (7) 
n = 12 
8 (3) 
n = 12 
52 (25) 
n = 10 
48 (23) 
n = 8 
6.4.4 Baseline Skin Temperature 
Baseline Tsk between CAU and AFD did not differ for either the foot or finger skin 
sites following consumption of either placebo or aspirin (Table 6.2, P > 0.05). 
There were no within-participant differences (P > 0.05). 
 
Table 6.2 Mean (SD) baseline skin temperature (°C) for foot and finger skin sites 
following placebo and aspirin consumption in CAU and AFD 
 Baseline Skin Temperature (°C) 
 Foot Finger 
 Placebo Aspirin Placebo Aspirin 
CAU 27.1 (1.3) 
n = 12 
26.8 (1.3) 
n = 12 
29.4 (0.8) 
n = 11 
28.9 (1.1) 
n = 11 
AFD 27.0 (1.1) 
n = 12 
26.6 (1.3) 
n = 12 
28.8 (0.6) 
n = 10 
28.5 (0.7) 
n = 8 
6.4.5 Responses to Acetylcholine 
Foot Skin Site 
Figure 6.2 shows the SkBF responses to ACh for the foot skin site in CAU and 
AFD. CAU had a reduced vasodilator response to ACh following aspirin 
consumption when compared to placebo (P = 0.005 to 0.028, r = 0.82 to 0.63). 
Additionally, following aspirin consumption in CAU compared with placebo, ED50 
occurred at a greater cumulative current (Table 6.3, P < 0.01), the AUC was 
smaller (P = 0.031, d = 0.80) but maximal vasodilatation did not differ (P > 0.05). 
There were no within-participant differences in AFD (P > 0.05). 
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AFD demonstrated a significantly lower vasodilatation compared with CAU in 
response to ACh following both placebo (between the first and sixth pulse, P = 
0.000 to 0.044, r = 0.41 to 0.68) and aspirin consumption (between the first and 
sixth pulse, P = 0.001 to 0.020, r = 0.47 to 0.64). Following placebo consumption 
ED50 occurred at greater cumulative current for AFD compared with CAU (Table 
6.3, P < 0.001), maximal vasodilatation was significantly lower in AFD than CAU 
(P = 0.003, r = 0.59) as well as AUC (P = 0.001, r = 0.62). Following aspirin 
consumption, ED50 did not differ between groups (P > 0.05), however maximal 
vasodilatation (Table 6.3, P < 0.001, r = 0.67) and AUC (P = 0.002, r = 0.60) was 
significantly lower in AFD compared with CAU.  
 
Table 6.3 95 % confidence intervals of ED50 (microamps) and mean (SD) or 
median (IQR) maximal skin blood flow (%) and area under the curve in response 
to acetylcholine in the foot skin site 
 Variable 
 ED50 (μA) Max (%) AUC 
Within 
Foot  
CAU 
PLACEBO 
n = 12 
54 to 116 ^943 (490) 4808 (2678) 
ASPIRIN  
n = 12 
116 to 174 † ^775 (784) 2998 (1761) † 
Foot  
AFD 
PLACEBO 
n = 12 
150 to 268 ^81 (370) ^190 (1329) 
ASPIRIN  
n = 12 
118 to 418 ^50 (148) ^95 (894) 
Between 
Foot 
placebo 
CAU  
n = 12 
54 to 116 ^943 (490) ^4516 (2601) 
AFD 
n = 12 
153 to 302 * ^81 (370) * ^190 (1329) * 
Foot 
aspirin 
CAU  
n = 12 
116 to 174 ^775 (784) ^3120 (3170) 
AFD  
n = 12 
97 to 424 ^50 (148) * ^95 (894) * 
Note: as pairwise analyses were conducted within-groups, the values reported do not always 
match the between-groups analyses which included all participants or until a participant did not 
receive all applied current. ^ Mdn (IQR). 
† 
Significant difference between placebo and aspirin (P < 
0.05). * Significant difference between CAU and AFD (P < 0.05). AUC = Area under the curve.  
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Figure 6.2 Individual CAU (a) and AFD (b) skin blood flow responses to 
acetylcholine in the foot skin site presented as percentage change from rest 
† Significant difference between placebo and aspirin (P < 0.05). * Significant difference between 
CAU and AFD (P < 0.05). Thick black line represents Mdn. 
 
 
 
0
500
1000
1500
2000
2500
0 25 50 75 100 125 150 200 300 0 25 50 75 100 125 150 200 300
Sk
in
 b
lo
o
d
 f
lo
w
 (
%
 c
h
an
ge
 f
ro
m
 r
e
st
)
Cummulative current (uA)
CAU
PLACEBO
CAU
ASPIRIN
† 
* *
a
0
500
1000
1500
2000
2500
0 25 50 75 100 125 150 200 300 0 25 50 75 100 125 150 200 300
Sk
in
 b
lo
o
d
 f
lo
w
 (
%
 c
h
an
ge
 f
ro
m
 r
e
st
)
Cummulative current (uA)
AFD
PLACEBO
AFD
ASPIRIN
b
121 
 
There was no relationship between electrical skin resistance and SkBF responses 
in the non-glabrous foot skin site in either CAU or AFD (Figure 6.3). 
 
Figure 6.3 Relationship between average skin blood flow (%) and average 
electrical skin resistance (kΩ) for both CAU and AFD in the foot skin site 
Finger Skin Site 
Figure 6.4 shows the SkBF responses to ACh for the finger skin site in CAU and 
AFD. For CAU, aspirin did not affect the vasodilator response to ACh when 
compared to placebo (Table 6.4, P > 0.05). This was confirmed with no difference 
in ED50, maximal vasodilatation or AUC (P > 0.05). Vasodilatation in AFD was 
reduced following aspirin consumption (following pulse one only, P = 0.025, r = 
0.65). ED50 did not differ for AFD following aspirin consumption (P > 0.05), but 
aspirin appeared to have a tendency to reduce the maximal vasodilatation (P = 
0.064, d = 1.28) and AUC (P = 0.053, d = 1.32) compared with placebo. 
 
AFD had a significantly lower vasodilator response compared with CAU in 
response to ACh following both placebo (between the first and fourth pulse, P = 
0.003 to 0.036, r = 0.43 to 0.59) and aspirin (following all pulses, P = 0.001 to 
0.033, r = 0.44 to 0.64). Following placebo consumption ED50 for AFD occurred at 
greater cumulative current than CAU (Table 6.4, P < 0.01). Additionally, maximal 
vasodilatation was lower (P = 0.013, r = 1.27) and AUC was smaller (P = 0.002, r 
= 1.78) in AFD than CAU. Following aspirin, ED50 was similar between groups (P 
y = 3.9658x + 327.42
R² = 0.0628
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> 0.05) but AFD demonstrated a lower maximal vasodilatation (P = 0.001, r = 0.64) 
and smaller AUC (P = 0.001, d = 1.96).  
 
Table 6.4 95 % confidence intervals of ED50 (microamps) and mean (SD) or 
median (IQR) maximal skin blood flow (%) and area under the curve in response 
to acetylcholine in the finger skin site 
Note: as pairwise analyses were conducted within-groups, these do not always match the between-
groups analyses which included all participants or until a participant did not receive all applied 
current. ^ Mdn (IQR). * Significant difference between CAU and AFD (P < 0.05).  
 Variable 
 ED50 (μA) Max (%) AUC 
Within 
Finger 
CAU 
Placebo  
n = 11 
49 to 98 301 (76) 1542 (597) 
Aspirin  
n = 11 
24 to 137 311 (222) 1255 (872) 
Finger 
AFD 
Placebo  
n = 8 
105 to 187 188 (139) 642 (632) 
Aspirin  
n = 8 
37 to 113 57 (43) 22 (202) 
Between 
Finger 
placebo 
CAU  
n = 11 
49 to 98 301 (76) 1542 (597) 
AFD  
n = 10 
125 to 282 * 160 (139) * 539 (660) * 
Finger 
aspirin 
CAU  
n = 11 
24 to 137 ^287 (162) 1255 (872) 
AFD  
n = 8 
35 to 117 ^53 (88) * 35 (218) * 
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Figure 6.4 Individual CAU (a) and AFD (b) skin blood flow responses to 
acetylcholine in the finger skin site presented as percentage change from rest 
† Significant difference between placebo and aspirin (P < 0.05). * Significant difference between 
CAU and AFD (P < 0.05). Thick black line represents Mdn. 
  
There was no relationship between electrical skin resistance and SkBF responses 
in the non-glabrous finger skin site in either CAU or AFD (Figure 6.5). 
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Figure 6.5 Relationship between average skin blood flow (%) and average 
electrical skin resistance (kΩ) for both CAU and AFD in the finger skin site 
6.4.6 Repeatability of Skin Blood Flow Responses 
The results of the two repeat tests completed on a separate day were also 
compared to the main trial for placebo. Site A and B refer to the participants’ first 
and second skin site used in the main protocol, respectively. Results for the foot 
skin site are shown in Figure 6.6. There was good repeatability for the foot skin 
site for day two site A with site B for average, maximum and AUC (Table 6.5 and 
Table 6.6). Other comparisons did not produce repeatable data. As the data 
appeared variable between days, test of differences were conducted using a 
repeated measures ANOVA. No differences were found between days or skin 
sites on the same day (P > 0.05). 
 
Table 6.5 Mean (SD) skin blood flow variables for the foot skin site for the three 
repeat trials 
 Variable 
 Average (%) Maximum (%) AUC 
Day 1, Site A 720 (304) 1298 (620) 6410 (2727) 
Day 2, Site B 380 (247) 686 (343) 3525 (2306) 
Day 2, Site A 399 (268) 725 (407) 3356 (2135) 
n = 6 
y = -1.54x + 227.07
R² = 0.097
y = -0.4898x + 94.328
R² = 0.0176
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Table 6.6 Repeatability of skin blood flow variables for the foot skin site 
 Variable 
 Average (%) Max (%) AUC 
 CV % ICC CV % ICC CV % ICC 
Day 1, Site A vs. 
Day 2, Site A 
57 % 0.14 45 % 0.27 56 % 0.15 
Day 1, Site A vs. 
Day 2, Site B 
56 % -0.44 46 % -0.30 56 % -0.43 
Day 2,  
Site A vs. Site B 
26 % 0.74 23 % 0.65 25 % 0.73 
Shaded boxes meet criteria for repeatability. n = 6. 
 
Figure 6.6 Individual skin blood flow responses to acetylcholine in the foot skin 
site for three repeats presented as percentage change from rest 
Thick black line represents mean. 
 
The results of the three repeat tests for the finger skin site are shown in Figure 6.7. 
Due to technical difficulties day two site A only tested five participants. Therefore, 
only comparisons between day one site A and day two site B include all six 
participants, with other comparisons utilising the remaining five participants. No 
SkBF variables met the repeatability criteria (Table 6.7 and Table 6.8). Despite 
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this, test of differences, using a repeated measures ANOVA, reported no 
differences between the three trials (P > 0.05).  
 
Table 6.7 Mean (SD) skin blood flow variables for the finger skin site for the three 
trials 
 Variable 
 Average (%) Max (%) AUC 
Day 1, Site A 225 (43) 332 (48) 1966 (356) 
Day 2, Site B  242 (166) 454 (215) 2403 (1425) 
Day 2, Site A 272 (210) 416 (237) 2377 (1789) 
n = 6 except for day 2 site A (n = 5). 
 
Table 6.8 Repeatability of skin blood flow variables for the finger skin site 
 Variable 
 Average (%) Max (%) AUC 
 CV % ICC CV % ICC CV % ICC 
Day 1, Site A vs. 
Day 2, Site A * 
57 % 0.21 39 % 0.22 55 % 0.21 
Day 1, Site A vs. 
Day 2, Site B 
43 % 0.18 31 % 0.09 42 % 0.17 
Day 2,  
Site A vs. Site B * 
65 % 0.06 39 % 0.41 61 % 0.13 
* n = 5. 
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Figure 6.7 Individual skin blood flow responses to acetylcholine in the finger skin 
site for three repeats presented as percentage change from rest 
Thick black line represents mean. 
6.5 Discussion 
The present study observed that the vasodilator response to local application of 
ACh in the foot and finger skin sites were lower in AFD than those observed in 
CAU irrespective of whether COX was inhibited or not; this confirms and furthers 
findings from Study Two. Therefore, the present study rejects H01, and accepts 
HA1. The results of the present study supports previous research that has shown 
an attenuated vasodilator response in AFD compared with CAU to infused ACh or 
methacholine in the forearm (Stein et al. 1997; Jones et al. 1999; Cardillo et al. 
1999). CAU experienced a lower vasodilator response to ACh following COX 
inhibition in the foot skin site whilst AFD were unaffected. In contrast to the foot 
skin site for CAU, COX inhibition did not affect vasodilatation on the finger skin 
sites but had a marginal effect on AFD; therefore the present study rejects H02, 
and provides partial support for HA2. 
 
The SkBF responses to ACh in the foot skin site were repeatable within the same 
day but not between days. However, the finger skin site responses to ACh were 
not repeatable either between days or within the same day. The use of laser 
Doppler imaging has been shown to improve reliability when compared with LDF 
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(technique used in the present study) (Puissant et al. 2013). Future research 
should consider the use of laser Doppler imaging when using iontophoresis in 
extremity skin sites to improve repeatability. As day-to-day repeatability of 
iontophoresis of ACh is low, the present study also recommends the use of 
iontophoresis within the same day but at different skin sites. 
 
Pienaar et al. (2014) reported lower SkBF responses were correlated with greater 
electrical skin resistance. However, a correlation between electrical skin resistance 
and SkBF responses was not observed in the present study (Figure 6.3 and Figure 
6.5). Pienaar et al. (2014) correlated SkBF response with electrical skin resistance 
but did not split the data into CAU and AFD. The conclusion that iontophoresis in 
AFD is limited by resistance may be flawed as alluded to in Study Two, though the 
possibility that electrical resistance may influence vasoactive agent delivery is 
appreciated. Pienaar et al. (2014) utilised five charges of >2 mC on the forearm 
skin site whilst in the present study a range of 0.5 mC to 2 mC on the non-
glabrous foot and finger skin sites was used. Thus, skin site (i.e. forearm vs. foot) 
and electrical charge appears to influence the correlation between electrical skin 
resistance and SkBF responses. Therefore, it is suggested from the present study 
that when comparing ethnic groups a charge of <2 mC should be utilised. 
 
Prostaglandins have been shown to be primarily responsible for the vasodilatation 
in response to local administration of ACh (Noon et al. 1998; Holowatz et al. 
2005). Hendry and Marshall (2004) showed that COX inhibition led to a greater 
vasodilator response to ACh in the non-glabrous finger skin sites of young healthy 
males; neither CAU or AFD from the present study match these findings. It is not 
clear why the present study observed different responses than those observed 
previously in the non-glabrous finger. Hendry and Marshall (2004), who utilised 
higher current strengths than in the present study, observed a peak change from 
baseline of approximately 130 LDU following placebo consumption which was 
lower than that observed in the present study (Mean [SD], CAU placebo, 161 [76] 
LDU). Hendry and Marshall (2004) also conducted a time control protocol to 
observe the vasodilator response to ACh at different time points without COX 
inhibition. From this it is interesting to note that each trial (four in total) reported a 
peak change from baseline of ~150 LDU which may not have differed from the 
COX inhibition trial if included in the main protocol.  
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The data from the present study suggests that the role of prostanoids for CAU in 
response to ACh are similar amongst the non-glabrous foot and those previously 
observed in the forearm (i.e. a reduced response is observed with COX inhibition) 
(Noon et al. 1998; Kellogg et al. 2005; Holowatz et al. 2005) but may not have a 
role in finger vasodilator responses. AFD may have a greater role of prostanoids in 
the finger than the foot in response to local application of ACh but the contribution 
appears minimal. To the author’s knowledge these are novel findings.  
 
Blocking COX inhibits prostanoid production (Vane 1971; Roth et al. 1975); that is, 
synthesis of all vasodilator and vasoconstrictor prostanoids are inhibited. With 
ageing and hypertension in human vasculature, COX inhibition restores the 
response to ACh which is mediated by an increase in nitric oxide dependent 
vasodilatation (Taddei et al. 1993; Taddei et al. 1997a; Taddei et al. 1997b). In the 
present study it was hypothesised that COX inhibition in AFD may have 
accentuated the vasodilator response to ACh by inhibiting the COX associated 
oxidative stress (Kukreja et al. 1986; Taddei et al. 1998; Virdis et al. 2013) and 
synthesis of TXA2; however, this was not observed in the present study. By 
deduction it appears that the lower vasodilator response to ACh in AFD compared 
with CAU may not be due to the COX pathway. 
 
Whilst the pharmacological data suggests a role of prostanoids in response to 
ACh, they do not play a role in the vasodilator responses to local heating (Golay et 
al. 2004; McCord et al. 2006; Dahmus et al. 2013) but are involved in whole-body 
heating (McCord et al. 2006). This demonstrates that pharmacological 
interventions such as those used to deliver vasoactive agents such as ACh may 
not always reflect what occurs in an applied setting. Recently, Belvins, Tipton and 
Marshall (2014) provided preliminary evidence that COX inhibition may reduce 
cold-induced vasoconstriction in CAU during local cooling of the foot. During 
cooling there is a release of TXA2 (Serneri et al. 1981; Serneri et al. 1990) and 
ROS in smooth muscle cells which potentiates vasoconstriction (Bailey et al. 2005) 
and given that AFD already exhibit a heightened level of oxidative stress which is 
partly mediated by COX (Kalinowski et al. 2004; Feairheller et al. 2011), it is 
hypothesised that COX may play some role in the exaggerated vasoconstrictor 
response in AFD during cooling. This was investigated next.  
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7 Study Four - Skin Blood Flow Responses to Local Hand and Foot 
Cooling in Caucasian and African Descent Individuals With and Without 
Cyclooxygenase Inhibition 
7.1 Introduction 
Study One and Study Two demonstrated that AFD experience an attenuated 
rewarming response following hand cooling which may be as a result of altered 
endothelium reactivity in the microcirculation. It was hypothesised in Study Three 
that COX may be contributing to the increased oxidative stress in AFD, thereby 
attenuating the vasodilator responses to ACh. However, as discussed, the COX 
pathway was not responsible for the attenuated vasodilatation in AFD compared 
with CAU in response to ACh. Study Three used a pharmacological protocol 
(combined local and systemic) to help identify potential differences in endothelium 
function. This approach may have limitations when trying to link to an applied 
setting, such as local cooling. 
 
A large proportion (60 %) of the cooling-induced vasoconstriction involves an 
inhibition of NOS, the remaining response being mediated through adrenergic and 
non-adrenergic mechanisms (Hodges et al. 2006; Thompson-Torgerson et al. 
2007). Furthermore, cooling increases ROS (Bailey et al. 2005) which, along with 
reducing the bioavailability of nitric oxide, leads to a translocation of α2C
 receptors 
to the cell surface, capable of exaggerating the response to local cooling (Chotani 
et al. 2000; Chotani et al. 2004). 
 
As well as the release of NA during local cooling (cold air or water [0 °C to 2 °C]), 
there is a release of PGI2 and TXA2 (Serneri et al. 1981; Tindall et al. 1985; 
Serneri et al. 1990). The role of COX in the control of SkBF in response to local 
cooling may (Serneri et al. 1981) or may not (Cowley et al. 1983; Cowley et al. 
1985; Gresele et al. 1985) be an important mediator in healthy individuals. 
Individuals with Raynaud’s phenomenon appear to have a shortened time to blood 
flow recovery following local cooling when TXA2 is inhibited (Tindall et al. 1985), 
suggesting this vasoconstrictor prostanoid plays some role during cooling in those 
who exhibit compromised vascular function. Additionally, at rest in thermoneutral 
conditions, individuals ~53 years of age demonstrate greater SkBF when COX is 
inhibited demonstrating a functional shift toward COX derived vasoconstricting 
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factors (Holowatz and Kenney 2009) which may be due, in part, to PGI2 activating 
thromboxane-prostanoid receptors (Yang et al. 2002).  
 
Coupled with the information that AFD experience greater levels of oxidative 
stress (Kalinowski et al. 2004; Feairheller et al. 2011), and COX increases ROS 
(Kukreja et al. 1986; Virdis et al. 2013), and TXA2 it is possible COX may 
contribute to the accentuated vasoconstrictor response in AFD during cooling. 
Therefore, the aim of Study Four was to determine whether the accentuated 
vasoconstrictor response during local cooling and attenuated vasodilator response 
during rewarming in AFD involves the COX pathway. 
7.2 Hypotheses 
H01. SkBF and Tsk responses during the foot and hand immersion 
protocols following placebo or aspirin consumption will not differ 
between CAU and AFD. 
HA1. CAU will have a warmer Tsk and greater SkBF compared with AFD 
during the foot and hand immersion protocols following placebo or 
aspirin consumption. 
 
H02. Within-participant SkBF and Tsk responses during the foot and hand 
immersion protocols will not differ between placebo and aspirin 
consumption. 
HA2. Within-participant SkBF and Tsk responses during the foot and hand 
immersion protocols will differ between placebo and aspirin 
consumption. 
7.3 Methods 
7.3.1 Participants 
A favourable ethical opinion was received from the Science Faculty Ethics 
Committee in accordance with University regulations (SFEC 2014-050a). All 
participants that volunteered for Study Three also volunteered for the present 
study. Participants were made aware of the purpose, procedure and risk of the 
study prior to giving their informed written consent. 12 CAU and 12 AFD male 
volunteers participated in the study. All CAU were born in the UK. Eight AFD were 
born in the UK whilst four were born in Africa (Zimbabwe, Ghana, Kenya and 
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Uganda) and had resided in the UK for an average of 11 years with a minimum of 
seven years. 
7.3.2 Experimental Procedures and Measurements 
Participants attended the laboratory on two occasions at the same time of day 
where they were asked to immerse their foot and hand, separately, into cold water 
(Figure 7.1). The immersion protocol in this study was adopted from the hand 
immersion protocol in Study One. The two sessions were separated by at least 48 
hours. Immediately prior to entering the climate controlled room participants were 
asked to consume 150 mL of diluted orange squash with or without soluble aspirin 
(600 mg, Boots Inc., UK), blinded to the participant. 
 
Participants entered the climate controlled room (mean [SD] Tdb: 30.3 [0.9] °C, Twb: 
22.9 [0.9] °C, WBGT: 25.1 [0.9] °C) and rested for 25 minutes whilst being 
instrumented. Following the 25 minute rest period, participants placed their right 
foot into a plastic bag and immersed their foot just above the medial malleoli in a 
water bath maintained at 35.0 (0.3) °C for five minutes whilst SkBF and Tsk data 
were recorded. Following this, participants removed their foot from the warm 
water, still within the plastic bag, and immediately placed it in a mechanically 
stirred water bath maintained at 8.2 (0.1) °C for a further 30 minutes. After foot 
cooling, participants removed their foot from the water bath and plastic bag to 
allow spontaneous rewarming of the foot for 15 minutes. Following this, 
participants were given 150 mL of diluted orange squash with or without soluble 
aspirin (300 mg). The reason for adding an extra dose of aspirin was due to the 
return of endothelium COX function within 90 minutes and to ensure that COX 
function was inhibited as much as possible (Heavey et al. 1985). If a participant 
received aspirin at the beginning of the protocol they also received aspirin in their 
second drink; if the participant was not given aspirin in their first drink, then they 
were not given aspirin in their second drink (Figure 7.1).  
   
Twenty five minutes post foot rewarming participants placed their hand into a 
plastic bag and immersed it to the styloid process in a water bath maintained at 
35.0 (0.2) °C for five minutes whilst SkBF and Tsk data were recorded. The 
protocol for the hand was the same as for the foot in that cooling (8.1 [0.1] °C) and 
spontaneous rewarming followed. The order in which the participant received 
aspirin or placebo was balanced between participants but the foot was always 
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cooled before the hand. SkBF and Tsk was assessed from both glabrous and non-
glabrous skin sites as detailed in the General Methods (see page 74). 
 
Blood pressure was measured from the left arm, using an automated monitor, for 
both the foot and hand cooling protocols and was recorded two minutes prior to 
cooling, 30 seconds, five and 15 minutes into cooling, followed by 30 seconds and 
five minutes into rewarming. 
 
Thermal sensation and thermal comfort both overall and local was assessed as 
described in the General Methods (see page 71). Participants were asked at: 
baseline (final minute of local warm water immersion), five and 15 minutes of local 
cooling, final minute of cooling, five minutes into rewarming and final minute of 
rewarming. 
Figure 7.1 Schematic of the experimental procedure for Study Four 
7.3.3 Data Analyses 
As MAP differed over time (see results), SkBF was calculated as cutaneous 
vascular conductance (LDU / MAP = CVC). For the CIVD test, Tsk obtained from 
the thermistor was plotted every minute, and from the sampled data, which was 
recorded every five seconds, the CIVD variables were determined as explained 
previously (see General Methods, Figure 3.7). For the SkBF assessment during 
local cooling and rewarming, average, minimum and AUC were calculated. SkBF 
was also split into relative quartiles (< 25 %, 25 % to 49 %, 50 % to 74 % and > 75 
%) calculated from change from CVC baseline (set at 100 % during warm water 
immersion) and the time spent in each quartile was calculated for each individual 
during cooling and rewarming. 
  Foot  Hand 
  25 min 5 min 30 min 15 
min 
 25 min 5 min 30 min 15 
min 
Order 
1 
Aspirin 
600 mg 
Baseline 
Local 
water 
35 °C 
Local 
water 
8 °C 
Local 
air 
30 °C 
Aspirin 
300 mg 
Baseline 
Local 
water 
35 °C 
Local 
water 
8 °C 
Local 
air 
30 °C 
Order 
2 
Placebo Placebo 
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7.3.4 Statistical Analyses 
Participant characteristics were analysed using an independent samples t-test. 
MAP throughout immersion was analysed between- and within-participants with a 
repeated measures ANOVA to identify any differences in blood pressure between 
ethnicities and between aspirin and placebo. Baseline CVC (taken as the final 
minute of warm water immersion) and Tsk (taken at five seconds prior to cold water 
immersion) was analysed using an independent samples t-test or a Mann-Whitney 
U test. CVC average, minimum and AUC during cooling and rewarming was 
analysed using an independent samples t-test or a Mann-Whitney U test. 
Between- and within-subjects CVC throughout immersion was analysed using a 
Mann-Whitney U and Wilcoxon signed rank test, respectively. 
7.4 Results 
7.4.1 Participant Characteristics 
All participant characteristics were similar (Table 7.1, P > 0.05) except AFD had a 
larger hand length (P = 0.018, d = 1.04) and hand volume (P = 0.043, d = 0.87) 
than CAU. 
 
Table 7.1 Mean (SD) participant characteristics for Study Four  
 Participant Characteristics 
 CAU AFD 
Age (years) 20 (4) 20 (2) 
Height (cm) 178.2 (6.9) 176.0 (7.9) 
Mass (kg) 73.1 (12.3) 74.1 (12.8) 
Hand Length (cm) 20.0 (1.1) * 21.2 (1.2) 
Foot Length (cm) 26.3 (1.2) 27.0 (1.8) 
Hand Volume (L) 0.42 (0.12) * 0.53 (0.13) 
Foot Volume (L) 1.16 (0.19) 1.24 (0.32) 
* Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 
7.4.2 Mean Arterial Pressure 
There was no main effect for ethnicity or condition (placebo vs. aspirin) for both 
foot or hand immersion protocols (mean [SD], baseline placebo, foot, CAU: 83 [5] 
mmHg, AFD: 83 [7] mmHg; hand, CAU: 82 [7] mmHg, AFD: 81 [8] mmHg, P > 
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0.05). However, there was a main effect for time for both the foot (P = 0.001) and 
hand (P = 0.022) immersion protocols (Table 7.2). There was no significant 
interaction between condition, time and ethnicity for both immersion protocols (P > 
0.05). 
 
Table 7.2 Mean (SD) mean arterial pressure (mmHg) for the foot and hand 
protocol as an average of both ethnic groups in both placebo and aspirin trials 
 Mean Arterial Pressure (mmHg) 
Time Foot Hand 
Baseline 83 (7) 82 (8) 
30 seconds cooling 88 (9) * 84 (9) 
5 minutes cooling 87 (9) * 86 (9) † 
15 minutes cooling 84 (6) 85 (7) 
30 seconds rewarming 85 (8) 83 (8) 
5 minutes rewarming 82 (7) 82 (7) 
* Significant difference compared with baseline (P < 0.05). 
† 
P = 0.068. 
7.4.3 Heart Rate 
There were no between- or within-participant differences for heart rate at baseline 
(mean [SD], placebo, foot, CAU: 82 [9] beats·min-1; AFD [n = 11]: 76 [6] beats·min-
1; hand, CAU: 73 [10] beats·min-1; AFD [n = 11]: 71 [4] beats·min-1) or throughout 
the immersion and rewarming period for both foot and hand immersion protocols 
(P > 0.05). 
7.4.4 Baseline Cutaneous Vascular Conductance 
CAU had a significantly lower baseline CVC than AFD following aspirin 
consumption for the glabrous foot skin site (Table 7.3, P = 0.019, d = 1.03).  
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Table 7.3 Mean (SD) or median (IQR) cutaneous vascular conductance at the end 
of warm water immersion for the foot and hand protocol 
  Baseline Cutaneous Vascular Conductance 
  Placebo Aspirin 
Skin site CAU AFD CAU AFD 
Foot 
Glabrous 2.2 (1.7) 3.1 (1.1) 1.8 (1.5) * 3.4 (1.7) 
Non-glabrous ^ 0.3 (0.3) 0.2 (0.3) 0.2 (0.2) 0.2 (0.2) 
Hand 
Glabrous 4.7 (0.8) 4.8 (1.0) 4.3 (1.2) 5.1 (1.1) 
Non-glabrous 0.8 (0.1) 0.9 (0.3) 0.8 (0.3) 0.9 (0.5) 
^ Mdn (IQR). * Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 
7.4.5 Baseline Skin Temperature 
CAU had a significantly lower baseline Tsk than AFD following aspirin consumption 
for the glabrous (Table 7.4, P = 0.045, r = 0.41) and non-glabrous (P = 0.029, d = 
0.96) foot skin sites.  
 
Table 7.4 Mean (SD) or median (IQR) skin temperature (°C) at the end of warm 
water immersion for the foot and hand protocol 
  Baseline Skin Temperature (°C) 
  Placebo Aspirin 
Skin site CAU AFD CAU AFD 
Foot 
Glabrous ^ 35.1 (1.1) 35.6 (1.2) 34.8 (1.6) * 35.5 (0.6) 
Non-glabrous  34.6 (0.7) 34.8 (1.1) 34.3 (0.9) * 35.1 (0.7) 
Hand 
Glabrous ^ 35.9 (0.4) 35.8 (0.2) 35.8 (0.2) 35.8 (0.1) 
Non-glabrous 35.5 (0.2) 35.5 (0.1) 35.5 (0.2) 35.5 (0.1) 
^ Mdn (IQR). * Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 
7.4.6 Foot Responses to Cooling and Subsequent Rewarming 
Skin Blood Flow Responses 
Glabrous 
During cooling and subsequent rewarming CVC for the glabrous foot skin site was 
not significantly different between- or within-participants (Figure 7.2, P > 0.05). 
There were no significant differences for the SkBF variables between- or within-
participants for the glabrous foot skin site (Table 7.5, P > 0.05). Following aspirin 
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consumption, during rewarming, CAU compared with AFD spent a greater period 
of time in the 25 % to 49 % (Figure 7.4, P = 0.014, r = 0.50) and 50 % to 74 % 
quartiles (P = 0.017, r = 0.48). 
 
Table 7.5 Mean (SD) or median (IQR) skin blood flow variables (CVC) for the 
glabrous foot skin site during cooling and rewarming 
  Cutaneous Vascular Conductance 
  Placebo Aspirin 
  CAU AFD CAU AFD 
Cooling 
Average 1.6 (1.7) 1.7 (1.4) 1.3 (1.3) 2.3 (1.6) 
Minimum ^ 0.2 (0.6) 0.2 (0.4) 0.1 (0.2) 0.2 (0.7) 
AUC 49 (51) 55 (43) 40 (39) 70 (51) 
Rewarming 
Average ^ 1.2 (2.8) 1.5 (2.9) 1.5 (2.3) 1.5 (3.6) 
Minimum ^ 0.2 (1.2) 0.2 (0.6) 0.3 (0.3) 0.4 (2.3) 
AUC 25 (23) 27 (22) 25 (22) 32 (32) 
^ Mdn (IQR). AUC = Area under the curve. n = 12 for each group. 
Non-glabrous 
During cooling and subsequent rewarming CVC for the non-glabrous foot skin site 
was significantly lower for AFD than CAU following both placebo (Figure 7.3, P = 
0.000 to 0.033, r = 0.44 to 0.77) and aspirin (P = 0.017 to 0.045, r = 0.41 to 0.48). 
Aspirin consumption significantly lowered CVC for CAU during immersion and 
rewarming compared with placebo (P = 0.007 to 0.042, r = 0.42 to 0.53).  
 
In the placebo condition, during cooling of the non-glabrous foot skin site, AFD 
experienced a significantly lower average CVC (P = 0.001, r = 0.65), minimum 
CVC (P = 0.001, r = 0.66) and AUC (P < 0.000, d = 1.77) compared with CAU 
(Table 7.6). During rewarming AFD, again, had a significantly lower average CVC 
(P = 0.001, r = 0.51), minimum CVC (P = 0.002, r = 0.61) and AUC (P = 0.014, r = 
0.49) compared with CAU. Following aspirin consumption, during rewarming, AFD 
experienced a significantly lower minimum CVC compared with CAU (P = 0.028, r 
= 0.45) whilst average CVC and AUC did not differ (P > 0.05). During cooling in 
the CAU group, aspirin consumption significantly lowered minimum CVC (P = 
0.038, d = 0.63) and AUC (P = 0.030, r = 0.68) compared with placebo.  
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Following aspirin consumption, during rewarming, CAU spent a greater period of 
time compared with AFD in the >75 % quartile (Figure 7.5, P = 0.024, r = 0.45). 
CAU spent a greater period of time in the 50 % to 74 % quartile following aspirin 
consumption compared with placebo (P = 0.041, r = 0.59).  
 
Table 7.6 Mean (SD) or median (IQR) skin blood flow variables (CVC) for the non-
glabrous foot skin site during cooling and rewarming 
  Cutaneous Vascular Conductance 
  Placebo Aspirin 
  CAU AFD CAU AFD 
Cooling 
Average ^ 0.3 (0.1) * 0.2 (0.1) 0.3 (0.1) 0.1 (0.2) 
Minimum ^ 0.2 (0.1) *$ 0.1 (0.0) 0.2 (0.1) 0.1 (0.1) 
AUC 9 (3) *$ 5 (2) 7 (2)  6 (4) 
Rewarming 
Average ^ 0.2 (0.3) * 0.1 (0.1) 0.3 (0.1) 0.2 (0.2) 
Minimum ^ 0.1 (0.2) * 0.1 (0.0) 0.1 (0.1) * 0.1 (0.1) 
AUC ^ 3 (6) * 2 (2) 4 (3) 2 (3) 
^ Mdn (IQR). * Significant difference between CAU and AFD (P < 0.05). $ Significant difference 
between placebo and aspirin (P < 0.05). AUC = Area under the curve. n = 12 for each group.  
139 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2 Cutaneous vascular conductance of the glabrous foot skin site for CAU placebo (a) and aspirin (c) responses and AFD placebo (b) 
and aspirin (d) responses during local foot cooling and subsequent rewarming 
Thick black line represents Mdn. 
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Figure 7.3 Cutaneous vascular conductance of the non-glabrous foot skin site for CAU placebo (a) and aspirin (c) responses and AFD 
placebo (b) and aspirin (d) responses during local foot cooling and subsequent rewarming 
Thick black line represents Mdn.* Significant difference between CAU and AFD (P < 0.05). $ Significant difference between placebo and aspirin (P < 0.05). 
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Figure 7.4 Mean time spent in each quartile of skin blood flow for both CAU and AFD in the glabrous foot skin site following placebo during 
cooling (a) and rewarming (b) and following aspirin during cooling (c) and rewarming (d) 
* Significant difference between CAU and AFD (P > 0.05). n = 12 for each group. 
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Figure 7.5 Mean time spent in each quartile of skin blood flow for both CAU and AFD in the non-glabrous foot skin site following placebo 
during cooling (a) and rewarming (b) and following aspirin during cooling (c) and rewarming (d) 
* Significant difference between CAU and AFD (P < 0.05). $ Significant difference between placebo and aspirin (P < 0.05). n = 12 for each group.  
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Skin Temperature Responses 
Glabrous 
Tsk for the glabrous foot skin site during foot cooling and rewarming was not 
significantly different between-groups following placebo (Figure 7.6, P > 0.05) but 
was significantly lower in CAU than AFD following aspirin consumption (P = 0.010 
to 0.042, r = 0.41 to 0.51). Following placebo, only two CAU and four AFD 
experienced CIVD (Table 7.7). Following aspirin consumption, only two CAU and 
seven AFD experienced CIVD. Therefore, analyses on these variables could not 
be conducted. There was a tendency for CAU to have a lower average Tsk 
compared with AFD following aspirin consumption (Table 7.7, P = 0.052, d = 0.84).  
 
Table 7.7 Mean (SD) or median (IQR) cold-induced vasodilatation variables of the 
glabrous foot skin site during foot cooling 
 Placebo Aspirin 
 CAU AFD CAU AFD 
Average Tsk (°C) 14.4 (3.4) 15.9 (4.1) 13.7 (3.1) 16.4 (3.3) 
Minimum Tsk (°C) ^ 9.3 (4.1) 10.9 (7.8) 9.1 (2.4) 12.6 (6.6) 
 CAU (n = 2) AFD (n = 4) CAU (n = 2) AFD (n = 7) 
Number of waves 1.0 (0.0) 1.5 (0.6) 1.5 (0.7) 1.6 (0.5) 
Onset time (min) 19.3 (4.0) 3.6 (0.8) 4.8 (3.3) 4.9 (3.6) 
Tsk prior to onset of CIVD (°C) 14.0 (5.1) 19.9 (1.8) 19.6 (0.7) 18.1 (2.4) 
Max Tsk during CIVD (°C) 15.7 (5.2) 22.5 (2.1) 21.2 (1.4) 20.5 (2.0) 
Amplitude (°C) 1.7 (0.1) 2.7 (0.4) 1.7 (0.6) 2.4 (1.6) 
^ Mdn (IQR). n = 12 for average and minimum Tsk. 
Non-glabrous 
Tsk for the non-glabrous skin site was not different between-groups following 
placebo (Figure 7.7, P > 0.05) but was significantly lower in CAU than AFD 
following aspirin consumption (P = 0.039 to 0.045, r = 0.41 to 0.42). Following 
placebo, there were no CIVD experienced by CAU and only one AFD 
demonstrating CIVD (Table 7.8). Following aspirin consumption, there were no 
CIVD for CAU whilst two AFD demonstrated CIVD. Therefore, analyses could not 
be conducted on these variables. There was a tendency for CAU to have a lower 
average Tsk compared with AFD following aspirin consumption (Table 7.8, P = 
0.060, d = 0.81).  
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Table 7.8 Mean (SD) cold-induced vasodilatation variables of the non-glabrous 
foot skin site during foot cooling 
 Placebo Aspirin 
 CAU AFD CAU AFD 
Average Tsk (°C) 15.0 (2.1) 15.3 (2.7) 14.5 (1.5) 15.9 (2.0) 
Minimum Tsk (°C) 11.5 (2.5) 12.3 (3.0) 11.1 (1.6) 12.4 (2.1) 
 CAU (n = 0) AFD (n = 1) CAU (n = 0) AFD (n = 2) 
Number of waves - 1.0 - 1.0 (0.0) 
Onset time (min) - 18.2 - 10.3 (7.1) 
Tsk prior to onset of CIVD (°C) - 14.2 - 16.9 (2.5) 
Max Tsk during CIVD (°C) - 15.7 - 18.9 (2.6) 
Amplitude (°C) - 1.5 - 2.0 (0.1) 
n = 12 for average and minimum Tsk. 
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Figure 7.6 Skin temperature (°C) of the glabrous foot skin site for CAU placebo (a) and aspirin (c) responses and AFD placebo (b) and aspirin 
(d) responses during local foot cooling and subsequent rewarming 
Thick black line represents Mdn.* Significant difference between CAU and AFD (P < 0.05). 
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Figure 7.7 Skin temperature (°C) of the non-glabrous foot skin site for CAU placebo (a) and aspirin (c) responses and AFD placebo (b) and 
aspirin (d) responses during local foot cooling and subsequent rewarming 
Thick black line represents Mdn. * Significant difference between CAU and AFD (P > 0.05). 
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7.4.7 Finger Responses to Cooling and Subsequent Rewarming 
Skin Blood Flow Responses 
Glabrous 
During cooling and subsequent rewarming CVC for the glabrous finger skin site 
was significantly lower in AFD than CAU following both placebo (Figure 7.8, P = 
0.000 to 0.039, r = 0.42 to 0.67) and aspirin consumption (P = 0.000 to 0.039, r = 
0.42 to 0.79). AFD experienced a significantly greater CVC at two time points 
during cooling following aspirin consumption compared to placebo (P = 0.034 to 
0.042, r = 0.42 to 0.43). 
 
During cooling following placebo there was a tendency for average CVC to be 
lower in AFD compared with CAU (Table 7.9, P = 0.050, d = 0.84). Minimum CVC 
was significantly lower in AFD compared with CAU (P < 0.000, d = 2.03). Again 
there was a tendency for AUC to be lower in AFD compared with CAU (P = 0.053, 
d = 0.83). During rewarming AFD had a significantly lower average CVC (P = 
0.009, d = 1.17) and AUC (P = 0.009, d = 1.18) compared with CAU. 
 
During cooling following aspirin consumption there was a tendency for average 
CVC to be lower in AFD compared with CAU (P = 0.052, d = 0.85) and AUC to be 
lower in AFD compared with CAU (P = 0.055, d = 0.84). During rewarming, 
following aspirin consumption, AFD experienced a lower average CVC (P < 0.000, 
d = 1.69), minimum CVC (P = 0.017, d = 1.05) and AUC (P = 0.001, d = 1.63) 
compared with CAU. AFD experienced a lower minimum CVC following placebo 
compared with aspirin consumption (P = 0.039, d = 0.78). 
 
During cooling following placebo AFD spent a greater period of time in the <25 % 
quartile (Figure 7.10, P = 0.017, r = 0.48) and less time in the 25 % to 49 % 
quartile (P = 0.012, r = 0.51) compared with CAU. During rewarming AFD spent a 
greater period of time in the <25 % quartile (P = 0.011, d = 1.20) and less time in 
the >75 % quartile (P = 0.007, d = 1.23) compared with CAU. 
 
During cooling following aspirin consumption AFD spent a greater period of time in 
the <25 % quartile (P = 0.008, r = 0.53) and less time in the 50 % to 74 % quartile 
(P = 0.012, r = 0.51) compared with CAU. During rewarming AFD spent a greater 
148 
 
period of time in the <25 % quartile (P = 0.002, d = 1.61), 25 % to 49 % quartile (P 
= 0.003, d = 1.34), 50 % to 74 % quartile (P = 0.027, d = 1.01) and less time in the 
>75 % quartile (P < 0.000, d = 2.62) compared with CAU. 
 
Table 7.9 Mean (SD) skin blood flow variables (CVC) for the glabrous finger skin 
site during cooling and rewarming 
  Cutaneous Vascular Conductance 
  Placebo Aspirin 
  CAU AFD CAU AFD 
Cooling 
Average 2.1 (0.9) 1.4 (0.8) 2.3 (1.1) 1.6 (0.6) 
Minimum 0.8 (0.2) * 0.5 (0.1) $ 0.9 (0.5) 0.6 (0.3) 
AUC 66 (27) 44 (24) 74 (35) 50 (18) 
Rewarming 
Average 4.3 (1.0) * 2.8 (1.6) 4.3 (0.6) * 2.8 (1.0) 
Minimum 1.5 (0.6) 1.2 (1.1) 1.6 (0.8) * 0.9 (0.5) 
AUC 66 (16) * 43 (24) 66 (10) * 45 (16) 
* Significant difference between CAU and AFD (P < 0.05). $ Significant difference between placebo 
and aspirin (P < 0.05). AUC = Area under the curve. n = 12 for each group. 
Non-glabrous 
During cooling and subsequent rewarming, CVC for the non-glabrous finger skin 
site was significantly lower in AFD than CAU following both placebo (Figure 7.9, P 
= 0.001 to 0.045, r = 0.65 to 0.41) and aspirin consumption (P = 0.000 to 0.042, r = 
0.41 to 0.71). CAU experienced a significantly greater CVC at two time points 
during rewarming following aspirin consumption compared with placebo (P = 0.016 
to 0.034, r = 0.43 to 0.48).  
 
During cooling following placebo AFD experienced a significantly lower average 
CVC (Table 7.10, P = 0.014, d = 1.21), minimum CVC (P = 0.026, d = 0.98) and 
AUC (P = 0.010, d = 1.19) compared with CAU. During rewarming, again, AFD 
experienced a significantly lower average CVC (P = 0.006, r = 0.55), minimum 
CVC (P = 0.007, d = 1.22) and AUC (P = 0.010, r = 0.52) compared with CAU.  
 
During cooling following aspirin consumption AFD experienced a significantly 
lower average CVC (Table 7.10, P = 0.014, d = 1.13), minimum CVC (P = 0.004, d 
= 1.32) and AUC (P = 0.012, d = 1.11) compared with CAU. During rewarming 
following aspirin consumption, again, AFD experienced a significantly lower 
149 
 
average CVC (P = 0.006, r = 0.56), minimum CVC (P < 0.000, d = 1.77) and AUC 
(P = 0.002, r = 0.60) compared with CAU. 
 
During cooling following placebo AFD spent a greater period of time in the <25 % 
quartile (Figure 7.11, P = 0.007, r = 0.56), 25 % to 49 % quartile (P = 0.024, r = 
0.46) and less time in the >75 % quartile (P = 0.017, r = 0.48) compared with CAU. 
During rewarming AFD spent a greater period in the 25 % to 49 % quartile (P = 
0.012, r = 0.51), 50 % to 74 % quartile (P = 0.012, r = 0.50) and less time in the 
>75 % quartile (P = 0.003, r = 0.59) compared with CAU.  
 
During cooling following aspirin consumption AFD spent a greater period of time in 
the <25 % quartile (P = 0.014, r = 0.52) and less time in the >75 % quartile (P = 
0.024, r = 0.46) compared with CAU. During rewarming following aspirin 
consumption AFD spent a greater period in the 25 % to 49 % quartile (P = 0.020, r 
= 0.47), 50 % to 74 % quartile (P = 0.028, r = 0.45) and less time in the >75 % 
quartile (P = 0.005, r = 0.56) compared with CAU. 
 
Table 7.10 Mean (SD) or median (IQR) skin blood flow variables (CVC) for the 
non-glabrous finger skin site during cooling and rewarming 
  Cutaneous Vascular Conductance 
  Placebo Aspirin 
  CAU AFD CAU AFD 
Cooling 
Average 0.7 (0.3) * 0.4 (0.1) 0.8 (0.2) * 0.5 (0.2) 
Minimum 0.3 (0.1) * 0.2 (0.1) 0.4 (0.1) * 0.3 (0.1) 
AUC 21 (8) * 13 (4) 23 (7) * 16 (7) 
Rewarming 
Average ^ 0.9 (0.2) * 0.6 (0.5) 1.0 (0.3) * 0.6 (0.5) 
Minimum 0.6 (0.2) * 0.4 (0.2) 0.7 (0.2) * 0.3 (0.2) 
AUC ^ 14 (4) * 9 (7) 15 (4) * 9 (7) 
^ Mdn (IQR). * Significant difference between CAU and AFD (P < 0.05). AUC = Area under the 
curve. n = 12 for each group. 
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Figure 7.8 Cutaneous vascular conductance of the glabrous finger skin site for CAU placebo (a) and aspirin (c) responses and AFD placebo 
(b) and aspirin (d) responses during local hand cooling and subsequent rewarming 
Thick black line represents Mdn.* Significant difference between CAU and AFD (P < 0.05). $ Significant difference between placebo and aspirin (P < 0.05). 
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Figure 7.9 Cutaneous vascular conductance of the non-glabrous finger skin site for CAU placebo (a) and aspirin (c) responses and AFD 
placebo (b) and aspirin (d) responses during local hand cooling and subsequent rewarming 
Thick black line represents Mdn. * Significant difference between CAU and AFD (P < 0.05). $ Significant difference between placebo and aspirin (P < 0.05). 
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Figure 7.10 Mean time spent in each quartile of skin blood flow for both CAU and AFD in the glabrous finger skin site following placebo during 
cooling (a) and rewarming (b) and following aspirin during cooling (c) and rewarming (d) 
* Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 
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Figure 7.11 Mean time spent in each quartile of skin blood flow for both CAU and AFD in the non-glabrous finger skin site following placebo 
during cooling (a) and rewarming (b) and following aspirin during cooling (c) and rewarming (d) 
* Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 
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Skin Temperature Responses 
Glabrous 
Tsk for the glabrous finger skin site during cooling and rewarming was significantly 
lower in AFD compared with CAU following both placebo (Figure 7.12, P = 0.000 
to 0.045, r = 0.41 to 0.75) and aspirin consumption (P = 0.000 to 0.021, r = 0.47 to 
0.72). Aspirin consumption in CAU caused a warmer Tsk at one time point during 
cooling when compared with placebo (P = 0.012, r = 0.50). Minimum Tsk was 
significantly lower in AFD compared with CAU following both placebo (Table 7.11, 
P = 0.004, d = 1.30) and aspirin consumption (P = 0.034, d = 0.92). Following 
aspirin consumption average Tsk was significantly warmer compared with placebo 
for CAU (P = 0.049, r = 0.28) and there was a faster onset time of CIVD (P = 
0.035, r = 0.13).  
 
Table 7.11 Mean (SD) or median (IQR) cold-induced vasodilatation variables of 
the glabrous finger during hand cooling 
 Placebo Aspirin 
 CAU AFD CAU AFD 
Average Tsk (°C) 14.6 (2.3)
$ 13.0 (3.0) 15.2 (2.5) 13.5 (1.9) 
Minimum Tsk (°C) 10.7 (1.3)* 9.5 (1.4) 10.4 (0.9)* 9.5 (1.2) 
 CAU (n = 7) AFD (n = 4) CAU (n = 4) AFD (n = 5) 
Number of waves ^ 1.0 (1.0) 1.0 (0.0) 2.0 (1.5) 1.0 (0.5) 
Onset time (min) 9.7 (6.2)$ 10.7 (8.5) 6.1 (5.9) 7.3 (5.6) 
Tsk prior to onset of CIVD (°C) 13.8 (4.3) 14.1 (4.2) 15.8 (6.2) 14.9 (4.4) 
Max Tsk during CIVD (°C) 17.5 (6.2) 19.1 (3.8) 19.3 (5.6) 18.2 (5.1) 
Amplitude (°C) 3.6 (2.3) 5.0 (1.4) 3.5 (3.3) 3.3 (1.0) 
^ Mdn (IQR). * Significant difference between CAU and AFD (P < 0.05). 
$
 Significant difference 
between placebo and aspirin (P < 0.05). n = 12 for average and minimum Tsk. 
Non-glabrous 
Tsk for the non-glabrous finger skin site during cooling and rewarming was 
significantly lower in AFD compared with CAU following both placebo (Figure 7.13, 
P = 0.000 to 0.045, r = 0.41 to 0.79) and aspirin consumption (P = 0.000 to 0.045, 
r = 0.41 to 0.71). Aspirin consumption resulted in a warmer Tsk during cooling in 
both CAU (P = 0.016 to 0.028, r = 0.44 to 0.48) and AFD (P = 0.003 to 0.016, r = 
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0.48 to 0.57) when compared with placebo. Minimum Tsk was significantly lower in 
AFD compared with CAU following both placebo (Table 7.12, P = 0.004, d = 1.30) 
and aspirin consumption (P = 0.034, d = 0.92). 
 
Table 7.12 Mean (SD) cold-induced vasodilatation variables of the non-glabrous 
finger skin site during hand cooling 
 Placebo Aspirin 
 CAU AFD CAU AFD 
Average Tsk (°C) 12.8 (1.2) 11.8 (1.4) 13.6 (1.6) 12.6 (1.0) 
Minimum Tsk (°C) 9.9 (0.7)* 9.0 (0.6) 9.8 (0.7)* 9.2 (0.7) 
 CAU (n = 7) AFD (n = 4) CAU (n = 5) AFD (n = 2) 
Number of waves 1.4 (0.5) 1.0 (0.0) 1.0 (0.0) 1.0 (0.0) 
Onset time (min) 12.1 (6.0) 12.0 (8.2) 17.2 (1.9) 8.5 (8.1) 
Tsk prior to onset of CIVD (°C) 11.4 (2.1) 12.1 (3.1) 10.1 (0.7) 13.3 (4.5) 
Max Tsk during CIVD (°C) 13.9 (3.2) 15.1 (2.5) 15.1 (2.9) 15.0 (5.8) 
Amplitude (°C) 2.4 (1.9) 3.0 (1.8) 5.0 (2.6) 1.7 (1.3) 
* Significant difference between CAU and AFD (P < 0.05). n = 12 for average and minimum Tsk. 
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Figure 7.12 Skin temperature (°C) of the glabrous finger skin site for CAU placebo (a) and aspirin (c) responses and AFD placebo (b) and 
aspirin (d) responses during local hand cooling and subsequent rewarming 
Thick black line represents Mdn. * Significant difference between CAU and AFD (P < 0.05). $ Significant difference between placebo and aspirin (P < 0.05). 
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Figure 7.13 Skin temperature (°C) of the non-glabrous finger skin site for CAU placebo (a) and aspirin (c) responses and AFD placebo (b) and 
aspirin (d) responses during local hand cooling and subsequent rewarming 
Thick black line represents Mdn. * Significant difference between CAU and AFD (P < 0.05). $ Significant difference between placebo and aspirin (P < 0.05). 
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7.4.8 Thermal Sensation 
During the foot immersion protocol for overall and local thermal sensation (Figure 
7.14) there was a main effect for time (P < 0.000) and ethnicity (P = 0.014 and P = 
0.039, respectively). However, there was no main effect for condition (placebo vs. 
aspirin) (P > 0.05) nor was there any significant interaction between condition, time 
and ethnicity for either overall or local thermal sensation (P > 0.05).  
 
During the hand immersion protocol for overall and local thermal sensation there 
was a main effect for time (P < 0.000). There was also a main effect for ethnicity 
for overall (P = 0.002) but not local thermal sensation (P > 0.05). There was no 
main effect for condition for either overall or local thermal sensation (P > 0.05). 
There was no significant interaction between condition, time and ethnicity for 
overall thermal sensation (P > 0.05) whilst there was for local thermal sensation (P 
= 0.019) with pairwise comparisons identifying a change over time for CAU 
following placebo (Figure 7.14, P = 0.000 to 0.004, d = 1.72 to 6.75) and aspirin (P 
= 0.000 to 0.014, d = 1.21 to 4.61) as well as AFD following placebo (P = 0.000 to 
0.016, d = 1.75 to 4.78) and aspirin (P < 0.000, d = 2.34 to 5.26). 
7.4.9 Thermal Comfort 
During the foot immersion protocol for overall and local thermal comfort (Figure 
7.15) there was a main effect for time (P < 0.000). There was a main effect for 
ethnicity for overall (P < 0.000) but not local (P > 0.05) thermal comfort. There was 
no main effect for condition (P > 0.05) nor was there any significant interaction 
between condition, time and ethnicity for either overall or local thermal comfort (P 
> 0.05).  
 
During the hand immersion protocol for overall and local thermal comfort there 
was a main effect for time (P < 0.000). There was a main effect for ethnicity for 
overall (P < 0.000) but not local (P > 0.05) thermal comfort. There was a main 
effect for condition for overall (P = 0.022) but not local thermal comfort (P > 0.05). 
There was no significant interaction between condition, time and ethnicity for either 
overall or local thermal sensation (P > 0.05).  
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Figure 7.14 Mean (SD) thermal sensation for the foot overall (a) and local (b) and hand overall (c) and local (d) 
“ Significant difference from baseline. 0 = Very cold, 20 = Very hot. n = 12 for each group.  
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Figure 7.15 Mean (SD) thermal comfort for the foot overall (a) and local (b) and hand overall (c) and local (d) 
0 = Very uncomfortable, 20 = Very comfortable. n = 12 for each group.  
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7.4.10 Results Overview 
For clarity an overview of the statistical CVC and Tsk results over time are 
presented below. 
 
Table 7.13 Summary of the effect of ethnicity on responses to foot and hand 
cooling (between-participants) 
  Foot placebo Foot aspirin Hand placebo Hand aspirin 
Glabrous 
CVC  CAU = AFD CAU = AFD CAU > AFD CAU > AFD 
Tsk  CAU = AFD CAU < AFD CAU > AFD CAU > AFD 
Non-
glabrous 
CVC  CAU > AFD CAU > AFD CAU > AFD CAU > AFD 
Tsk  CAU = AFD CAU < AFD CAU > AFD CAU > AFD 
n = 12 for each group. 
 
Table 7.14 Summary of the effect of aspirin and placebo on responses to foot and 
hand cooling (within-participants) 
 FOOT HAND 
 CAU AFD CAU AFD 
CVC glabrous P = A P = A P = A P < A 
CVC non-glabrous P > A P = A P < A P = A 
Tsk glabrous P = A P = A P < A P = A 
Tsk non-glabrous P = A P = A P < A P < A 
P = Placebo, A = Aspirin. n = 12 for each group. 
7.5 Discussion 
The present study aimed to identify differences between CAU and AFD in 
response to local foot and hand cooling and the contribution of the COX pathway 
to these responses. The present study rejects H01 and H02; however, only partial 
acceptance of HA1 and HA2 is reported. The principal findings of this study were 1) 
CVC and Tsk did not differ between ethnic groups following placebo in the glabrous 
foot skin site during the foot immersion protocol (Figure 7.2, Figure 7.6) and 2) 
AFD experienced a significantly lower finger CVC and Tsk compared with CAU 
during the hand immersion protocol following both placebo and aspirin 
consumption (Figure 7.8, Figure 7.9 Figure 7.12, and Figure 7.13) which confirms 
and furthers the findings from Study One (Maley et al. 2014). These data suggest 
that 1) the vascular responses of the foot in AFD are comparable to those of CAU 
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and 2) a dysfunctional COX pathway in young healthy AFD is not the reason for 
the exaggerated vasoconstrictor response to hand cooling compared with CAU; 
therefore other mechanisms are primarily responsible for the ethnic differences 
observed. 
 
Previous research has shown that the reflex vascular responses to arm or foot 
cooling are not altered by COX inhibition (Cowley et al. 1983; Cowley et al. 1985; 
Gresele et al. 1985; Hechtman and Jageneau 1985), with one study showing that 
the reflex vascular resistance is increased during cooling following  COX inhibition 
(Serneri et al. 1981). As the present study observed the local vascular response to 
cooling, the results are difficult to compare to previous studies as the reflex 
vasoconstrictor response is controlled differently compared with the local 
vasoconstrictor response. 
 
There were no ethnic differences in response to foot cooling following placebo, but 
following aspirin consumption CAU experienced a lower glabrous and non-
glabrous foot Tsk compared with AFD (Figure 7.6 and Figure 7.7). It is interesting 
to note that despite the greater CVC in the non-glabrous foot skin site in CAU 
compared with AFD following COX inhibition (Figure 7.3), CAU experienced a 
lower Tsk at this skin site compared with AFD (Figure 7.7). This seems counter-
intuitive, however there does seem to be a possible explanation for this. The 
cutaneous blood flow in the non-glabrous foot skin site is relatively low compared 
with the glabrous foot skin site and it is thought that the glabrous skin site 
influenced the Tsk responses at the non-glabrous skin site. Therefore, in light of the 
present study results it appears that the glabrous skin site is more important for 
the thermoregulation of extremities. This finding highlights the importance of 
measuring both SkBF and Tsk during local cooling as Tsk may be substantially 
influenced by other adjacent skin regions. 
 
The non-glabrous finger skin site demonstrated a warmer Tsk at the start of cooling 
following COX inhibition for both CAU (third minute to fourth minute) and AFD (first 
minute to ninth minute) (Figure 7.13). These data suggest that the initial decrease 
in local Tsk may, in part, be influenced by the COX pathway. Indeed, local 
vasoconstriction is initially (<10 min) mediated by the release of NA from 
sympathetic nerves (Johnson et al. 2005). As the decrease in Tsk during the early 
phase of cooling (<10 min) was attenuated with COX inhibition it is possible that 
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prostanoids may modulate the release / action of NA. Srinivasa and Marshall 
(2011) delivered α1 and α2 agonists (using iontophoresis) to non-glabrous finger 
skin sites of young healthy males with and without COX inhibition. It was reported 
that α1 receptor activation appears to release COX vasodilator products, but α2 
receptor activation leads to vasoconstriction that is blocked with COX inhibition. In 
light of these findings, coupled with the knowledge that α2 receptor activation is 
primarily responsible for the cooling-induced vasoconstriction (Flavahan et al. 
1985; Ekenvall et al. 1988), it is postulated that COX inhibition in the present study 
blunted (in the initial minutes) the release of COX vasoconstrictor products (e.g. 
TXA2) and / or ROS as a result of α2 activation in the non-glabrous skin sites.  
 
As COX inhibition did not alter the exaggerated vasoconstrictor response to 
cooling in AFD in the finger skin sites, the reason for the enhanced vasoconstrictor 
capacity in AFD compared with CAU during cooling, and the increased 
susceptibility of NFCI is still not known. It could be that the heightened oxidative 
stress known in AFD does not play a major role in the control of SkBF during 
cooling or that the source of oxidative stress is not primarily produced through the 
COX pathway. The control of SkBF is complex with multiple pathways working 
synergistically, thus it could be possible that the reason for the exaggerated 
response to cooling involves multiple pathways that do not rely on COX. 
 
Taken together the present study suggests that AFD respond similarly to CAU in 
response to local foot cooling. This finding is at odds with the research that 
highlights NFCI is more prominent in the lower extremities, and AFD are more 
susceptible to NFCI. A standing individual will experience a lower skin blood flow 
at their feet than a supine individual; therefore, it is thought that the standing 
individual is more at risk of sustaining a NFCI during cooling. Future research 
should consider posture during cooling. The reason for the similar response to foot 
cooling between ethnic groups may be linked to the increased adrenergic function 
in the lower extremities versus the upper extremities (Yamazaki and Yuge 2011) 
which may have masked any ethnic differences as observed during hand cooling. 
 
A potential limitation of the present study could be the timing of trials for those who 
consumed aspirin on their first trial. An increased platelet Ca2+ mobilisation 
releases AA which is subsequently metabolised by platelet COX stimulating the 
release of TXA2, which is capable of eliciting smooth muscle contraction (Hamberg 
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et al. 1975). Aspirin inhibits COX by acetylation of the active site of COX and since 
platelets are incapable of protein synthesis they cannot produce new active COX, 
where full replenishment of platelet COX function takes approximately 10 days (i.e. 
10 % replenishment per day) (Burch et al. 1978). In contrast to the irreversible 
action of COX on platelets, endothelium and smooth muscle COX function 
appears to return within 24 hours (Jaffe and Weksler 1979; Hla and Bailey 1989) 
and responses to bradykinin appear to be maximally inhibited for less than 90 
minutes (Heavey et al. 1985).  
 
There were 12 participants (six CAU and six AFD) who completed the aspirin trial 
first; of these 12 there were four CAU and four AFD participants who completed 
both trials within ten days. Within these eight participants it is probable that platelet 
COX may not have been at full function during their second trial. Therefore, it is 
possible that these volunteers may have participated in their second trial (placebo) 
without full platelet derived TXA2 contribution which may have affected results. 
However, when reanalysing the placebo results without these eight participants, 
foot and hand glabrous and non-glabrous Tsk results were the same as the main 
study results. Therefore, this limitation appears to be of minor importance in the 
present study.  
 
Together the present findings suggest that foot cooling and subsequent rewarming 
in AFD is comparable to CAU, whilst COX inhibition results in lower Tsk in CAU 
compared with AFD. This is in contrast to the responses of the hand in that AFD 
experienced lower CVC and Tsk compared with CAU with and without COX 
inhibition. These data show that young healthy AFD compared with CAU appear to 
be at a greater risk of NFCI in the hands but not the feet. Given that NFCI is more 
prominent in the feet, it is postulated that other factors also contribute to the 
increased injury rate of AFD.  
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8 General Discussion and Conclusions 
8.1 General Discussion 
The work presented in this thesis provides an insight into the vascular responses 
of different ethnic groups to both local cooling with subsequent rewarming and 
locally delivered vasoactive agents. The experiments described in this thesis 
tested the general hypothesis that SkBF and Tsk would differ between CAU and 
AFD during cooling and subsequent rewarming, with ASN responding similarly to 
CAU. Tsk responses of AFD and CAU during prolonged hand cooling have 
previously been reported (Meehan 1955b; Iampietro et al. 1959; Newman 1969; 
Jackson et al. 1989) but the initial study in this thesis (Study One) (Maley et al. 
2014) was the first to investigate the vascular responses at glabrous skin sites to 
hand and foot cooling between CAU, ASN and AFD. This section will discuss how 
the studies were developed as well as explore areas that were not addressed 
previously and how these results can be viewed together to give an overview of 
the studies and help understand why AFD are more susceptible to NFCI. 
 
The principal findings of each study are listed below: 
 Study One - During hand cooling, AFD experienced a more intense and 
protracted finger vasoconstriction than CAU. ASN had intermediate 
responses. There were no physiological differences between ethnic groups 
in response to either mild foot cooling or a sensory threshold test. 
 Study Two - ACh induced a smaller increase in SkBF in the non-glabrous 
finger and toe skin sites in AFD compared with CAU. There were no ethnic 
differences in response to SNP or NA at these skin sites. 
 Study Three - The vasodilator responses to local application of ACh in the 
non-glabrous foot and finger skin sites were lower in AFD than CAU 
irrespective of whether COX was inhibited or not. 
 Study Four - Following placebo, SkBF and Tsk did not differ between ethnic 
groups at the glabrous toe skin sites during more severe foot cooling 
(period of time extended and water temperature lowered compared with 
Study One). Following aspirin consumption the glabrous toe skin site was 
cooler in CAU than AFD but SkBF did not differ between groups. 
Conversely, AFD experienced significantly lower finger SkBF and Tsk 
compared with CAU during hand cooling irrespective of whether COX was 
inhibited or not. 
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The experiments in this thesis tested the responses to both thermal and 
pharmacological stimuli in different ethnic groups in an attempt to understand why 
AFD are more susceptible to NFCI. Utilising pharmacological stimuli enabled 
differentiation between putative pathways that control SkBF during cooling and 
subsequent rewarming. Study One was undertaken to identify if there were 
differences between ethnic groups during cooling and subsequent rewarming. The 
methods utilised were SkBF assessed with LDF and Tsk assessed with skin 
thermistors during local extremity cooling between three different ethnic groups. 
CAU and AFD differed during local hand cooling whilst the responses from ASN 
were intermediate; therefore, ASN population was not studied subsequently. From 
this it was hypothesised that the control of SkBF was different between CAU and 
AFD. 
 
In an attempt to elucidate the mechanisms that may affect the responses during 
local cooling and subsequent rewarming Study Two investigated the vascular 
responses in CAU and AFD to various vasoactive agents utilising iontophoresis. 
Three vasoactive agents were used - ACh, SNP and NA. These three vasoactive 
agents were chosen to gain an insight into the functional capacity of endothelium-
dependent and -independent vasodilatation as well as the vasoconstrictor 
capacity, respectively. The results from Study Two led to the finding that AFD have 
an attenuated endothelium-dependent vasodilator response to locally delivered 
ACh in the non-glabrous finger and toe skin sites compared with CAU (Maley et al. 
2015). There were no ethnic differences at these skin sites with SNP or NA 
suggesting that the responses to nitric oxide per se and the vasoconstrictor 
responses were similar between ethnic groups. These findings suggest that 
differences between ethnic groups to thermal stimuli may be due to altered 
endothelium function. 
 
As the vasodilator response to ACh is predominantly mediated through the COX 
pathway (Noon et al. 1998; Kellogg et al. 2005; Holowatz et al. 2005) and there is 
an accentuated vasodilator response when COX is inhibited prior to ACh delivery 
in those with endothelium dysfunction (Taddei et al. 1990; Taddei et al. 1997a; 
Taddei et al. 1997b), Study Three utilised COX inhibition and local delivery of ACh. 
It was hypothesised there would be an augmented vasodilator response in AFD 
with COX inhibition; however this was not observed. The results from this study 
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suggest that the endothelium dysfunction in AFD may not be due to alterations in 
the COX pathway. However, whether the role of COX is greater during thermal 
stimuli was not known, so this was addressed subsequently. 
 
Study Four investigated the responses of CAU and AFD with and without COX 
inhibition during foot and hand cooling and subsequent rewarming. COX inhibition 
would abolish the contribution from prostaglandins and the COX associated 
oxidative stress to the SkBF responses in CAU and AFD. As AFD have a 
heightened oxidative stress (Kalinowski et al. 2004) it is possible that COX 
inhibition may reduce the exaggerated cooling-induced vasoconstriction in AFD. 
During hand cooling with COX inhibition, the differences in SkBF and Tsk remained 
between CAU and AFD, however, these findings were not reproduced during foot 
cooling. Collectively, the present thesis provides evidence that the endothelium 
dysfunction observed in non-glabrous skin sites in response to ACh and the 
greater vasoconstrictor response in AFD during hand cooling is not primarily 
governed by the COX pathway. Other pathways which result in a lower finger 
SkBF must therefore be adversely affected in AFD compared with CAU.  
 
The ability of an individual to keep their extremities warm when exposed to a cold 
environment may be attributed to a mix of genetic and phenotypic adaptation 
(Krog et al. 1960; LeBlanc et al. 1960; Miller and Irving 1962; Nelms and Soper 
1962). The experiments presented in this thesis tested volunteers who had known 
ancestors and were self-classified either as CAU, ASN or AFD. When considering 
the AFD participants tested, some were born in the UK, some in Africa whilst one 
was born in Italy. As all AFD had resided in the UK for a minimum of three years it 
was assumed that they were adequately acclimatised to the UK environment; that 
is, no climatic differences were present at time of testing between CAU and AFD. 
This would lend support to a genetic difference between CAU and AFD rather than 
a phenotypic adaptation that AFD may have developed to their African climate. 
However, it is not known how long these phenotypic adaptations remain for.  
 
To test between genetic and phenotypic differences a comparison would need to 
be made between AFD born in the UK versus AFD born and life-time residents in 
Africa. This test would allow a more thorough comparison between genetic and 
phenotypic differences between AFD to thermal and pharmacological stimuli. 
Furthermore, the present thesis did not test a group that identified themselves as 
168 
 
European African (i.e. those who descend from Europe and reside in Africa). Only 
one participant was tested in this thesis (Study One) who would fall into this 
category. This participant had a typical CAU SkBF and Tsk response during hand 
cooling (see typical trace of Tsk in General Methods). Testing individuals of 
European descent residing in Africa would, again, give more insight into the 
genetic and phenotypic differences between those who descend from black 
African race and those of CAU (e.g. UK) race. In the present thesis, therefore, we 
can only assume that there may be a mix of genetic and phenotypic adaptations in 
CAU which facilitate greater SkBF and warmer Tsk during local hand cooling 
(enhanced protection to NFCI) compared with AFD. 
 
Within this thesis the studies investigated the responses of the feet and hands to 
local cooling. The results demonstrate that the feet and hands may be controlled 
differently in response to thermal stimuli. Study One demonstrated the glabrous 
finger skin vasculature during hand cooling responded with a greater 
vasoconstrictor response in AFD than CAU and a delayed release of 
vasoconstriction during subsequent rewarming leading to a slower rate Tsk
 
rewarming. However, the responses to a two minute foot immersion (15 °C) did 
not differ between ethnic groups. It was speculated that the cold stimulus to the 
foot was not strong enough to elicit any ethnic differences.  
 
In Study Four the foot immersion duration was extended (30 minute) and water 
temperature lowered to 8 °C giving the same stimulus as for the hands and being 
arguably more representative of the stimulus causing NFCI. However, the 
responses were similar between ethnic groups during the foot immersion protocol; 
the reason for this is unknown. Cold injuries are more prevalent in the feet 
compared with the hands (Taylor 1992; Conway and Husberg 1999; DeGroot et al. 
2003; Daanen and van der Struijs 2005; Burgess and Macfarlane 2009) and given 
that AFD compared with CAU are more susceptible to NFCI this finding was not 
expected. 
 
During thermal stimuli an investigator can measure SkBF and Tsk from both 
glabrous and non-glabrous skin sites. The glabrous skin sites contain numerous 
AVAs which are located deeper than the superficial capillary loops, but AVAs are 
capable of substantially increasing SkBF given their greater internal diameter 
compared with capillary loops (Grant 1930; Hale and Burch 1960; Taylor et al. 
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2014). Therefore, the greater SkBF delivered to the slower moving venous 
circulation provides relatively larger heat exchange with the surrounding tissue and 
thus has a greater influence on Tsk. In Study Four both finger and foot glabrous 
and non-glabrous skin sites were measured during local cooling and rewarming. 
From inspection of the figures, it appears that the SkBF through the glabrous foot 
skin site is more representative of the Tsk responses at both the glabrous and non-
glabrous foot skin site. Turning our attention to the differences between the hand 
and foot protocols, the non-glabrous finger skin site appears to have a larger SkBF 
compared with the non-glabrous foot skin site and better reflects the rewarming of 
finger Tsk. Whilst this suggests that the blood flow through the glabrous skin sites 
may be more important for the protection of NFCI, the SkBF through the non-
glabrous skin sites (at least in the hand) will provide some line of defence to the 
cold. 
 
Study Two examined the SkBF responses to vasoactive agents to both glabrous 
and non-glabrous skin sites. No vasodilator response to either ACh or SNP was 
noted in the glabrous skin sites of the finger and toe pads. Previous research has 
also failed to elicit an increase in SkBF with SNP in the finger pad even with a 
greater concentration than the present thesis (i.e. 1.25 % vs. 0.01 %, respectively) 
(Roustit et al. 2009). The reason for this is not clear but may be due to an 
increased drug clearance from the local skin site due to AVAs causing a greater 
SkBF. The thicker skin at the glabrous skin site may also be a factor affecting drug 
delivery. However, an increase in forearm SkBF in response to SNP delivered via 
iontophoresis was reported in individuals with an increased skin thickness due to 
systemic sclerosis (Roustit et al. 2009).  
 
During foot cooling in Study Four it is clear that in both ethnic groups that some 
participants exhibited near maximal vasoconstriction of the glabrous skin site, 
whilst SkBF in a number of participants was only slightly decreased with some 
exhibiting no change (Figure 7.2). Given that the water temperature was 8 °C it 
was presumed that this would have provided adequate stimulus to vasoconstrict 
AVAs; this occurred readily with hand cooling under the same conditions. The 
thermal stimuli tests were conducted in a room maintained at 30 °C as a warmer 
environmental temperature elicits greater CIVD reactions (Keatinge 1957; Daanen 
et al. 1997; Sawada et al. 2000). However, the environmental conditions that lead 
to NFCI occur at a much lower environmental temperature of 30 °C. Therefore, it is 
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suggested that local cooling whilst sat in a warm room may not be best suited to 
studying the vascular differences which may be responsible for the increased 
susceptibility of AFD to NFCI. Despite this, during hand cooling and subsequent 
rewarming AFD appear to have a dysfunctional mechanism that elicits greater 
vasoconstriction and slower rewarming.  
 
Previous research has shown AFD compared with CAU experience a lower deep 
body temperature, finger Tsk and oxygen uptake during whole-body cooling 
(Rennie and Adams 1957; Adams and Covino 1958; Farnell et al. 2008) and, 
given that the CIVD responses are blunted with colder environments / lower deep 
body temperatures (Keatinge 1957; Sawada et al. 2000; Daanen 2003; Dobnikar 
et al. 2009), it is possible that other factors differ, such as thermogenesis and / or 
centrally-induced vasoconstriction, in combination with a depressed CIVD reaction 
during whole-body cooling may play a role in the increased susceptibility of AFD to 
NFCI.  
8.2 Conclusions 
It is concluded that, compared with CAU, AFD demonstrate 1) an increased 
vasoconstrictor response to local hand cooling, 2) a delayed rewarming and 3) an 
attenuated endothelium-dependent vasodilatation in non-glabrous finger and toe / 
foot skin sites. These differences between CAU and AFD are not altered with COX 
inhibition providing evidence that a dysfunctional COX contribution is not the 
primary reason for these differences. From the four experiments presented in this 
thesis comparing ethnic groups, the thesis hypotheses (see page 57) H01 and H02 
are rejected, whilst partial support is provided for HA1 and HA2. Other pathways 
appear to be responsible for the differences between ethnic groups to hand 
cooling and may include, but not be limited to, other sources of oxidative stress 
which diminish nitric oxide availability. Although the responses from the hand 
provide some possible insight into the reason for the increased susceptibility of 
AFD to NFCI, the foot responses during local cooling, where AFD respond 
similarly to CAU, are in stark contrast. Further testing is required to study the 
possibility that the centrally-induced vasoconstrictor responses (especially in the 
extremities) are greater in AFD compared with CAU during whole-body cooling. 
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9 Assumptions, Delimitations and Limitations 
9.1 Assumptions 
The following assumptions were made in this thesis: 
 The inhibition of COX was assumed to be successful and equal between 
participants.  
 It was assumed that all participants abstained from alcohol for 24 hours and 
did not consume caffeine or participate in exercise for 12 hours prior to 
testing. 
 The subjective recall of participants’ exposure to cold was assumed to be 
true and complete. 
9.2 Delimitations 
The following delimitations, created prior to experimentation, were limitations set in 
this thesis to reduce the amount of time spent in certain areas that were beyond 
the scope of this thesis: 
 Only young male participants were recruited for testing. Therefore, the 
results of the present study should only be interpreted to this population. 
 Those with any history of hypertension or any other vascular disorders, 
including cold sensitivity, were not recruited in the studies as these factors 
are known to elicit lower absolute SkBF responses to various stimuli. 
 Participants were only eligible to participate if both parents and 
grandparents were known to be of the same ethnic group.  
9.3 Limitations 
Limitations are defined as factors, such as experimental design, that may have 
impacted on the results of an experiment. In the present thesis the following 
limitations occurred: 
 The number of AFD participants during the iontophoresis studies was 
reduced at a current of and above 50 μA which may have prevented the 
protocol demonstrating a maximal response for each participant. The use of 
local heating (~25 min at 43 °C) or local cooling (~25 min at 10 °C) at the 
end of the protocol would be able to elicit maximal responses with results 
expressed as change in SkBF from maximum / minimum. 
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 The ethnic groups were not controlled in relation to whether participants 
were born in UK or not. Additionally, the country of descent was not 
controlled. Both of these limitations may have led to variable responses 
within groups.  
 Participants were not eligible to participate in the experiments if they had 
any history of hypertension including family history. As AFD are more likely 
to have a history of hypertension than CAU (Mozaffarian et al. 2015), with 
this vascular disorder associated with a diminished endothelium-dependent 
vasodilator response (Taddei et al. 1993), the present thesis is limited in 
that the experiments in this thesis do not include these individuals. 
Therefore, the present thesis may not be representative of the UK AFD 
population as a whole who may be exposed to the environmental conditions 
which cause NFCI. 
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10 Recommendations for Future Work 
From the results presented in this thesis it is clear that more work is needed to 
elucidate the reasons for the increased susceptibility of NFCI in AFD, especially in 
the feet. The following is a list of possible directions for future research: 
 As the present thesis did not control whether participants were born in UK 
or not, it may be of interest to compare AFD born in Africa and those who 
were born in the UK. The period of residency in Africa and how long these 
individuals have lived in UK would need to be carefully controlled. 
Alternatively, a longitudinal study could be conducted where measurements 
are made in AFD living in Africa, who subsequently move to the UK, where 
additional measurements are conducted to observe any changes in their 
response. This study would give more insight into the genetic and 
phenotypic contribution to the cooling-induced vasoconstriction. 
 Although NFCI is a local injury it appears that this may be as a result of, in 
part, centrally-induced vasoconstriction during cold exposures. Future 
research should investigate the extremity vascular and Tsk differences 
between CAU and AFD in response to whole-body cooling with and without 
local cooling. 
 Responses to SNP were similar in the fingers and feet between ethnicities 
(Study Two) which suggest smooth muscle function in response to nitric 
oxide is equal. The amount of nitric oxide available to the smooth muscle 
cell, however, may not be equal due to an increased oxidative stress in 
AFD compared with CAU. By increasing the availability of nitric oxide, faster 
rewarming may be observed following local cooling. Therefore, a nitric 
oxide donor such as glycerol trinitrate may improve SkBF in AFD during 
hand cooling and subsequent rewarming. Similar research has utilised this 
approach for individuals with cold sensitivity (Hope et al. 2014) and 
Raynaud’s phenomenon (Tucker et al. 1999; Baumhäkel and Böhm 2010). 
 Iontophoresis is a useful tool for investigating the local responses to a 
select few agonists / antagonists. However, the usefulness of iontophoresis 
is limited by skin resistance (especially in AFD) that prevents delivery of 
greater vasoactive agent concentrations. Additionally, the vasoactive agent 
delivered locally using iontophoresis to the glabrous skin sites may be 
cleared too quickly to observe an effect. Therefore, the use of microdialysis 
may be a useful alternative. Furthermore, there are no previous 
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investigations that have utilised microdialysis in glabrous skin sites such as 
the toe pads studying the control of SkBF. Pilot work conducted at the Noll 
Laboratory, Penn State University (USA) between the thesis author, Dr. 
Clare Eglin, Dr. Lacy Alexander and Professor Larry Kenney observed that 
microdialysis is feasible in the Great toe pads. 
 The use of antioxidants may reduce oxidative stress and facilitate SkBF 
responses during cooling and rewarming. In vitro data have provided 
evidence that an antioxidant (nebivolol) decreased oxidative stress in AFD 
and increased nitric oxide availability to similar levels to CAU (Mason et al. 
2005). Infusion or consumption of an antioxidant in CAU and AFD prior to 
local cooling could be utilised to explore this further. 
 It is possible that the increased oxidative stress may decrease the 
availability of an essential co-factor, tetrahydrobiopterin (BH4) causing 
endothelial NOS uncoupling and decreased nitric oxide availability. 
However, given that NA synthesis is also dependent on BH4 and the 
present thesis observed an augmented vasoconstrictor response in AFD 
compared with CAU during hand cooling this mechanism remains plausible 
though less likely. Local infusion of BH4 would restore any deficiency and 
the ability of endothelial NOS to synthesise nitric oxide. Therefore, any 
differences observed subsequently between ethnic groups would 
presumably be activated by mechanisms other than a lower BH4 availability. 
 Given that vasoconstrictor responses to local cooling are elicited through α 
adrenergic receptor activation it would be useful to know the contribution of 
α (and β) adrenergic receptor activation between ethnic groups. 
Furthermore, it appears that ROCK is involved in this process, perhaps 
through an upregulation of α2C receptors. Infusion of yohimbine, terazosin 
and propranolol antagonise α2, α1 and non-selective β receptors, 
respectively, whilst fasudil inhibits ROCK; these agents could be used 
separately and combined during local cooling. This study would 
demonstrate the specific contribution of α and β adrenergic receptors and 
also highlight the contribution of ROCK (non-neural) to the vasoconstrictor 
response to cooling. 
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12 Annex 1 - Repeatability of Finger Vasomotor Thresholds during Cooling 
and Subsequent Warming 
12.1 Introduction 
Local cooling of the skin elicits local vasoconstriction in an attempt to prevent heat 
loss, but this may increase an individual’s susceptibility to cold injury. This 
cutaneous vasoconstriction is progressively released during rewarming resulting in 
a progressive rise in SkBF to a level comparable with warmed skin. The identity of 
these points of change, termed vasomotor thresholds (VT), (i.e. the onset and 
release of vasoconstriction) may be identified and comparisons made between 
individuals. As AFD are more susceptible to NFCI (Miller and Bjornson 1962; 
Taylor 1992; Conway and Husberg 1999; DeGroot et al. 2003; Burgess and 
Macfarlane 2009; Connor 2014), the point at which these VT occur may not be the 
same between ethnicities. Specifically, it could be that AFD vasoconstrict at a 
warmer Tsk compared with CAU thereby exposing those individuals to a greater 
"dose" of cold skin. Developing a test that will gradually cool and rewarm an 
individual’s extremity could reveal differences in both the onset and release of 
vasoconstriction. To the author’s knowledge no such test has been established 
previously.  
 
To help with the interpretation of such a test it is important to assess its 
repeatability. The term repeatability is often used interchangeably with other words 
such as reliability, reproducibility, consistency, agreement and stability (Atkinson 
and Nevill 1998; Bartlett and Frost 2008). Repeatability refers to how repeatable a 
measure is between two or more exact tests (Bartlett and Frost 2008). Extending 
this, repeatability can also refer to the agreement of an assessor rating the same 
thing, known as intra-observer repeatability1, or refer to the agreement between 
two different assessors rating the same thing, known as inter-observer 
agreement2. 
 
Repeatability may be influenced by various factors, including equipment errors and 
human (participant) biological variation. This biological variation can be attenuated 
by a structured protocol, but there may still be large variation even under well 
                                            
1
 The word repeatability was chosen as ratings were made by one assessor and can be assessed 
using both ICC and CV %; the word reliability would refer only to ICC (Bartlett and Frost 2008). 
2
 The word agreement was chosen as both ICC and CV % can be calculated, the word repeatability 
was not chosen as it generally signifies one assessor which would be misleading in this context. 
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controlled experiments. To add to the complexity of studies assessing the 
repeatability of tests, there are a number of statistical methods used to calculate 
repeatability; these are broadly classified into tests of absolute and relative 
repeatability. Absolute repeatability refers to the variation in an individual's score 
from repeated measurements (Atkinson and Nevill 1998). This type of repeatability 
is usually expressed as a proportion of the measured value or in actual units of 
measurement. Relative repeatability (often referred to as reliability) refers to an 
individual's result position in a sample and whether that position is maintained with 
repeated measurements assessed with a type of correlation. 
 
Absolute repeatability is often tested using a co-efficient of variation of the typical 
error (sometimes referred to as standard error) of measurement (CV %) (Atkinson 
and Nevill 1998; Hopkins 2000). It is simply calculated, on a single case, by 
dividing the SD by the mean (of at least two repeat measurements) and multiplying 
by 100. This calculation can be performed on each individual's data which can 
then provide a group average CV %. This value conveys the variance in the values 
of repeated measures (Hopkins 2000). By expressing the data as a percent, the 
value becomes relative to the mean and thus easier to interpret between studies. 
Another method of calculating absolute repeatability is the use of limits of 
agreement (LoA) which are able to provide a visual representation of repeatability 
as well as a range in which an individual's difference scores may fall 95 % of the 
time (Bland and Altman 1986; Hopkins 2000). LoA are affected directly by sample 
size (n > 40 required; Atkinson and Nevill, 1998) therefore, the present study opted 
to calculate CV %. 
 
Relative repeatability (reliability) may be calculated using an intra-class correlation 
(ICC) which produces values which range from 0 (no reliability) to 1 (perfect 
reliability). There are many ways in which ICC can be calculated (Table 12.1) 
(Shrout and Fleiss 1979; McGraw and Wong 1996). Simply put, Shrout and Fleiss 
(1979) determined that there are six different ways in which ICC may be 
calculated. Table 12.1 shows each type of ICC and how each is interpreted. The 
type of ICC used should be denoted by two numbers with the first referring to the 
model and second to the form (i.e. single or average measures). It is important 
also to consider whether assessment of consistency or absolute agreement is 
required. Consistency refers to rank order and if differences between sets of data 
are similar then the reliability will be high. However, for example, if one assessor is 
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consistently scoring a lower value compared with another assessor, then the 
absolute agreement will be low (i.e. the relative magnitude of ratings matters). The 
statistical testing in the present study therefore utilised the absolute agreement 
option. The present study utilised both a relative (i.e. ICC) and an absolute (CV %) 
measure of repeatability. The type of ICC used in the present study is discussed in 
the methods below. 
 
Table 12.1 Different types of intra-class correlation 
ICC Type Description 
1,1 One-way random effects model, comparisons are assessed within-participant 
or -rater etc. Calculated from a single measure. Referred to as the intra-
observer model. 
 
SPSS: One-way random effects single measures model 
2,1 Each participant measured by each rater from a population of similar raters. 
Calculated from a single measure. Referred to as the inter-observer model. 
 
SPSS: Two-way random effects single measures model 
3,1 As 2,1 but raters are the only raters of interest. 
 
SPSS: Two-way fixed effects single measures model 
1,k As 1,1 but reliability is calculated from an average of ratings or raters 
 
SPSS: One-way random effects average measures model 
2,k As 2,1 but reliability is calculated from an average of ratings or raters 
 
SPSS: Two-way random effects average measures model 
3,k As 3,1 but reliability is calculated from an average of ratings or raters 
 
SPSS: Two-way fixed effects average measures model 
 
The present study utilised hand and forearm cooling and utilised the fingers for the 
identification for the VT, which may be assessed both objectively and subjectively. 
Therefore, the aim of the present study was to use both approaches in an attempt 
to identify the most repeatable method. Utilising subjective methods raises 
problematic error sources, such as differences between- and within-assessors 
(raters). For this approach to be adopted by researchers, the subjective criteria 
should be repeatedly identified between- and within-assessors. Therefore, the 
subjective criteria were firstly assessed between- and within-assessors.  
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12.2 Hypotheses 
H01. The onset and release of finger vasoconstriction will be repeatable 
within-assessors. 
HA1. The onset and release of finger vasoconstriction will differ within-
assessors. 
 
H02. There will be agreement between the onset and release of finger 
vasoconstriction between-assessors. 
HA2. There will not be agreement between the onset and release of finger 
vasoconstriction between-assessors. 
 
H03. The onset and release of finger vasoconstriction between visits will 
be repeatable. 
HA3. The onset and release of finger vasoconstriction between visits will 
not be repeatable. 
12.3 Methods 
12.3.1 Participants 
A favourable ethical opinion was received from the BioSciences Research Ethics 
Committee in accordance with University regulations (BSREC 12 / 071). 
Participants were made aware of the purpose, procedure and risk of the study 
prior to giving their informed written consent. Nine CAU male volunteer 
participants were recruited after completion of an exercise and health history 
questionnaire. The mean (SD) age, height and body mass were; 20 (2) years, 1.8 
(0.1) m, 78.1 (13.0) kg, respectively. The mean (SD) physical characteristics were: 
BSA 2.0 (0.1) m2; body mass to BSA ratio 38.9 (4.0) kg⋅m2; hand length 20.0 (0.7) 
cm; forearm length 28.5 (2.0) cm; forearm girth 27.5 (2.3) cm; and hand and 
forearm volume 1.7 (0.3) L. 
12.3.2 Experimental Procedures and Measurements 
Each participant repeated the experimental protocol three times on separate visits 
to the laboratory, each at the same time of day, separated by at least seven days. 
Participants wore the same clothing on each occasion which included a t-shirt and 
tracksuit trousers. All anthropometric measurements were recorded prior to 
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testing, with the exception of the hand and forearm volume which was recorded on 
completion of all trials. The equipment and skin sites utilised in the present study 
has been explained in the General Methods (see page 76). Participants sat in a 
climate controlled room (mean [SD] Tdb: 30.1 [0.4] °C, Twb: 19.7 [1.5] °C and 
WBGT: 22.9 [1.1] °C) whilst being instrumented. Participants then placed their arm 
in warm water (35.2 [0.2] °C) for ten minutes. After ten minutes the water 
temperature was gradually reduced to 10.0 (0.1) °C over 32 (1) minutes. Following 
this, the water bath was reheated over 25 (1) minutes (Figure 12.1). 
 
 Vasomotor Threshold Test 
20 min 10 min ~32 min ~25 min 
Instrumentation 
Baseline  
35 °C 
Cooling to 10 °C Rewarming to 35 °C 
Figure 12.1 Schematic of the experimental procedure for assessing the 
repeatability of the vasomotor threshold test 
12.3.3 Definition of Finger Vasomotor Thresholds 
Attainment of the most repeatable criterion for the VT required testing various 
criteria. The individual participant data were printed and displayed on a figure of 
normalised (see data analyses) SkBF (y-axis) and Tsk (x-axis) which was used for 
the subjective identification of Tsk for the onset and release of vasoconstriction. 
Listed below are the criteria for the VT. Figure 12.2 and Figure 12.3 show a 
representation of finger SkBF and Tsk during cooling and rewarming; the letters 
highlight the subjective criteria. 
Vasoconstriction 
A. The point just preceding the onset of a substantial fall in finger SkBF which 
was prolonged and did not return; identifiable by eye (i.e. onset of 
vasoconstriction). 
B. The point up to which there was a preceding substantial fall in SkBF that 
subsequently did not rise or fall significantly; identifiable by eye (i.e. onset of 
maximal, or near maximal, vasoconstriction). 
C. The point at which there was a preceding substantial fall in SkBF that 
subsequently did not decrease by > 5 % nor increase by > 10 %. 
D. The first point at which SkBF fell and remained below the cumulative 1SD. 
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Release of Vasoconstriction  
E. The point just preceding the onset of an obvious and progressive increase 
in SkBF; identifiable by eye (i.e. release of vasoconstriction).  
F. The first point at which SkBF rose above the cumulative 1SD. 
 
Figure 12.2 Representative tracing of normalised finger skin blood flow during 
cooling in water to 10 °C. Point of vasoconstriction identified using criteria A and B. 
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Figure 12.3 Representative tracing of normalised finger skin blood flow during 
rewarming in water to 35 °C. Point of release of vasoconstriction identified using 
Criterion E. 
12.3.4 Data Analyses 
Data for SkBF were analysed as minute averages during immersion and 
expressed as a percentage change from baseline (defined as the average of the 
final minute of the ten minute immersion period in 35 °C water) which was set at 
100%. Tsk was recorded at five second intervals during the immersion period and 
calculated as minute averages. As criteria A, B and E are subjective, three 
assessors (including the principle investigator), each with experience in analysing 
SkBF, marked each participant, each visit, twice. Thus, each assessor was given 
two batches of identical data, each containing 27 figures (nine participants × three 
repeat trials) with each batch mixed using a random numbers generator. These 
numbers corresponded to a participant number and trial. Each assessor marked 
both batches of data within a 24 hour period. Once completed, the principal 
investigator input the data from the sheets in to a computer for storage. This 
allowed profiling of assessor’s agreement with themselves (intra-observer) as well 
as the agreement between each assessor (inter-observer). 
 
Participants’ perception of thermal sensation and thermal comfort, both overall and 
local (immersed arm), were recorded at the final minute of the ten minute period at 
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35 °C (baseline), every five minutes during cooling, final minute of cooling, every 
five minutes during rewarm and final minute of rewarm. As there were slight 
differences in the length of cooling and rewarming, the rate of change in finger Tsk 
was calculated from the same 15 minute period for both cooling and rewarming 
periods.  
12.3.5 Statistical Analyses 
The within-assessor repeatability (intra-observer) for the subjective onset points, 
was analysed using ICC (type 1,1) (Shrout and Fleiss 1979; McGraw and Wong 
1996) known as the one-way, absolute agreement, single measures model. This 
model was also used to characterise the repeatability of SkBF, Tsk and water 
temperature at baseline, cooling and rewarming times, change in water 
temperature and Tsk, thermal sensation and thermal comfort scales between visits. 
The subjective onset points between assessors (inter-observer) was analysed 
using ICC (type 2,1) known as the two-way absolute agreement, single measures 
model (Shrout and Fleiss 1979; McGraw and Wong 1996). Assessors were 
compared to other assessors using their first mark only. There is much debate 
regarding the level of acceptable repeatability (Atkinson and Nevill 1998; Hopkins 
2000), with many investigations using an arbitrary < 10 % threshold for CV % and 
an ICC value of > 0.8 (Atkinson and Nevill 1998; Hopkins 2000; Baumgartner et al. 
2007). However, this “one size fits all” approach may not take into account the 
type of data measured. For example, in an individual sat at rest in a thermoneutral 
environment, SkBF in glabrous skin sites is highly variable and therefore the limits 
of repeatability will not be met using the above criteria. In an attempt to factor in 
this known variability investigators have set threshold limits for CV % and ICC as 
35 % and > 0.40, respectively (Harris et al. 2007). However, more conservatively 
other investigators have utilised CV % values of 20 % to 25 % (Abbink et al. 2001; 
Roustit et al. 2010). Data were considered repeatable if the criteria set a priori 
were met; ICC > 0.60 and CV % < 20 %. 
12.4 Results 
12.4.1 Baseline Variables 
SkBF was not repeatable between visits (Table 12.2) and despite Tsk being nearly 
identical between visits, the ICC values did not represent repeatable data; this was 
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the same for water temperature. The possible reason for this is considered in the 
discussion. 
 
Table 12.2 Mean (SD) baseline variables during the vasomotor threshold test 
n = 9. Square brackets indicate 95 % confidence intervals. 
12.4.2 Water Temperature and Skin Temperature Rate of Change 
The cooling period was completed within 31 to 34 minutes whilst the rewarming 
was quicker and completed within 23 to 27 minutes. The CV % for both cooling 
and rewarming times were indicative of repeatable values but the ICC values were 
not (Table 12.3). This was the same for the change in water temperature during 
both cooling and rewarming. The rate of change in finger Tsk during cooling and 
rewarming water was within acceptable limits of repeatability (Table 12.3). 
 
Table 12.3 Mean (SD) cooling and rewarming times and change in water and skin 
temperature 
Variable Visit 1 Visit 2 Visit 3 CV % ICC 
Cooling time (minute) 32 (1) 32 (1) 32 (1) 1.9 
[0.8 to 3.0] 
0.10 
[-0.23 to 0.59] 
Warming time (minute) 25 (1) 25 (1) 25 (1) 2.8 
[2.0 to 3.5] 
0.57 
[0.18 to 0.87 
Cooling δ water 
temperature (°C
.
min
-1
) 
0.78 (0.02) 0.78 (0.03) 0.79 (0.02) 1.9 
[0.9 to 2.9] 
0.19 
[-0.17 to 0.66] 
Warming δ water 
temperature (°C
.
min
-1
) 
1.02 (0.05) 1.05 (0.04) 1.04 (0.05) 2.8 
[1.9 to 3.6] 
0.58 
[0.19 to 0.87] 
Cooling δ Tsk (°C
.
min
-1
) 0.85 (0.08) 0.85 (0.06) 0.83 (0.09) 4.4 
[2.0 to 6.8] 
0.71 
[0.37 to 0.92] 
Warming δ Tsk (°C
.
min
-1
) 1.02 (0.09) 1.06 (0.08) 1.03 (0.1) 4.6 
[3.0 to 6.3] 
0.67 
[0.31 to 0.90] 
n = 9. Shaded boxes meet a priori requirements for repeatability. Square brackets indicate 95 % 
confidence intervals. 
Variable Visit 1 Visit 2 Visit 3 CV % ICC 
Skin Blood Flow (LDU) 261 (67) 289 (35) 299 (69) 16.9 
[8.3 to 25.4] 
0.22 
[-0.15 to 0.68] 
Skin Temperature (°C) 35.5 (0.2) 35.5 (0.1) 35.6 (0.1) 0.3 
[0.2 to 0.5] 
0.06 
[-0.25 to 0.56] 
Water Temperature (°C) 35.2 (0.1) 35.2 (0.2) 35.3 (0.1) 0.5 
[0.4 to 0.6] 
-0.19 
[-0.38 to 0.27] 
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12.4.3 Vasomotor Thresholds 
Agreement between mark 1 and mark 2 within-assessors for each criterion was 
within acceptable limits (Table 12.4, Table 12.5 and Table 12.6). Assessor 3 
showed “perfect agreement” for Criterion A between marks 1 and 2 (Table 12.4). 
 
Table 12.4 Mean (SD) onset point (°C) for vasoconstriction (Criterion A), 
coefficient of variation (CV %) [95 % confidence interval] and intra-class 
correlation coefficient (ICC) [95 % confidence interval] for each assessor for their 
respective mark 1 and mark 2 (intra-observer) 
  Mark 1 (°C) Mark 2 (°C) CV % ICC 
Assessor 1 
Visit 1 24.0 (6.3) 24.0 (6.3) 0 
- 
1.00 
- 
Visit 2 23.0 (4.3) 22.5 (4.6) 1.7 
[-2.2 to 5.6] 
0.95 
[0.79 to 0.99] 
Visit 3 21.7(2.7) 20.8 (3.0) 3.2 
[-2.1 to 8.6] 
0.71 
[0.18 to 0.93] 
Assessor 2 
Visit 1 22.8 (5.5) 22.9 (6.0) 2.6 
[-1.4 to 6.6] 
0.92 
[0.72 to 0.98] 
Visit 2 20.7 (3.6) 21.3 (3.6) 1.9 
[-1.8 to 5.5] 
0.92 
[0.70 to 0.98] 
Visit 3 20.1 (3.3) 20.1 (3.3) 0 
- 
1.00 
- 
Assessor 3 
Visit 1 24.0 (6.3) 24.0 (6.3) 0 
- 
1.00 
- 
Visit 2 23.1 (5.1) 23.1 (5.1) 0 
- 
1.00 
- 
Visit 3 21.2 (2.6) 21.2 (2.6) 0 
- 
1.00 
- 
Criterion A defined as the point just preceding the onset of a substantial fall in finger SkBF which 
was prolonged and did not return. Confidence intervals not included where there was agreement 
between mark 1 and mark 2. Shaded boxes meet a priori requirements for repeatability. Square 
brackets indicate 95 % confidence intervals. 
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Table 12.5 Mean (SD) onset point (°C) for vasoconstriction (Criterion B), 
coefficient of variation (CV %) [95 % confidence interval] and intra-class 
correlation coefficient (ICC) [95 % confidence interval] for each assessor for their 
respective mark 1 and mark 2 (intra-observer) 
  Mark 1 (°C) Mark 2 (°C) CV % ICC 
Assessor 1 
Visit 1 16.3 (2.9) 16.7 (3.1) 1.4 
[-0.7 to 3.5] 
0.97 
[0.89 to 0.99] 
Visit 2 15.6 (2.0) 15.2 (1.8) 2.5 
[0.4 to 4.7] 
0.91 
[0.68 to 0.98] 
Visit 3 15.6 (1.9) 15.3 (1.2) 2.5 
[-0.6 to 5.6] 
0.85 
[0.50 to 0.96] 
Assessor 2 
Visit 1 16.6 (3.7) 16.5 (3.9) 1.8 
[-0.4 to 3.9] 
0.98 
[0.94 to 1.00*] 
Visit 2 15.0 (1.9) 14.8 (2.1) 2.8 
[-0.5 to 6.2] 
0.87 
[0.56 to 0.97] 
Visit 3 15.8 (1.7) 15.1 (1.7) 3.1 
[-0.7 to 7.0] 
0.75 
[0.25 to 0.94] 
Assessor 3 
Visit 1 15.7 (2.7) 16.2 (2.9) 1.7 
[-2.2 to 5.6] 
0.90 
[0.64 to 0.98] 
Visit 2 14.0 (2.3) 13.8 (2.0) 2.3 
[-1.4 to 6.1] 
0.89 
[0.61 to 0.97] 
Visit 3 14.5 (1.5) 15.2 (3.4) 3.1 
[-3.2 to 9.5] 
0.60 
[-0.01 to 0.89] 
Criterion B defined as the point up to which there was a preceding substantial fall in SkBF that 
subsequently did not rise or fall significantly. Shaded boxes meet a priori requirements for 
repeatability. * Exact value = 0.996. Square brackets indicate 95 % confidence intervals. 
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Table 12.6 Mean (SD) onset point (°C) for vasoconstriction release (Criterion E), 
coefficient of variation (CV %) [95 % confidence interval] and intra-class 
correlation coefficient (ICC) [95 % confidence interval] for each assessor for their 
respective mark 1 and mark 2 (intra-observer) 
  Mark 1 (°C) Mark 2 (°C) CV % ICC 
Assessor 1 
Visit 1 12.7 (2.2) 12.4 (2.1) 1.5 
[-0.8 to 3.7] 
0.96 
[0.86 to 0.99] 
Visit 2 14.3 (4.9) 14.3 (5.0) 1.3 
[-0.8 to 3.5] 
1.00* 
[0.98 to 1.00
#
] 
Visit 3 15.9 (5.6) 14.8 (5.7) 5.1 
[-4.1 to 14.2] 
0.88 
[0.59 to 0.97] 
Assessor 2 
Visit 1 15.6 (4.4) 
 
15.1 (4.5) 2.4 
[-1.0 to 5.8] 
0.98 
[0.92 to 1.00*] 
Visit 2 15.9 (5.2) 
 
15.9 (5.2) 1.4 
[-0.8 to 3.6] 
1.00
+ 
[0.98 to 1.00
#
] 
Visit 3 16.6 (5.8) 
 
16.5 (5.6) 0.4 
[-0.5 to 1.2] 
1.00^ 
[0.99 to 1.00] 
Assessor 3 
Visit 1 13.2 (2.1) 
 
13.8 (4.0) 5.6 
[-3.2 to 14.4] 
0.58 
[-0.43 to 0.86] 
Visit 2 14.5 (4.8) 
 
14.5 (5.2) 1.1 
[-0.7 to 3.0] 
0.99 
[0.98 to 1.00
#
] 
Visit 3 16.4 (5.7) 
 
16.3 (5.7) 0.3 
[-0.3 to 0.8] 
1.00 
- 
Criterion E defined as the point just preceding the onset of an obvious and progressive increase in 
SkBF. Confidence intervals not included where there was agreement between mark 1 and mark 2. 
Shaded boxes meet a priori requirements for repeatability. * Exact value = 0.995. # Exact value = 
0.999. + Exact value = 0.996. ^ Exact value = 0.998. Square brackets indicate 95 % confidence 
intervals. 
 
Table 12.7, Table 12.8 and Table 12.9 show the agreement between each 
assessor as well as the overall agreement (i.e. agreement between all three 
assessors) for each criterion for each visit. There was agreement between 
assessor 1 and 3 for each criteria for each visit, whereas assessor 1 and 3 did not 
always agree with assessor 2. However, overall there was agreement between 
assessors for each criterion and for each visit except for Criterion E visit 1. 
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Table 12.7 Coefficient of variation (CV %) [95 % confidence interval] and intra-
class correlation coefficient (ICC) [95 % confidence interval] between each 
assessor (inter-observer) for Criterion A 
  Visit 
Assessor Variable 1 2 3 
1 vs. 2 
CV % 3.3 
[-1.9 to 8.4] 
8.0 
[0.4 to 15.5] 
5.8 
[-1.5 to 13.2] 
ICC 0.91 
[0.65 to 0.98] 
0.56 
[-0.03 to 0.88] 
0.54 
[-0.04 to 0.87] 
1 vs. 3 
CV % 0 
- 
2.6 
[-1.2 to 6.3] 
2.6 
[-2.4 to 7.6] 
ICC 1.00 
- 
0.93 
[0.70 to 0.98] 
0.71 
[0.15 to 0.92] 
2 vs. 3 
CV % 3.3 
[-1.9 to 8.4] 
7.5 
[-1.7 to 16.7] 
4.1 
[-2.5 to 10.6] 
ICC 0.91 
[0.65 to 0.98] 
0.48 
[-0.12 to 0.84] 
0.68 
[0.14 to 0.91] 
Overall 
CV % 2.6 
[-1.5 to 6.6] 
6.7 
[0.0 to 13.4] 
4.9 
[-1.0 to 10.9] 
ICC 0.94 
[0.83 to 0.99] 
0.66 
[0.30 to 0.89] 
0.63 
[0.27 to 0.89] 
Confidence intervals not included where there was agreement between assessors. Shaded boxes 
meet a priori requirements for repeatability. Square brackets indicate 95 % confidence intervals. 
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Table 12.8 Coefficient of variation (CV %) [95 % confidence interval] and intra-
class correlation coefficient (ICC) [95 % confidence interval] between each 
assessor (inter-observer) for Criterion B 
  Visit 
Assessor Variable 1 2 3 
1 vs. 2 
CV % 3.7 
[-0.5 to 7.9] 
6.2 
[2.4 to 10.1] 
4.0 
[0.3 to 7.6] 
ICC 0.91 
[0.65 to 0.98] 
0.63 
[-0.05 to 0.91] 
0.73 
[0.16 to 0.93] 
1 vs. 3 
CV % 4.0 
[-0.2 to 8.3] 
5.5 
[-0.2 to 11.2] 
4.9 
[0.6 to 9.2] 
ICC 0.84 
[0.49 to 0.96] 
0.70 
[0.10 to 0.92] 
0.63  
[0.00 to 0.90] 
2 vs. 3 
CV % 6.2 
[-0.3 to 12.8] 
5.4 
[0.5 to 10.2] 
5.8 
[0.6 to 10.9] 
ICC 0.70 
[0.16 to 0.92] 
0.75 
[0.14 to 0.94] 
0.49 
[-0.10 to 0.85] 
Overall 
CV % 5.3 
[0.8 to 9.9] 
6.4 
[2.0 to 10.8] 
5.8 
[2.1 to 9.4] 
ICC 0.82 
[0.56 to 0.95] 
0.70 
[0.35 to 0.91] 
0.61 
[0.23 to 0.88] 
Shaded boxes meet a priori requirements for repeatability. Square brackets indicate 95 % 
confidence intervals. 
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Table 12.9 Coefficient of variation (CV %) [95 % confidence interval] and intra-
class correlation coefficient (ICC) [95 % confidence interval] between each 
assessor (inter-observer) for Criterion E 
  Visit 
Assessor Variable 1 2 3 
1 vs. 2 
CV % 12.8 
[-1.3 to 26.9] 
7.3 
[-3.2 to 17.7] 
3.2 
[0.7 to 5.8] 
ICC 0.17 
[-0.31 to 0.68] 
0.80 
[0.37 to 0.95] 
0.98 
[0.87 to 1.00
#
] 
1 vs. 3 
CV % 3.0 
[-2.1 to 8.1] 
1.6 
[-0.4 to 3.7] 
2.3 
[-0.4 to 5.1] 
ICC 0.85 
[0.50 to 0.96] 
1.00* 
[0.98 to 1.00] 
0.99 
[0.93 to 1.00
#
] 
2 vs. 3 
CV % 9.9 
[-4.7 to 24.4] 
6.4 
[-3.1 to 16.0] 
0.9 
[-0.5 to 2.2] 
ICC 0.11 
[-0.42 to 0.67] 
0.83 
[0.43 to 0.96] 
1.00
#
 
[0.99 to 1.00
#
] 
Overall 
CV % 11.3 
[-1.7 to 24.3] 
6.5 
[-2.3 to 15.3] 
2.6 
[0.5 to 4.7] 
ICC 0.24 
[-0.08 to 0.68] 
0.87 
[0.66 to 0.97] 
0.99 
[0.96 to 1.00
#
] 
Shaded boxes meet a priori requirements for repeatability. * Exact value = 0.995. # Exact value = 
0.997. Square brackets indicate 95 % confidence intervals. 
 
As assessors’ markings were repeatable (Table 12.4, Table 12.5 and Table 12.6) 
but did not always agree with other assessors on the points of vasoconstriction 
(Table 12.7 and Table 12.8) and the release of this vasoconstriction (Table 12.9), 
it was decided the data should be further inspected with all three assessors 
present to assess the repeatability for each criteria (Table 12.10). From this only 
criterion met the a priori requirements (Criterion B). 
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Table 12.10 Mean (SD) onset points (°C) for vasoconstriction and release of 
vasoconstriction between participants, coefficient of variation (CV %) [95 % 
confidence interval] and intra-class correlation coefficient (ICC) [95 % confidence 
interval] for each criteria assessed by all three assessors together 
Variable Visit 1 Visit 2 Visit 3 CV % ICC 
Onset of Vasoconstriction 
Criteria A (°C) 24.7 (5.9) 23.1 (5.2) 21.1 (2.7) 14.2 
[9.0 to 19.3] 
0.46 
[0.06 to 0.82] 
Criterion B (°C) 17.0 (3.3) 16.0 (2.6) 15.7 (1.7) 7.3 
[2.7 to 11.8] 
0.60 
[0.22 to 0.88] 
Criterion C (°C) 14.4 (2.4) 14.8 (2.9) 14.8 (1.6) 10.5 
[5.5 to 15.6] 
0.35 
[-0.09 to 0.77] 
Criterion D (°C) n = 8 23.3 (4.5) 21.4 (4.5) 20.6 (3.6) 15.4 
[11.2 to 19.6] 
0.35 
[-0.06 to 0.78] 
Release of Vasoconstriction 
Criterion E (°C) 13.8 (4.0) 14.5 (5.2) 13.4 (3.7) 12.3 
[3.3 to 21.3] 
0.49 
[0.09 to 0.83] 
Criterion F (°C) n = 8 20.4 (6.4) 20.4 (6.4) 19.8 (5.0) 17.8 
[9.3 to 26.3] 
0.35 
[-0.12 to 0.79] 
n = 8 for Criteria D and F as data from one participant did not match definition. n = 9 for other 
criteria. Shaded boxes meet a priori requirements for repeatability. Square brackets indicate 95 % 
confidence intervals. 
12.4.4 Thermal Sensation and Thermal Comfort 
Overall thermal sensation was outside the preferable limits for repeatability when 
all time points were analysed together (CV % = 11.8, ICC = 0.58). When analysing 
individual time points, the final minute of cooling was the only point to yield 
repeatable values (CV % = 19.4, ICC = 0.60). Local thermal sensation was within 
limits of repeatability when all time points were analysed together (CV % = 20.3, 
ICC = 0.90). For local thermal sensation individual recordings at baseline (CV % = 
9.0, ICC = 0.63) and the final minute of rewarming (CV % = 3.2, ICC = 0.81) were 
accepted as repeatable. 
 
Overall thermal comfort was within limits of repeatability when all time points were 
analysed together (CV % = 11.0, ICC = 0.77). Overall thermal comfort ratings were 
repeatable at baseline (CV % = 9.9, ICC = 0.82), five minutes cooling (CV % = 8.5, 
ICC = 0.75), ten minutes of cooling (CV % = 10.5, ICC = 0.66), 15 minutes cooling 
(CV % = 11.3, ICC = 0.75) and 20 minutes cooling (CV % = 15.7, ICC = 0.72), five 
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minutes rewarming (CV % = 10.4 %, ICC = 0.78), ten minutes rewarming, (CV % = 
7.8, ICC = 0.70), 15 minutes rewarming (CV % = 8.8, ICC = 0.67), 20 minutes 
rewarming (CV % = 4.1, ICC = 0.90) and at the final minute of rewarming (CV % = 
6.5, ICC = 0.79). Local thermal comfort was within limits of repeatability when all 
time points were analysed together (CV % = 16.7, ICC = 0.87). Local thermal 
comfort ratings were repeatable at baseline (CV % = 10.6, ICC = 0.79), five 
minutes cooling (CV % = 10.6, ICC = 0.72), 15 minutes cooling (CV % = 11.8, ICC 
= 0.80), ten minutes rewarming (CV % = 11.8, ICC = 0.70) and 20 minutes 
rewarming (CV % = 4.1, ICC = 0.83). 
12.5 Discussion 
The principal findings from this study were: 1) assessors repeatedly identified the 
different points of VT, 2) assessors did not always agree (when marking 
independently), and 3) only one criterion (B) was repeatedly identified with all 
assessors present. Therefore, the present study accepts H01 and rejects HA1. The 
latter two null hypotheses are only partially supported by the present study.  
 
Importantly, the rate of change for finger Tsk during cooling and subsequent 
rewarming water was repeatable between visits. Therefore, it is assumed that the 
VT were not influenced by a different rate of change in finger Tsk between visits. 
Baseline Tsk and starting water temperature, change in water temperature (both 
cooling and rewarming) and time spent during each period (cooling and 
rewarming) did not meet the a priori criteria. The CV % for each of these variables 
were repeatable, reflecting almost “perfect” repeatability for baseline Tsk (i.e. CV % 
= 0.3 %). Despite this, the ICC values appear to reflect little repeatability. The ICC 
value relates the measurement error to the variability between study objects (e.g. 
participants) (de Vet et al. 2006). If the measurement error is small, relative to the 
variability between participants, the ICC value approaches 1 (i.e. discrimination 
between individuals is hardly affected by measurement error). However, if the 
measurement error equals the between participant error the ICC will be 0.5. In the 
present study, as the variability (between participants) was small for baseline Tsk 
and starting water temperature, change in water temperature and time spent 
during each period between participants, it appears this impacted on the ICC 
values. This highlights the importance of using more than one technique to 
“measure” repeatability; specifically utilising both an absolute (CV %) and relative 
(ICC) measure of repeatability is important. 
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As assessors were able to consistently identify the points of the VT but not always 
agree with other assessors, the data were considered subsequently with all 
assessors present. Only one criterion for onset of vasoconstriction was identified 
as repeatable, with no release of vasoconstriction criteria meeting the preferable 
limits. Criterion A was not repeatedly identified possibly due to the large variability 
in SkBF at glabrous skin sites. SkBF changes over a small range of Tsk (33 °C to 
35 °C) aim to balance body temperature within a “null zone” or “vasomotor zone” 
(Savage and Brengelmann 1996; Brengelmann and Savage 1997). In the present 
study, large finger SkBF fluctuations at local Tsk of 35 °C to 25 °C were observed 
in all participants. From this, it appears that the variable SkBF between these Tsk 
does not provide an adequate point for identifying vasoconstriction. Contrary to 
this, when finger Tsk was below 25 °C, there appeared to be a shift to a strong and 
sustained vasoconstriction (Figure 12.2). This has been noted previously in the 
finger pad during whole-body cooling (Elstad et al. 2014). 
 
Vasoconstriction involves several intact systems working together (see Review of 
Literature, page 36) ; an initial phase mediated by sympathetic activation and a 
prolonged phase (> 10 minutes) mediated by adrenergic, non-adrenergic, non-
neural mechanisms and NOS inhibition (Johnson et al. 2005; Hodges et al. 2006; 
Thompson-Torgerson et al. 2007). Criterion B appears to be in this secondary 
prolonged phase of vasoconstriction. Although Criterion B appears to fit into the 
later stages of vasoconstriction, glabrous skin sites, as investigated in this study, 
appear to be under a different control compared with non-glabrous skin sites. 
Similar to non-glabrous skin, blockade of pre-synaptic release of adrenergic 
neurotransmitters (with bretylium) during local cooling of the ventral hand was not 
successful in abolishing the local cold induced vasoconstriction (Kingma et al. 
2010). The mechanism that stimulates the remaining vasoconstrictor response in 
glabrous skin can only be speculated. 
 
Criterion E, identifying the release of vasoconstriction, was outside the limits of 
repeatability. The reason for this is unclear and may be multi-factorial. Given that 
sensory contributions from the skin are involved in the control of SkBF during local 
cooling and warming (Minson et al. 2001; Johnson et al. 2005; Hodges et al. 2007) 
it is possible that differences in thermal sensation and thermal comfort may have 
influenced VT between visits.  
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Another source of variation in the present study may relate to the method used to 
measure SkBF. There is large SkBF variability between skin sites, even in close 
proximity, which appears to be due, in part, to the ascending arterioles spaced 
~1.5 mm to 1.7 mm apart; therefore, the laser Doppler probe may potentially 
“miss” high flow regions causing variability between skin sites (Braverman et al. 
1990). Additionally, in a resting individual, SkBF measured using LDF at the same 
skin site varies greatly over minutes to days (Tenland et al. 1983; Braverman and 
Schechner 1991). In line with this, as the blood perfusing through AVAs is 
measured by the laser Doppler probe, and given that AVAs are particularly 
variable (Grant 1930; Lewis 1930; Grant and Bland 1931; Elstad et al. 2014; 
Flavahan 2015) this may account, in part, for why particular criteria were not 
repeatable. That is, if placement of the laser Doppler probe on one testing session 
was outside of the "viewing window" of AVAs and / or descending arterioles then 
SkBF for that visit may differ from other visits. Whilst attempts were made to 
position the probe at the same place between visits, SkBF expressed as LDU at 
baseline was not repeatable, thereby supporting the argument that the laser 
Doppler probe was positioned over different vascular beds between visits. 
 
In conclusion, the results demonstrate that gradual cooling and subsequent 
rewarming water produces repeatable changes in finger Tsk that result in a 
threshold for the onset of maximal, or near maximal, vasoconstriction during 
cooling that can be repeatedly identified. However, the threshold for the release of 
this vasoconstriction during subsequent rewarming was not within the a priori 
criteria. Put in to context, the utilisation of the onset of maximal, or near maximal, 
vasoconstriction may be a useful and repeatable methodological approach for 
those interested in profiling vasoconstrictor sensitivity between-groups or even 
within-individuals following an intervention. Therefore, in Study One where the 
responses to various cooing protocols were investigated between ethnic groups, 
Criterion B was used to identify the onset of vasoconstriction, and despite Criterion 
E falling slightly outside the a priori criteria this method was used to identify the 
release of vasoconstriction.  
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13 Annex 2 - Favourable Ethical Opinion for Study One 
 
  
 
 
 
 
 
Dr Martin Barwood 
Department of Sport & Exercise Science 
University of Portsmouth 
Spinnaker Building 
Cambridge Road 
PORTSMOUTH 
PO1 2ER 
Department of Sport & Exercise Science 
University of Portsmouth 
Spinnaker Building 
Cambridge Road 
PORTSMOUTH 
PO1 2ER 
 
T: 023 9284 3545 
F: 023 9284 3620 
martin.barwood@port.ac.uk 
 
6th September 2012
 
ETHICAL APPROVAL – BSREC 12/070 
 
Protocol Title: A comparison of the vascular responses to cold challenges in Caucasian, 
African Amercican and Asian individuals. 
Date Submitted: 15th August 2012 
 
Dear Mr Maley, 
 
Thank you for submitting your protocol for ethical review. As all elements of the protocol 
adhere to the Schedule of Approved Procedures the protocol has been reviewed by the 
undersigned in accordance with current procedures1 on behalf of the BioSciences 
Research Ethics Committee. 
 
The Committee is happy to approve your application under Approval Code BSREC 
12/070. 
 
 
 
 
 
 
 
 
Dr Martin Barwood 
Member of the BioSciences Research Ethics Committee 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
The Schedule of Approved Procedures (Annex C to Procedures for Ethical Review). Biosciences Research 
Ethics Committee, University of Portsmouth, January 2011). 
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14 Annex 3 - Favourable Ethical Opinion for Study Two 
 
  
 
 
 
 
Mr Matt Maley 
Department of Sport & Exercise Science 
University of Portsmouth 
Spinnaker Building 
Cambridge Road 
PORTSMOUTH 
PO1 2ER 
Science Faculty Ethics Committee 
Department of Sport & Exercise Science 
University of Portsmouth 
Spinnaker Building 
Cambridge Road 
PORTSMOUTH 
PO1 2ER 
 
T: 023 9284 5170 
F: 023 9284 3620 
matt.dicks@port.ac.uk 
 
11th October 2013
 
Dear Matt 
 
FAVOURABLE OPINION 
 
Protocol Title:        A comparison of the vascular responses to locally applied vasoactive 
agents between Caucasian and African or Caribbean individuals. 
Date Submitted:    10th October 2013 
 
 
 
Thank you for resubmitting your protocol for ethical review and for the clarifications 
provided. 
 
Your responses have been reviewed and I am pleased to inform you that your application 
has been given a favourable opinion by the Science Faculty Ethics Committee (SFEC). 
 
Please notify us in the future of any substantial amendments that may be required. 
Please also submit a final study report / publication in due course. 
Good luck with the study. 
 
 
 
 
 
 
 
Dr Matt Dicks 
Member Science Faculty Ethics Committee 
 
 
 
Information: 
 
Dr Chris Markham – Chair of SFEC Dr 
Jim House – Vice Chair of SFEC Holly 
Shawyer – Faculty Administrator 
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15 Annex 4 - Favourable Ethical Opinion for Study Three and Study Four 
 
 
  
 
 
 
 
 
 
 
 
 
 
Faculty of Science 
University of Portsmouth 
St Michael’s Building 
White Swan Road 
PORTSMOUTH 
PO1 2DT 
 
Date 30/07/2014 
 
FAVOURABLE OPINION 
 
Protocol Title: SFEC 2014 – 050, Skin blood flow responses to locally applied acetylcholine and 
extremity immersion in cold water in Caucasian and African descent individuals 
with and without cyclooxygenase activity.   
Date Reviewed: 28th July 2014 
 
Dear Matthew,  
 
Thank you for resubmitting your protocol for ethical review and for the clarifications provided.  
 
Your responses have been reviewed and I am pleased to inform you that your application has been given a 
favourable opinion by the Science Faculty Ethics Committee.  Please notify us in the future of any 
substantial amendments that may be required and send us a final study report. 
 
 
Good luck with the study. 
 
 
 
 
 
 
Chris Markham  
(Dept) Science Faculty Ethics Committee 
 
 
CC -  
Dr Chris Markham – Chair of SFEC 
Dr Jim House – Vice Chair of SFEC 
Holly Shawyer – Faculty Administrator 
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16 Annex 4 - Favourable Ethical Opinion for Annex (Repeatability) Study 
 
 
 
 
 
 
 
Dr Martin Barwood 
Department of Sport & Exercise Science 
University of Portsmouth 
Spinnaker Building 
Cambridge Road 
PORTSMOUTH 
PO1 2ER 
Department of Sport & Exercise Science 
University of Portsmouth 
Spinnaker Building 
Cambridge Road 
PORTSMOUTH 
PO1 2ER 
 
T: 023 9284 3545 
F: 023 9284 3620 
martin.barwood@port.ac.uk 
 
11th September 2012
 
ETHICAL APPROVAL – BSREC 12/071 
 
Protocol Title: An evaluation of the reproducibility of a test of hand and forearm 
vasomotion 
Date Submitted: 16th August 2012 (1st submission) 
 
Dear Mr Maley, 
 
Thank you for submitting your protocol for ethical review. As all elements of the protocol 
adhere to the Schedule of Approved Procedures the protocol has been reviewed by the 
undersigned in accordance with current procedures1 on behalf of the BioSciences 
Research Ethics Committee. 
 
The Committee is happy to approve your application under Approval Code BSREC 
12/071. 
 
 
 
 
 
 
 
 
Dr Martin Barwood 
Member of the BioSciences Research Ethics Committee 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
The Schedule of Approved Procedures (Annex C to Procedures for Ethical Review). Biosciences Research 
Ethics Committee, University of Portsmouth, January 2011). 
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